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Abstract
A growing range of artificial cell-mimicking compartments (e.g., liposomes) have been
demonstrated as technological platforms for applications ranging from model systems
in bottom-up cell biology to miniature chemical reactors. Here, I describe work on
developing a liposomal compartment for capturing light-energy. The harvesting of light
energy starts at a photoactive centre, where light-excited electrons are generated and
then transferred to an electron acceptor. The efficiency of this electron transfer is often
limited due to charge recombination (i.e., re-assembly of photo-separated electrons and
electron holes) within the photoactive chromophore. Inspired by natural photosynthesis,
this study envisions a strategy to limit charge recombination by rapid transfer of the light-
excited electrons away from the photoactive molecules (dye-sensitized TiO2 nanoparticles
or carbon dots) and across the liposome membrane via conductive transmembrane protein
complex MtrCAB from Shewanella oneidensis MR-1. Furthermore, such compartment
enables localisation of the oxidation and reduction processes in separate environments.
The assembly of the envisioned compartment begins with a study of the molecular
interface between TiO2 nanoparticles, a commonly used material for photocatalysis
studies, and the MtrC(AB) conduit. This interface is mapped using an approach called
protein footprinting, which involves protein labelling and subsequent analysis of the
modified peptides by mass spectrometry. Understanding the molecular interactions at
this bio-inorganic interface is crucial for engineering electronic communication between
these materials. Then, a proof of concept is demonstrated of a half-reaction: light energy
capture, charge separation across the membrane and use of the energy to drive a chemical
reaction. Transmembrane electron transfer is achieved chemically and photochemically
using dye sensitized TiO2 nanoparticles or carbon dots located outside the liposomes.
The electron transfer through MtrCAB conduit is confirmed optically by monitoring
the destructive reduction of an encapsulated azo-dye Reactive Red 120. Finally, work
on encapsulation of fuel evolving catalysts (i.e., hydrogen producing Pt nanoparticles
and a hydrogenase HydA1) within the lipid-enclosed compartment (i.e., liposome lumen
and porous silica support) is discussed alongside the challenges for combining different
materials within ordered structures.
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1Chapter 1
Introduction
1.1 Bio-inspired compartments
Many crucial cell functions rely on a border separating compartments with different
environments. Above all, the cell membrane sets the boundaries of a cell and regulates the
transport of molecules in and out of the cell, thus creating and controlling the asymmetry
between cytoplasm and the external medium. Furthermore, cells have evolved the use
of compartments for optimal organization of simultaneous yet incompatible metabolic
processes. [1, 2] For example, various protein compartments are used to assist in protein
folding by providing a shielded hydrophobic environment (chaperones, see example in
Figure 1.1a) [3] or storing and transporting minerals (ferritins, Figure 1.1b). [4] Similarly,
organelles provide membrane-bound specialist environments for functions ranging from
biomolecule degradation and recycling to energy assimilation and respiration. For
example, lysosomes contain enzymes for cleaning-up the cell from obsolete nucleic acids,
proteins, polysaccharides and material taken up for digestion from outside the cell (see
Figure 1.1c). [5] The lysosomal membrane separates cell cytoplasm from the acidic
pH environment maintained within lysosomes, optimal for the function of hydrolytic
enzymes, and also stores these harmful enzymes shielded from the rest of the cell. [6]
Compartments also allow the regulation and increase of local enzyme and substrate
concentrations, thus optimizing conditions for successful reactions. [7] Finally, lipid
membranes and the formation of ion gradients across them are fundamental to energy
accumulation and storage in cells. [8]
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a)    Chaperone b)   Ferritin
c)   Lysosomes
1.2 nm 0.65 nm
4 ± 3 μm
Figure 1.1: Examples of various natural compartments present within cells. (a) A cartoon
depiction of a chaperone protein MjHSP16.5 belonging to the class of small heat-shock protein.
The interior is viewed along the crystallographic three-fold axis (left) and four-fold axis (right).
Different colours represent individual HSP 16.5 tetramers. Panel modified after ref. [9]. (b) A
cartoon of the exterior surface and interior cavity of human heavy-chain ferritin (HFn). Figure
panel modified after reference [10]. (c) An electronmicroscopy image of lysosomes reprined
from [11] (left) and a schematic showing how lysosomes fuse with vesicles containing material
(e.g., old mitochondiron andd engulfed bacterium) to be digested (schematic modified after [5].)
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Appreciation of the variety of roles membranes and compartments take in natural cells can
also create curiosity of how similar cell-like compartments could be made artificially and
what technological novelties these could bring. Over the years, much effort has been made
to mimic biological compartments using a variety of available materials and methods,
ranging from natural lipids to synthetic polymers. [12, 13] Applications including drug
delivery, chemical microreactors and artificial cell model systems have been demonstrated
and a variety of methods used to tailor these compartments for their potential use have
been proposed. [2, 7, 14]
Artificial compartments can be created from a variety of materials including lipids,
synthetic block copolymers, polyelectrolytes and proteins. [14, 15] The chosen material
determines the chemical properties of the intended capsule and available methods for
its formation. In particular, whether self-assembly or directed assembly could be used.
Nevertheless, capsule size and shape, as well as the distribution of thereof within a sample,
depends mainly on the preparation method used. For example, amphiphilic molecules
like phospholipids self-assemble into various architectures within a solution. Meanwhile
capsule formation from other materials (e.g., polyelectrolytes) might require surfaces for
deposition (e.g., layer-by-layer assembly). [2]
The field of micro-compartmentalization has greatly increased in scope over the years.
Thus this chapter will only introduce a selection of topics concerning compartment
assembly, materials and concepts relevant for constructing an artificial compartment able
to capture solar energy. However, the reader is provided with a selection of excellent
reviews on liposome engineering and biomedical applications [13, 15–18], polymer
and layer-by-layer capsules and their adaptation for different purposes [14, 19–24],
multicompartments [6, 7, 25–27], compartment use as biomimetic model systems [1, 28]
and biomimetic membrane use for sensor construction [29].
This chapter starts by describing self-assembly principles that underlay the formation
of liposomes. Introduced later will be a few examples of the applications of liposome
compartments. Next the motivation behind using liposomal compartments for solar
energy capture is provided, followed by an introduction to some of the key materials used
throughout this thesis. The chapter concludes with an overview of the work described in
the following chapters.
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1.2 Compartments created via self-assembly.
Most self-assembled structures are built from amphiphilic building blocks that contain
hydrophilic and hydrophobic moieties. The dual nature of amphiphilic molecules causes
them to self-organize in order to bury their hydrophobic chains while positioning their
polar groups towards the surrounding aqueous medium. [15] This process has been
used to create vesicles (originating from vesicula, small bubble, in the Latin) from
biological membrane-forming lipids called liposomes. [15] Amphiphile self-assembly
can also be applied to a range of other non-lipid molecules, such as polymersomes
formed by amphiphilic block copolymers (where copolymer consists of hydrophobic and
hydrophilic blocks) [15], dendrosomes assembled from amphiphilic branched polymers
called Janus dendrimers [30], and amphiphilic polypeptide compartments, which are
composed of hydrophobic (e.g., poly-leucine) and charged (e.g., poly-lysine) amino acid
residues [1, 31–33].
Figure 1.2: Schematic depiction of the variety of amphiphilic building blocks and types
of capsules they can form. Hydrophilic and hydrophobic entities are coloured blue and red,
respectively. Cartoon is not to scale.
Figure 1.2 illustrates some of the building blocks used to form self-assembled capsules.
The parallel self-orientation of amphiphilic building-blocks, required for capsule
formation, can also be achieved by other molecular interactions such as ligand binding,
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hydrogen bonding, charge interaction (e.g., poly-ion complexes termed PICsomes [34]),
dipolar assembly or molecular complementarity (e.g., DNA binding motifs). [15] This
illustrates the flexibility in the range of materials and self-assembly interactions available
for microcompartment construction.
Spherical micelles
p  < 1/3
v
a
l
Cylindrical micelles
1/3 < p < 1/2
Flexible bilayers,
Vesicles
1/2 < p < 1
Planar bilayers
p = 1
Inverted micelles
(hexagonal phase)
p > 1
Figure 1.3: Different assembled structures predicted from the shape of the amphiphilic
molecule using the packing parameter P. v is the volume of hydrophobic moiety, a - the
interfacial area, l - length normal to the interface. Figure reproduced from ref. [35].
Amphiphilic molecules self-organize within aqueous solutions and form various
structures such as micelles, planar lamellae, closed bilayer vesicles and even hexagonal
and cubic structures of liquid crystal phase lipids. [17] The shape of the resulting structure
is commonly described to depend on the geometry of the individual amphiphilic molecule.
[15] This is conveniently illustrated by the surfactant packing parameter (p) defined as
p  
v
a  l
,
where v is the volume of hydrophobic moiety, a - the interfacial area, l - length normal to
the interface (see Figure 1.3). [15] The packing parameter is related to the curvature of a
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vesicle and can be used to predict the aggregation structure within the solution. [15] Thus,
for p  13 amphiphiles will assemble into a spherical micelle, whereas for p  1 a molecular
bilayer will be formed. [15] However, in practice the assembled end-structure depends
on interactions between a variety of thermodynamic, biophysical and solution properties
such as surfactant concentration, ionic strength and the preparation method. [15–18]
1.2.1 Liposomes
As biological cell membranes are built of phospholipids, lipids have been extensively
studied since the mid-1960s. [17, 36] Hence, comprehensive knowledge has been
accumulated on their biological, chemical and structural properties as well as their
handling and synthesis. [17, 36, 37] Amongst the self-assembled structures mentioned
above, lipid vesicles (liposomes) can be regarded as the simplest and most studied
compartment systems that consist of an internal volume enclosed by self-assembled
lipid double-layer. [2] Over the years, many different methods for liposome preparation
have been reported. These are generally based on sonication, liposome extrusion, and
removal of solvent or detergent. [36, 38] Thus liposome fabrication and functionalization
(e.g., by using chemically-modified lipids or membrane proteins) are well established
processes. [2, 36] The advantages of liposomes are their fundamental biocompatibility
and biodegradability resulting in low toxicity and immunogenicity – properties that make
liposomes extremely attractive for pharmaceutical applications such as drug delivery. [13]
Although traditional liposome preparations are simple, their content is generally formed
during lipid self-assembly by the random enclosure of surrounding media. [36] Therefore
liposome size and content within a sample may vary. One example of a reproducible
generation of liposomes with uniform size has been demonstrated by Takeuchi and
colleagues (Figure 1.4). [39] They used a microfluidic device to deposit a lipid bilayer
within a micrometre-scale well that is connected to the main microfluidic channel with a
continuous fluid stream. Subsequent formation of a gas bubble within a narrow channel
at the bottom of the well pushes the lipid membrane up into the main channel, where
the membrane gets sheared off by the fluid flow. The diameter of liposomes created by
this method varied around 16-17 µm, [39] which is large for biomedical applications,
where the size governs particle distribution in vivo to different organs. [15] Yet, it might
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Figure 1.4: An example of a microfluidic process for liposome formation. a) The microfluidic
device consists of a main channel with many micro-chambers within its walls. At first the device is
infused in a step-wise manner with water, oil containing dissolved lipids and water. b) Water fills
the device and simulteneously pushes air out of the channel. c) Oil displaces water from the main
channel. The remaining water is confined within the chambers. d) Water is then used to again flush
out the oil. Remaining oil residue form an oil film in which amphiphilic lipid molecules form two
monolayers at the interface of water and oil. e - g) Schematic illustration of the vesicle formation.
e) A cross flow from below the main compartment thins the lipid film and drives the contact of
monolayers to form a bilayer. f) The bilayers are then further bent by a gentle outward flow. g)
The continuous fluid stream within the main chamber create shear forcer that lead to the fission
of the ’budding’ bilayer, creating a unilamellar vesicle. h) The aqueous cross-flow is controlled
using integrated system for optical generation of a microbubble. Figure reproduced from ref. [39].
be possible to tune the size of liposomes by adapting the dimensions of the microfluidic
device and the applied flow rate. [39]
Besides size, limitations that impede liposome experimental analysis and practical use
is the lack of control over liposome lifespan, due to their mechanical and chemical
instability. [14] Several strategies have been proposed to improve the structural integrity
of liposomes and reduce the leakage of encapsulated content. For example, chemically
modified lipids have been used to coat liposomes with inert hydrophilic polymers like
PEG. [17] Such coatings extend liposome circulation lifetime in vivo [40] by providing a
barrier between the lipids and serum lipases and other proteins that can disrupt the lipid
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membrane. [17] In addition, ’PEGylation’ reduces liposome aggregation, thus reducing
activation of immune response for biomedical applications. [41] However, increasing
the PEG content above a critical point can destabilize lipid self-assembly, changing the
liposome structure or increasing content leakage. [41]
1.3 Liposome applications
As introduced earlier, liposomes have been studied since the mid-1960s. [17, 36]. Since
then, different liposome-based systems have been tested for a range of applications. First
of all, as all microcompartments liposomes contain an internal space that is shielded from
the surrounding environment and may thus be made chemically distinct. This can then
be utilised to make liposomes a storage vessel for different loads, ranging from small
compounds (e.g., drugs, dyes, vitamins, flavours) and gas bubbles to larger assemblies
such as proteins, DNA and nanoparticles. [13, 17, 28, 35, 42]
The idea of using capsules as drug delivery vehicles within the body has been around
since the demonstration of the first liposomes in the1960s, while the first liposomes
loaded with cancer chemotherapeutic doxorubicin were approved in the1990s. [36,41,43]
Liposomes as pharmaceutical agents have many benefits. Firstly, they provide packaging
that maintains a compound-favourable environment, e.g., hydrophilic interior for water
soluble doxorubicin and hydrophobic lipid layer for hydrophobic drugs like anti-fungal
amphotericin B. [41] Liposomes also provide protection from premature degradation of
the encapsulated drugs from, for instance, serum enzymes. [41] Secondly, drug release
can be engineered to occur at the target site, which increases local drug concentration
and optimises drug biodistribution and pharmacokinetics within the body. [41] This, in
turn, allows reduction of drug dosage, which lowers risk of immunogenicity and side-
effects. [41]
Liposomes can be used to encapsulate other cargo, such as enzymes and their substrates
[44], which allows performing such reactions as PCR in liposomes. [42]. These
demonstrations have helped to develop uses of synthetic microcontainers as chemical
micro- or nanoreactors (previously referred as synthosomes). [45] These are often made
from block co-polymers as the resulting capsules are more cost-effective and durable
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than liposomes. [45] This approach of compartmentalizing reactions has benefits when an
enzyme needs to be protected from surrounding proteases. [22] However, microreactors
often need to overcome the limitation of small volumes in which substrate concentration
can rapidly run low or an accumulation of product can inhibit the reaction. [22] A possible
solution comes from functionalization of the compartment shell, e.g., by engineering its
permeability or reconstituting substrate importing membrane proteins to allow substrate
and product exchange with the surrounding medium. [45]
Another set of interesting applications emerge when liposomes are engineered to act as
artificial model-systems for biological membranes, or even cells. [46] Thus liposomes can
be used to study membrane properties, interactions between membrane lipids, proteins
and membrane supporting structures like cytoskeleton (e.g., use supported liposomes or
observe tubulin polymerisation within the liposome) as well as changes in membrane
permeability and responsiveness to internal and external stimuli. [28, 46, 47] In addition,
compartment-confined chemical reactions can be used to mimic cell metabolism (e.g.,
enzyme reactions, sugar synthesis, DNA replication), thus providing a very interesting
platform to study metabolic reaction dynamics and feed-back loops linking different
reactions. [28, 48] For example, an artificial cell-like gene expression system was
constructed to analyse fluctuations of gene expression present, even in clonal cell
populations. [49] A cell-size liposome was loaded with an in vitro transcription and
translation system and a plasmid containing genes for two fluorescent proteins (e.g., blue
and yellow) using the emulsion assembly method. The gene expression was assessed
by monitoring the fluorescence of these synthesized proteins. Detected fluctuation of
gene expression agreed well with a theoretical model of interactions between substrates,
intermediate molecules and products.
Liposomes can also be used to explore biological processes associated with lipid
membranes and membrane proteins such as energy storage and transformation across
the membrane. Biological systems store solar or chemical energy, generated in
photosynthesis and catabolism reactions respectively, in the form of transmembrane
proton gradients, which is then utilised by the transmembrane ATP-synthase to synthesize
the cellular energy ‘currency’ adenosine triphosphate (ATP). [50] Several groups have
reported the reconstitution of functional ATPase in liposomes [51] and later also in
other synthetic compartments [52, 53]. Furthermore, molecular systems establishing
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a light-driven proton gradient across the membrane, have also been introduced in
liposomes and polymersomes. [52, 54] These systems present artificial photosynthesis
strategies, where light energy is captured by membrane-integrated artificial light-
harvesting antennas [54] or bacterial light-responsive proton pump bacteriorhodopsin
and converted to chemical energy in the form of ATP. [52] In a different approach,
light energy is used to reduce NAD to NADH by encapsulated TiO2 nanoparticles.
[55] Liposomes containing TiO2 nanoparticles were illuminated with a UV light. The
energised electrons were then transferred from TiO2 nanoparticles to NAD by a
mediator, Rh(bipyridine)33 . Generation of the reduced NADH was then confirmed
spectroscopically and enzymatically. Thus light-energy was harvested within a
compartment. These approaches demonstrate synergistic use of different materials to
explore different aspects and strategies of energy transformation.
The work summarised within this PhD thesis uses nanocompartment architecture for
synergic assembly of different materials. In particular, coupling of light-harvesting
inorganic nanoparticles to a conductive membrane-spanning protein is explored in order
to channel light energy insidde the compartment. There this energy could be used to drive
such reductive chemical reactions as fuel synthesis, and demonstrate proof-of-concept
compartment for artificial photo-synthetic nano-reactor. Such compartments can be
used as bottom-up models exploring molecular arrangments for artificial photosynthesis
reactions as well as potential ways to couple microorganisms with light harvesting
nanoparticles or electrodes.
1.4 Motivation: bio-inspired liposomal compartments
for solar energy capture
The conversion of light energy into other forms of energy (e.g., electricity or chemical
bonds) typically requires several steps. [56–58] Capture of light energy starts by initial
light absorption at a chromophore. This absorbed energy is used to excite an electron to
higher energy levels and the energised electron can then be transferred to an electron
acceptor (e.g., electrode for electricity or a chemical catalyst for fuel production)
(Figure 1.5 a).
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Figure 1.5: Overview of light-harvesting and the required electron transfer steps. a) Light
energy is absorbed at the light-active centre and is used to excite an electron. The energised
electron is then transferred to the electron acceptor, which in this case is a catalyst reducing
hydrogen ions into gaseous hydrogen. b) Schematic of possible pathways of electron flow during
light-harvesting. Light energy is used to eject an electron from the Light-active centre (Path II).
The high energy electron then travels through electron mediator to an electron acceptor via Paths
III and IV. The hole at the light-active centre is subsequently filled by electron donor (Path I). The
dashed lines indicate that energised electrons can also be quenched and fall back to the ground
state without leading to completed energy conversion. Figure b) adapted from [59].
For a thermodynamically favourable reaction, electrons are transferred along the energy
gradient from compounds with more negative reduction-oxidation (redox) potential to
compounds with more positive redox potential. [59] Thus for successful electron transfer
the energy levels (i.e., reduction potentials) of the excited chromophore (light active
centre), the electron acceptor and any intermediate agents (i.e., electron mediators)
are required to be suitably placed along the energy gradient. [57, 59] This is shown
in Figure 1.5 b, where pathways of electron flow associated with light absorption are
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mapped. Despite global research efforts that are continuously advancing strategies
for harnessing solar energy into sustainable electricity, solar fuels and solar chemicals
[60–62], the light harvesting stage, i.e., photo-induced charge separation and electron
(or hole) transfer to electrode or catalyst, remains the principal efficiency limiting
step in the proposed strategies. [62] This is primarily due to back-electron transfer
and charge recombination (see the dashed lines in Figure 1.5 b). [57, 59] In contrast,
biological photosynthesis is able to achieve near-unity charge separation [56] and resist
the unfavourable charge recombination by rapid spatial charge separation along an
electron transport chain embedded in photosynthetic membranes. [63–65]
The stunning efficiency of biological light-harvesting systems results from a very precise
and sophisticated arrangement of photosynthetic components (organic photosensitizers,
protein co-factors and electron mediators, redox biocatalysts), which are optimized in
the dimensions of space (relative location of components), energy (light-excited state and
redox properties) and kinetics (rates of competing processes). [56,66] The composition of
biological photosynthetic assemblies allows efficient photon absorption at light harvesting
antennae, which is then passed along series of chromophores to the reaction centres (e.g.,
plant photosystems PSI and PSII), where this energy is used for electron excitation and
water oxidation. [50] The excited electrons are then relayed along an electron transfer
chain and ultimately stored as a transmembrane proton gradient and reduced redox-active
molecules such as NADPH (Figure 1.6 a). [58]
Such features as near-unity quantum yield (defined as photon absorbtion leading to the
formation of the charge-separated state despite competition between forward and back
processes [56]) and environmentally friendly operation put biological light-harvesting
systems above any other known system. [58] Hence, there is a lot of interest in directly
exploiting natural or genetically modified organisms [62, 68–71] or their components for
energy harvesting in artificial bio-hybrid systems. [72] Natural photosensitisers (PS) such
as photosystem I, photosystem II and whole plant thylakoid membranes have been directly
coupled to electrodes and inorganic catalysts in various photosynthetic devices to directly
produce electricity, fuel (e.g., molecular hydrogen) or evolve oxygen. [72–78] However,
light-induced damage and degradation limits the use of pigment-protein complexes,
isolated away from their natural repair mechanisms in their native environment (e.g.,
the half-life of photoanodes containing isolated photosystem II is 20 min [79]). [72, 80]
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Figure 1.6: Schematic of light-driven electron transfer across the lipid membrane in nature
(a), in the envisioned compartmentalised bio-mimicking system (b), and as presented in
chapter 4(c). a) Photosystems I and II (PSI, PSII) are photo-excited and electrons are transferred
via several electron acceptors across the membrane, where they are ultimately used for CO2
conversion into complex sugars. b) External electrons are supplied photo-chemically from a
light-harvesting nanoparticle (LHNP), which is regenerated by a water-oxidising catalyst (CAT).
Electrons are relayed across the membrane to a catalyst leading to fuel generation within the
compartment. c) Electron transfer across the lipid bilayer is ensured via transmembrane protein
complex MtrCAB and monitored following reductive bleaching of an internalised red azo dye,
Reactive Red 120 (RR120). SED – sacrificial electron donor. Figure adapted from [67].
An alternative approach is to mimic these natural systems using synthetic materials
by devising and interfacing synthetic analogues of natural photosynthetic components:
light harvesting antennae, reaction centres for charge separation, electron mediators,
redox catalysts, electron donors and a supporting membrane to arrange components and
physically separate the products. [56, 58] Reported systems include coupling of light-
harvesting PS (e.g., porphyrins, quantum dots) with various conductive materials ranging
from graphene to peptide nanotubes to semi-conductor nanoparticles, fuel producing
enzymes and electron mediators to regenerate cofactors for redox enzymes. [58, 81]
Synthetic materials generally have longer lifespan. Thus the lifetime of a system
consisting of dye-sensitised TiO2 coupled with H2 generating cobalt catalyst was limited
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by the stability of the cobalt catalyst after 4 hours of illuminations and not the TiO2
photosensitiser. [82] Efforts are also made to explore the effects of photosynthetic
component spatial organisation by mimicking such natural systems as stacked plant
thylakoid membranes [83] and chlorosomes of green sulfur bacteria [84].
The work described within this thesis aims to construct compartments mimicking another
aspect of plant photosynthesis, i.e., the use of a lipid membrane to arrange and spatially
separate photosynthetic components between the different environments of thylakoid
lumen and stroma (Figure 1.6 a). [50] Specifically, the objective is to spatially separate
photo-oxidation and reduction reactions in the external and internal space of liposome
compartments, respectively (Figure 1.6 b). Thus, the envisioned system combines several
processes: 1) generation of light-excited electrons on the outside of liposomes, 2)
transmembrane electron transfer, 3) storage of the excited electrons within chemical bonds
within the liposome compartment and 4) regeneration of light-harvesting nanoparticles
(LHNP). Thus use of liposomes provide means to direct spatial distribution of the involved
molecules. Furthermore, these reactions occur at the liposome membrane (i.e., inner and
outer surface), thus in order to achieve more effective surface to volume ratio, focus is
placed to utilise liposomes within the sub-micro scale.
1.5 Components required for the intended liposome
compartment
The intended light-harvesting system involves assembly of suitable molecular
components able to work together and perform the various tasks required for light energy
harvest. These are:
• light-harvesting nanoparticles (LHNP) - to generate light-excited electrons on the
outside of the liposome;
• electron conduit - to facilitate transmembrane electron transfer;
• reduction catalyst - to chemically store the excited electrons within the liposome
compartment;
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• oxidation catalyst or sacrificial electron donor (SED) - to regenerate the LHNPs;
• lipid membrane - to act as scaffolding and barrier, forming the compartment and
separating the internal and external environment.
The next few sections will briefly introduce the components selected acros the space
of biological and chemically synthesized materials. Many of the decisions concerning
material selection were taken building on the previous work within the Jeuken group by
Dr Ee Taek Hwang (see reference [63]) and the collaboration with Dr Emma Ainsworth
from the University of East Anglia (for more information see the doctoral thesis at
reference [85]).
1.5.1 Light-harvesting nanoparticles and SED
Synthetic LHNPs were chosen over their natural equivalents (e.g., plant photosystems I
and II) because they are simpler and cheaper to produce and because of their stability
and chemical inertness. [59, 86, 87] Many of the compounds used within the field of
artificial photosynthesis have been adopted from material development for solar panels,
more specifically, dye-sensitised solar panel research. [57] Here, a molecular dye is
absorbed onto a semi-conductor material, thus electrons from the photoexcited dye are
injected into the conductive band of the semi-conductor (e.g., TiO2), which accumulate
and transport multiple charge carriers to the electrode forming electric current. [57] This
principle has been further explored in the field of solar fuels, where molecular dye and
fuel-generating catalyst can be co-absorbed onto nanoparticles made of semiconducting
materials such as TiO2 NPs. [57] In this case the semiconducting particle functions
both as a scaffold and as a solid-state electron mediator. [57] Figure 1.7 summarises
some of the chromophores typically used for light absorption ranging from metal-
based dyes, such as ruthenium poly-pyridine complexes (e.g. [Ru(2,20-bipyridine)3]2
derivatives (Figure 1.7a), porphyrins (Figure 1.7b), and organic dyes, such as Eosin-
Y, donor–p–acceptor structures and chalcogenorhodamine dyes (Figure 1.7c–e). [57] In
addition to these, carbon based nanoparticles such as carbon nitride and carbon dots have
also been explored. [57]
The work described in this thesis tested and compared three LHNPs for solar energy
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Figure 1.7: Chemical structures of dyes commonly used in dye-sensitised solar panel and
dye-sensitised solar fuel research: (a) ruthenium bipyridine derivatives, (b) porphyrins (Ar =
aryl groups), (c) Eosin-Y, (d) donor–p–acceptor type and (e) chalcogenorhodamine dyes. All dyes
are shown in their fully protonated forms. Figure republished from reference [57].
capture. These were dye-sensitised TiO2 nanoparticles and two types of carbon
dots. Dye-sensitized TiO2 nanoparticles are well-studied and are among the most
active photocatalyst materials. [59] We used TiO2 nanoparticles photosensitized with a
Ru(II)(bipyridine)3 dye in which one of the bipyridines is phosphonated in the 4,4’-
position to enhance binding to TiO2 (RuP-TiO2, see Hwang et al. [63]). Carbon
dots form another group of emerging light-absorbing nanomaterials showing remarkable
photo-stability, water solubility, low toxicity and sustainable and cost-effective synthesis
avoiding use of rare metals. [86–88] Here, we test amorphous carbon dots (a-CD) [86]
and graphitic carbon dots with core nitrogen doping (g-N-CDs) [88, 89].
The choices made on LHNPs influenced the decisions on sacrificial electron donors
(SED). SEDs are often used in photosynthesis test systems for their ability to regenerate
the oxidised LHNP and also have the role in buffering the reaction solution. [57] Thus
SEDs simplify the photo-oxidation reactions and allow to focus on developing and
optimising photo-reduction reactions (i.e., photo-electron excitation at the chromophore
and subsequent electron trasfer leading to fuel generation). [57] Commonly used
SEDs include tertiary amines (e.g., triethanolamine, ethylenediaminetetraacetic acid,
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triethylamine), alcohols, organic acids (e.g., lactic acid, ascorbic acid, formic acid, oxalic
acid) and inorganic ions such as sulfite. [57] Previous research on carbon dot photo-
activity indicated that better photo-activity of carbon dot LHNPs were achieved using
EDTA as the SED (supplementary information of references [86, 89]). Thus EDTA was
used as the SED throughout the experiments.
1.5.2 Electron conduit and the lipid membrane
In the intended photo-synthetic compartment electrons generated from the light harvesting
nanoparticles are transferred across the membrane. This is achieved using MtrCAB - a
conductive transmembrane protein found in the bacterium Shewanella oneidensis. [90]
This bacterium is able to support its anaerobic respiration by using a diverse range of
extracellular electron acceptors. These include fumarate, nitrate, trimethylamine oxide
(TMAO), dimethyl sulfoxide (DMSO), sulfite, thiosulfate, elemental sulfur and various
metal oxides (insoluble iron and manganese minerals, e.g., hematite, goethite, lepidocrite
etc.) present either as soluble complexes or solid minerals. [90–92] The electrons are
shuttled to the external minerals via outer membrane protein complexes such as MtrCAB
and the closely related MtrDEF homologs. [90] These proteins form porin-cytochrome
structures (Figure 1.8), which consist of a 20 haems assembled in a conductive molecular
’wire’ made by MtrC (or homologus MtrF, OmcA) and MtrA (or homologus MtrD,
DmsE). [90, 93, 94] This MtrC and MtrA conduit i.e., molecular ’wire’) spans the outer
membrane through a pore formed by MtrB (or homologus MtrE and DmsF) [90, 93] The
final stages of ET to these minerals are supported by MtrC (and its related homologues
MtrF and OmcA) either by direct contact with the mineral or indirectly using soluble
electron mediators as flavins. [90] Thus electrons from the periplasm of bacterium can be
transferred across the outer membrane through the haem wire of MtrA and MtrC, which
is supported within the membrne region by MtrB forming a protein pore (via structural
β-barrel motif).
Purified MtrCAB has been shown to be used within liposomes, and have been observed
to exhibit fast transmembrane electron transfer estimated as 103 – 104 electrons per
second (measured by spectroscopic reduction of encapsulated methyl viologen). [91]
In adddition, efficient electron exchange has been previously demonstrated between
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MtrCAB MtrC
MtrB is a β-barrel, where 
MtrA inserts into
Figure 1.8: A diagram of the MtrCAB protein complex. Structure of a full MtrCAB complex
from a closely related bacterium species Shewanella baltica OS185 [94] and an insert showing the
structure of MtrC from S. oneidensis MR1 (PDB ID: 4LM8). Figure modified after [94].
the soluble decahaem subunit MtrC and LHNPs, in particular, with dye-sensitised
TiO2 nanoparticles. [95–97] Thus previous research has paved way for using MtrCAB
as electron conduits for developing the light-harvest liposome compartment envisaged
within this thesis.
Although many natural and synthetic lipids and lipid mixtures can be used to form
liposomes, Escherichia coli polar lipid extract was chosen as a way to better mimic the
natural outer membrane environment of the MtrCAB. This choice was made in order to
minimise potential phospholipid-dependent changes in MtrCAB activity. [98] Escherichia
coli polar lipid extract is estimated to primarily contain phosphatidyl ethanolamine (PE)
at 70–80%, phosphatidyl glycerol (PG) at 20–25%, and cardiolipin (CL) at 5% or less.
[99, 100]
1.5.3 Fuel-generating catalyst
There are many potential reduction reactions and compounds that could be used as
proof for photocatalysis. These include H2 evolution (i.e., generation of gaseous
Chapter 1. Introduction 19
H2 from water), carbon-based conversions such as fumarate to succinate reduction or
CO2 transformation to C1 products (e.g., CO, HCOOH, CH3OH, CH4), and nitrogen
transformations like NH3 generation from N2 or reductions of N3 and NO

2 . [101–103]
Several reasons make hydrogen evolution (i.e., production of hydrogen gas from water)
attractive for the compartmentalised photocatalysis envisioned in this work. Firstly,
H2 evolution from H present in water is a relatively simple two-electron reaction:
2H  2e   H2 (E0 = - 0.41 V vs NHE at pH 7). [101] Secondly, water (i.e.,
hydrogen/hydronium ions) as a substrate is already abundant in the system. Thirdly, the
reaction product (i.e., H2 gas) is able to diffuse across the compartment lipid membrane,
thus simplifying reactant mass transport and reaction kinetics within the compartment.
And finally, hydrogen evolution aligns well with the research interests of the field of solar
fuels, where sustainable fuel generation from widely abundant and cheap raw materials
(such as water or CO2) is key. [101, 102]
Hydrogen evolving catalysts (HEC)
A variety of HECs have been reported and these can be broadly grouped as material (non-
molecular) and molecular catalysts.
In material systems, hydrogen evolution reaction (HER) catalysis occurs on the surfaces
of metals, semi-conductors and nano-structured materials. [101] Pt is long-known as
the most efficient material for HER electrocatalysis, able to evolve H2 very close to
the reaction’s equilibrium potential. [104] The superiority of Pt can be assigned to a
near zero hydrogen binding (free) energy, and an optimal hydrogen bonding strength
for facile hydrogen atom rearrangements and desorption. [105] However, the scarcity
and cost of Pt [104, 106], makes it unsuitable for the needs of current and future
industrial and photo-fuel applications. In this regard, many strategies are reported to
reduce the size of Pt nanoparticles (i.e., increase Pt surface area) [106] and to develop
other materials for HER, such as semiconductors ranging from metal oxides (TiO2,
Cu2O, WO3, Fe2O3, BiVO4) and metal sulphides (CdS, CdZnS) to chalcogenides (e.g.,
Cu(Ga,In)(S,Se)2, CuGaSe2, Cu2ZnSnS4, ZnS-AgInS2) and graphitic polymeric carbon
nitride g-C3N4. [101] The strategies used for improving HER activity include material
and surface nanostructuring to improve surface-to-volume ratio and adding interfaces
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with electron accepting materials such as graphene or carbon nanotubes, as well as
integrating co-catalysts such as Pt, RuO2, NiO, MoS2, MoS2 composites and molecular
catalysts as reviewed in [101]. Other strategies exploring photocatalytic HER also include
material and surface nanostructuring to improve charge carrier transport properties and
light absorption for photocatalysis, quantum and optical confinement. [101]
Molecular catalysts evolve hydrogen at specific catalytic sites, which usually comprise of
one or more coordinated metals. The most efficient molecular hydrogen evolving catalysts
(HEC) are hydrogenases. Hydrogenases are enzymes produced by bacteria, archea and
lower eukaryotes, which use H2 either as a source of low-potential electrons (i.e., fuel)
or as a way to eject excess electrons (i.e., evolve H2). [107] Three types of hydrogenases
are distinguished and named after the metal composition in their active sites. [107, 108]
These are [FeFe]- and [NiFe]- hydrogenases reversibly oxidising H2 at their bimetallic
centers coordinated by CO and cyanide ligands, and [Fe]-hydrogenases able only to split
H2 at a mononuclear iron-carbonyl centre. [107, 108] Most hydrogenases require only a
minimal overpotential for H interconversion into H2 and demonstrate superiority over
Pt in terms of single-site catalytic activity. [57, 107, 109] Unfortunately, the practical use
of hydrogenases is limited due to their sensitivity to oxygen, instability, and the labour
required for their isolation and purification. [57, 107, 108]
The exceptional activity of hydrogenases have inspired development of synthetic
compounds mimicking features of the enzyme active centres. These efforts have also
contributed to the development of synthetic earth-abundant metal complexes as catalysts
for HER. Among the reported synthetic molecular catalysts are a few examples of Fe-,
Mn-, Cu- and Mo- based complexes, as well as the more commonly used Co-based
(e.g., cobaloxime catalyst family) and Ni-complexes (e.g., nickel phosphine complexes).
[57, 110] However, these synthetic HECs are still far from demonstrating the catalytic
activity of their biocatalytic counterparts. [102]
Catalysts used in this study
The aim for the work described within this thesis is to demonstrate a proof-of-concept
HEC activity within the lumen of a liposome compartment.
As the main light-harvesting and electron transfer steps occur at the liposome membrane
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(i.e., inner and outer surface), it is advantageous to increase the amount of liposome
surface versus the liposome volume. This can be achieved by preparing small unilamellar
vesicles, such as sub-micro scale liposomes. Focus on higher liposome surface-to-volume
ratios means that the liposome volume is quite small. For example, liposomes with an
average diameter of 100 - 200 nm constitute only about 0.5 - 1  1018 L per liposome.Thus
the main challenge lies in encapsulating enough of a potent HEC to record a detectable
signal. To mitigate the risk for missing the signal of hydrogen evolution within the
liposomal compartment, this stuy focused on testing benchmark catalysts from both types
of material and molecular catalysts (i.e., Pt and hydrogenases).
Two types of Pt NPs were obtained - commercially purchased Pt NPs (Ptcom) and in-house
synthesized Pt NPs (Ptsyn). The Ptcom consists of 99.9% pure Pt and have an average
particle size of 3 nm (specified by the manufacturer). Ptsyn were synthesized as described
in section 2.1 following previous work by Eklund and Cliffel, where glutathione was used
as a capping agent to inhibit particle overgrowth and aggregation, and yield soluble NPs
with an average size of about 2.5 nm. [111]
Hydrogenase HydA1 was provided by Dr. Gustav Berggren (Uppsala University). This
small 48 kDa [Fe,Fe]-hydrogenase originates from an algae Chlamydomonas reinhardtii.
[113] The HER occurs on the active site called the H-cluster, which consists of a [4Fe-
4S] iron-sulphur cluster covalently linked to the catalytic [Fe,Fe]-subcluster by a cysteine
thiolate. [114] Both irons in the binuclear [Fe,Fe]- subcluster are coordinated by bridging
dithiolate ligand, three CO ligands and two CN ligands (Figure 1.9). [112, 114] A key
step for the enzyme activity is the electron supply to the catalytic site buried within the
enzyme, which can be improved with electron mediators (e.g., methyl viologen) acting as
remote, freely diffusing communication agents between the enzyme and electron source
(e.g., electrode, photosensitiser, light harvesting nanoparticle or ditihionite). [81]
HydA1 is able to convert H into H2 reversibly with a minimal overpotential even
in the presence of H2 (which is known to inhibit some other hydrogenases), but is
also rapidly and irreversibly inactivated by even trace amounts of O2. [114, 115] The
production and purification of HydA1 has recently been facilitated in Berggren’s group
by heterologous expression of the apo-enzyme in Escherichia coli followed by an artificial
in vitro maturation with a chemically synthesized mimic of the di-iron cluster. [112] The
specific HER activity of the resulting HydA1 was reported as about 700 - 800 µmol H2
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a) b)
Figure 1.9: a) A cartoon representation of the HydA∆EFG hydrogenase from
Chlamydomonas reinhardtii with a space-filling representation of the associated [4Fe-4S]
cluster (Fe – white, S – dark grey). The ∆EFG denotes potein expression devoid of the protein
machinery responsible for the insertion of the [Fe,Fe]-subcluster, thus the [Fe,Fe]-subcluster
(shown in b) is absent from this structure. Protein Data Bank ID, 3LX4. The protein representation
is coloured according to the protein secondary structure (light green, loops; blue, a-helices; dark
green, b-sheet). The light orange represent the protein loop represented in (b). b) The active
centre of the HydA hydrogenase showing the chemical structure of the (Fe,Fe)-subcluster and the
shematics of the protein loop containing [4Fe-4S] cluster (shown as balls and sticks with Fe and S
shown as white and grey spheres, respectively). Figure republished from [112].
min1 mg1 [112], which is comparable to the reported activity of the wildtype enzyme
(e.g., 730 and 935 µmol H2 min1 mg1 reported in [113] and [115], respectively).
1.6 Development of a light-harvesting compartment and
chapter overview
This thesis describes work on developing light-energy harvesting compartments, where
the liposomal membrane is used to spatially arrange and separate the key molecular
components. This includes several ET steps across molecular interfaces: 1) light-
harvesting nanoparticle (LHNP) to MtrCAB, 2) MtrCAB to H2 evolving catalyst (HEC)
and 3) sacrificial electron donor to the LHNP. Figure 1.10 summarises the key steps
of the intended light-harvesting compartment and the chapters within this thesis, which
focuses on particular molecular interfaces and interactions. At first, Chapter 3 describes
attempts to understand the interface between light harvesting nanoparticles (e.g., dye
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Chapter 3
Chapter 4
Chapter 5
Figure 1.10: Overview of chapters describing work on developing light-harvesting
compartments.
sensitized TiO2) and the MtrC(AB) to aid with engineering of electron transfer from the
light harvesting nanoparticles to the MtrC, which forms the soluble part of the MtrCAB.
Then, Chapter 4 explores photo-electron transfer across the liposome membrane. This
is demonstrated using a liposomal compartment, where electrons from LHNPs are passed
through the MtrCAB and use to bleach an incapsulated red dye. Finally, Chapter 5
describes work attempting to finish the energy conversion across the membrane to a
chemical entity (e.g., hydrogen gas) by a catalytic electron acceptor (e.g., platinum
catalysts and a hydrogenase), thus separating and preventing oxidation and reduction
process in time and space. Chapter 6 summarises these approaches and suggests future
research directions in this area.
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Chapter 2
Materials and Methods
This chapter aims to describe in detail the materials and experimental techniques used
throughout this thesis. At first, section 2.1 lists sources of main chemicals, lipids,
proteins and nanoparticles. Then in sections 2.2 and 2.3 I describe generic methods
used throughout the thesis to create and characterize liposomes and nanoparticles. The
following sections 2.4, 2.5 and 2.6, along with 2.7.1 focus on specific experimental
methods used for work described in Chapters 3, 4 and 5, respectively.
2.1 Materials
Unless stated otherwise, all chemical substances were obtained from commercial
suppliers and used without further purification: 3-(N-morpholino)propansulfonic acid
(MOPS, >99.5%), sodium sulphate (Na2SO4, analytical reagent grade), ammonium
chloride (NH4Cl, tested according to Ph Eur), ammonium bicarbonate (NH4HCO3,
C99.0%), N,N-Dimethyldodecylamine N-oxide (LDAO, BioXtra, >99%), sodium
hydrosulfite (DT,>82%), Reactive Red 120 azo dye (RR120), methyl viologen dichloride
hydrate (MV), pentaethylenehexamine (PEHA) and sodium metasilicate pentahydrate
were purchased from Sigma–Aldrich. Ethylenediaminetetraacetic acid disodium salt
dehydrate (EDTA, >99.5%), n-octyl glucoside (OG, laboratory grade) and monobasic
potassium phosphate (KH2PO4, C98.0%) were acquired from Melfors. Di-Potassium
hydrogen phosphate (K2HPO4, 98.0%) was purchased from VWR Chemicals. Triton
X100 (TX, electrophoresis grade) detergent was purchased from Fisher Chemicals. Milli-
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Q system was used to generate ultrapure water (resistance 18.2 MΩ  cm) which was used
throughout.
The majority of lipids were purchased from Avanti Polar Lipids. These were
Escherichia coli polar lipid extract, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-
2-Oleoyl-sn-Glycero-3-Phosphoglycerol (POPG) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(carboxyfluorescein) (DGPE-CF). 1,2-Dihexadecanoyl-sn-
Glycero-3-Phosphoethanolamine (Texas Red-DHPE) and Alexa Fluor™488 hydrazide
fluorescent dye were purchased from Molecular Probes (Thermo Fisher Scientific).
Lipids were dissolved in chloroform, distributed in 5 mg aliquots in glass vials, dried
first under a stream of nitrogen gas and subsequently under vacuum for 2h. Lipids were
stored in dry aliquots under nitrogen atmosphere at -20°C.
Light Harvesting Nanoparticles (LHNPs) were a kind gift from Prof. Erwin Reisner from
the University of Cambridge. Ruthenium (Ru) dye sensitized TiO2 anatase nanoparticles
(RuP-TiO2) and Ru-free precursor 3,4-dihydroxy-benzoic acid (DHBA) functionalised
TiO2 anatase nanoparticles (DHBA-TiO2, diameter 6.8  0.7 nm) were synthesized and
characterized by Prof. Reisner group at Cambridge as described previously. [63] Graphitic
nitrogen doped carbon dots (g-N-CD; diameter 3.1  1.1 nm) and amorphous carbon
dots (a-CD; diameter 6.8  2.3 nm) were also synthesized and characterized by Prof.
Reisner group at Cambridge as described in [86]. Commercial Titanium Oxide (anatase)
nanopowder (a-TiO2, average particle size 5 nm) was purchased from Nanostructured &
Amorphous Materials, Inc. (Katy, USA).
Shewanella oneidensis MR1 protein MtrC and MtrCAB were provided by Prof. Julea
Butt (University of East Anglia). MtrCAB was also purified in-house using Triton X-100
to solubilise MtrCAB as described before. [116] The detergent was exchanged into 5 mM
LDAO using size-exclusion chromatography (i.e., Superdex 200 Increase, GE Healthcare)
eluted with 5mM LDAO, 20 mM HEPES, pH 7.8. Final purity of the purified MtrCAB
was confirmed by SDS-PAGE with protein visualized by Coomassie and haem stain. [117]
The concentration of protein was routinely measured using BCA assay (ThermoFisher
Scientific) according to the manufacturer’s protocol. As MtrC and MtrCAB contain
multiple haems (10 and 20, respectively), protein concentration and structural integrity
was also routinely monitored via haem absorbance by light spectroscopy. Thus UV-visible
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light spectroscopy of oxidized MtrC/MtrCAB displays a heme Soret (γ) absorption peak
centered at 410 nm, a visible-region peak at 531 nm and a shoulder at 560 nm. Upon
haem reduction the Soret (γ) peak shifts to 420 nm and two smaller a and b peaks can
be distinguished at around 552 and 523 nm. [118] An example of MtrCAB absorbance
spectrum is shown in Figure 2.8 a. All purified proteins were stored at -80 °C.
Commercial Pt (Ptcom) nanopowder water dispersion (3 nm in diameter, pH 7) was
bought from US Research Nanomaterials, Inc. (Houston, USA). The dispersion contains
1000 ppm 99.99% Pt, which corresponds to a concentration of 3   1015 nanoparticles per
one mililiter (NPs/ml).
Soluble glutathione capped Pt nanoparticles (Ptsyn) were synthesized following a protocol
by [111]. In short, 41.3 mg glutathione (reduced) and 101 mg chloroplatinic acid was
dissolved in 25 mL water and stirred for 30 min. Then 73.3 mg sodium borohydride
solution in 3 ml water was added dropwise to the platinum solution and stirred again for
30 min. Resulting particles were precipitated by mixing the sample with ethanol (1:3)
and collected by centrifugation for up to 40 min at 18 000 RCF. The resulting pellet was
re-suspended in deionised water (pH 8.8 - 11.0) and stored at 4 °C. In order to estimate
the amount of Ptsyn in the samples, Pt was measured by atomic absorption spectroscopy
(AAS). AAS is a technique commonly used to detect metals, which relies on observation
of the specific interaction between atoms and electromagnetic irradiation. [119] The
analytes are first atomised, then the applied light energy excites the valence electrons
to the available empty orbitals. Although these electron transitions are unstable, these
provide highly element specific radiative transitions, which are detectable optically. [119]
In some cases, AAS was unsuitable for measuring Pt concentration (e.g., sample volume
was too small or sample was too dilute). In these situations Pt concentration was estimated
spectroscopically at 280 or 368 nm using an optical absorbance-concentration calibration
curve constructed manually using sample with known Pt NP concentration.
Mesoporous silica nanoparticles (further abbreviated as meSiO2; 200 nm particle size,
pore size 4 nm) were bought from Sigma Aldrich (Cat.no. 748161).
The [FeFe]-hydrogenase HydA1 was provided by Dr. Gustav Berggren (Uppsala
University) in sealed anaerobic vials and stored at -80 °C.
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2.2 Liposome preparations
2.2.1 Liposome and MtrCAB proteoliposome formation with
simultaneous RR120 encapsulation by rapid dilution
(Chapter 4)
5 mg dried E. coli polar lipid extract was resuspended by vigorous vortexing for up to 20
minutes in 294 µl MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4) containing 6.6
mM RR120 and 85 mM n-octyl glucoside (OG). 50.5 µL of 10 µM MtrCAB (or 5mM
LDAO for control liposomes) was added to the lipid solution and kept on ice for further 10
min. The sample was then rapidly diluted while mixing in 50 mL ice-cold 20 mM RR120
in MOPS buffer. The sample was transferred to an ultracentrifuge tube (polycarbonate,
38 x 102 mm; Beckman Coulter) and centrifuged for 1h 40 min at 200 000 g (41 000 rpm)
at 4°C using Beckman Coulter and type 45 Ti Rotor. The supernatant containing most of
the non-encapsulated RR120 was discarded and the pellet was re-suspended in 500 µL
MOPS buffer. The proteoliposome sample was then centrifuged at 5000 g for about 5
minutes to pellet any aggregates. Remaining non-encapsulated RR120 was removed by
two consecutive rounds of 60 min sample incubation with 0.6 g Bio-Beads (Bio-Rad SM-
2) per 1 ml of sample at 4°C on a rolling shaker. Experiments were performed within 2
days from liposome preparation.
The amount of reconstituted MtrCAB was determined using a Bicinchoninic Acid (BCA)
assay [120] (ThermoFisher Scientific). This is a standart total protein concentration
assay, where the peptide bonds reduce copper ions (i.e., Cu2 to Cu), which is then
chelated by BCA. This reaction is accompanied with a sample color change from green
to purple, which is proportional to protein concentration. Thus protein concentration can
be be measured using colorimetric techniques. As the absorbance of encapsulated RR120
overlaps with BCA reagent absorbance, liposomes were first lysed with detergent (0.1%
v/v Triton X100) and RR120 was removed by two consecutive desalting columns (0.5 ml
Zeba™Spin, ThermoFisher). The effectiveness of the desalting columns was confirmed
using a control sample of RR120 loaded liposomes without MtrCAB. MtrCAB recovery
after desalting steps was estimated spectroscopically as more then 84%.
Chapter 2. Materials and Methods 29
The concentration and size distribution of liposomes was determined by Nanoparticle
Tracking Analysis (NTA) and DLS as described in section 2.3. The size and volume of
liposomes were estimated by treating liposomes as spherical particles with the average
diameter based on NTA data or DLS.
2.2.2 H2 evolving catalyst encapsulation within liposomes by rapid
dilution
Encapsulation of all H2 evolving catalysts were attempted using a modified version of the
protocol described in section 2.2.1.
For Ptcom encapsulation, 5 mg dried E. coli polar lipid extract was resuspended by
vigorously vortexing for up to 20 minutes in 624 µl MOPS buffer (20 mM MOPS, 30 mM
Na2SO4, pH 7.4) containing 125 µl Ptcom NP (100 mg Pt) and 55 mM n-octyl glucoside
(OG). The sample was then rapidly diluted while mixing in 50 mL ice-cold MOPS buffer.
For Ptsyn encapsulation, 2.5 mg dried E. coli polar lipid extract was resuspended by
vigorous vortexing for up to 20 minutes in 244 µl MOPS buffer (20 mM MOPS, 30
mM Na2SO4, pH 7.4) containing 100 µl Ptsyn NP (18.6 mg Pt) and 55 - 58 mM OG.
Afterwards, 22.5 µL of 10 µM MtrCAB (or MOPS buffer for control liposomes) was
added to the lipid solution and kept on ice for further 15 min. The sample was then
rapidly diluted while mixing in 50 mL ice-cold MOPS buffer.
For [FeFe]-hydrogenase (HydA1) encapsulation, 5 mg dried E. coli polar lipid extract was
resuspended by vigorously vortexing for up to 10 minutes in 181 µl MOPS buffer (20 mM
MOPS, 30 mM Na2SO4, pH 7.4). The sample was brought into an anaerobic glovebox
(O2 <0.01 ppm, Labmaster, MBraun) and an additional 100 µl 250 mM OG and 17 µl
HydA1 sample (4.8 nmol HydA1) were added. Then, 50.5 µL of 5 mM LDAO was added
to the lipid solution and kept at 4°C for further 10 min. The sample was rapidly diluted
while mixing in 50 mL ice-cold MOPS buffer.
After the rapid dilution step, samples were transferred to ultracentrifuge tubes and
centrifuged for 1h 40 min to 2h at rav of 125 000 - 140 000 g at 4°C using Beckman
Coulter and type 45 Ti Rotor. After returning the centrifuge tubes back into the anaerobic
glovebox (O2 <0.01 ppm, Labmaster, MBraun), the supernatants were discarded and the
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pellet was re-suspended in MOPS buffer. The resulting samples were then kept at 4°C.
Experiments were performed within 2 days from liposome preparation.
2.3 Liposome and nanoparticle characterization
Several methods were used to gain understanding of particle size distribution in samples
containing nanoparticles and liposomes. These were dynamic light scattering (DLS),
nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and
cryogenic electron microscopy (cryo-EM).
2.3.1 DLS
DLS measures hydrodynamic radius of particles dispersed within solution using physical
light properties. DLS relies on a beam of monochromatic laser, which is directed
through the solution containing the dispersed colloidal particles (e.g., macromolecules,
nanoparticles, liposomes) of interest. [121] As the light moves through the colloid, light
becomes scattered by the dispersed particles, and the resulting scattered light is detected.
Subsequent analysis of the fluctuations in the scattered light intensity allows to determine
the particle size. [121] DLS provides information of the average particle size within a
homogenous samples within the range from 1 nm to 10 µm. However, DLS accuracy is
limited in heterogenous samples, where presence of larger particles and small amounts of
dust particles can lead to biased results and misinterpretations. [122, 123]
Although DLS is not the most precise of available techniques, DLS is one of the
most accessible and easy-to-use method for obtaining an estimate of particle size
within a solution. As such DLS was used to estimate the particle size distribution of
samples containing different nanoparticles (e.g., a-TiO2, Ptcom, Ptsyn, silica nanoparticles)
and liposome preparations. DLS was performed using Zetasizer Nano Z (Malvern
Panalytical).
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2.3.2 NTA
NTA allows sizing of individual particles within a sample ranging in size from  30-
1000 nm. [123] Similarly to DLS, NTA also relies on light scattering, but couples the
light scattering with a direct analysis of the Brownian motion of individual particles. [123]
This is done utilising a special set-up, where laser light scattering microscopy is coupled
with a charge-coupled device (CCD) camera able to capture and visualise nanoparticle
movement in solution. The NTA software then identifies and tracks individual particles
and calculates particle size from their movement. [122, 123]
As NTA measures individual particles, it provides more reliable estimate of particle size
distribution and particle concentration. Unfortunately, NTA is not sensitive enough for
very small particles (i.e., B50 -100 nm), thus it was used for samples containing larger
particles or particle aggregates such as commercial PT NPs (Ptcom), silica nanoparticles
and liposomes. NTA was performed using Nanosight (NS300, Malvern Panalytical).
2.3.3 Electron microscopy
The most direct and practically more difficult techniques are TEM and cryo-EM. These
rely on sample imaging by using electron beam passing through thin section of samples.
[122] The sample irradiation with electron beam leads to excessive damage of organic
matter. Thus TEM use for imaging of biological samples has been limited until the
recent advances in cryo-EM, where the use of cryogenic temperatures reduces the effects
of radiation damage. [124] At first, the sample is fixed by snap-freezing, which traps
biomolecules within a thin vitrous layer of ice onto the imaging grid. Then the electron
microscopy itself is performed under cryogenic temperatures using liquid nitrogen or
liquid ethane. [124]
The TEM for nanoparticle (i.e., Pt and silica NPs) imaging was performed as follows.
2 µl NP sample was drop-casted on 400 mesh copper EM grids with holey carbon film
(Agar Scientific, S147-4). These copper grids use carbon film with holes for hosting and
supporting the sample. The presence of holes within the carbon film provide areas on
the grid with lower background noise. Grids were left to dry in room temperature for
about 20 minutes. TEM was performed at Leeds Electron Microscopy and Spectroscopy
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Centre (LEMAS) using FEI Tecnai TF20: FEGTEM Field emission gun TEM/STEM
fitted with HAADF detector, Oxford Instruments INCA 350 EDX system/80mm X-Max
SDD detector and Gatan Orius SC600A CCD camera. TEM of Ptcom and Ptsyn NPs were
performed with the help of Dr Sunjie Ye. The diameters of Ptsyn particles were then
measured manually using ImageJ [125]. Particle size distribution analysis was carried out
by counting particles, and the average particle size was determined by fitting a lognormal
distribution.
Cryo-EM as performed for liposome samples with and without RuP-TiO2 at the Electron
Microscopy unit of the Astbury Biostructure laboratory with the help of Dr Rebecca Thompson.
Liposome or RuP-TiO2 sample, or a sample containing both was placed onto lacey carbon grids
with 200 µm mesh (Agar Scientific), blotted, and plunged frozen into liquid ethane. In this case
lacey grids were used, which have even more open area (i.e. free from carbon film) as the holey
grids used for TEM. Cryo-EM was performed as described elsewhere. [126] In short, cryo-EM
was carried out at liquid nitrogen temperatures using an Oxford CT3500 holder and a FEI Tecnai-
F20 electron microscope. Images were recorded at 50000 x magnification on a Gatan US4000
CCD camera under low-dose conditions (20 e/A˚2).
2.4 Experiments for MtrCAB footprinting (Chapter 3)
2.4.1 Monitoring binding between MtrC / MtrCAB and TiO2
nanoparticles
Co-sedimentation assays
An aliquot of protein (MtrC or MtrCAB) stock sample was buffer-exchanged into 5 mM NH4Cl
(pH 8) with a desalting column (0.5 ml Zeba™Spin, ThermoFisher) according to manufacturer’s
instructions. MtrCAB samples contained also 5 mM LDAO detergent. The protein concentration
of the sample before and after buffer-exchange was determined by a BCA assay, which indicated
retention of  93% and 98% of MtrC and MtrCAB in samples, respectively. The protein samples
were then diluted to 3-10 µM MtrC and 2-5 µM MtrCAB working protein stocks, which were
used for co-sedimentation experiments.
A water suspension of 10 mg/ml commercial anatase TiO2 nanoparticles (a-TiO2) was further
diluted to 1.8 mg/ml working stock solution. An appropriate amount of working anatase stock
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solution was dispensed into polycarbonate centrifuge tubes (7 x 20 mm, Beckman Coulter), where
then appropriate amount of protein and buffer (e.g., MtrC in NH4Cl) were added. The final
solutions contained 160 nM MtrC and a-TiO2, ranging from 0 – 130 µg/ml (total NP surface
area of 0 - 7000 mm2) in 5 mM NH4Cl (total volume 190 µL). Samples containing MtrCAB were
set up the same way and contained 80 nM MtrCAB, a-TiO2, ranging from 0 – 80 µg/ml (total
NP surface area of 0 - 4300 mm2) in buffer containing 5 mM NH4Cl and 5 mM LDAO. Samples
monitoring co-sedimentation of MtrC samples without His-tag and a-TiO2 in 5 mM NH4Cl were
set-up the same way, and contained 80 nM MtrC and a-TiO2, ranging from 0 – 110 µg/ml (total
NP surface area of 0 - 6000 mm2) in 5 mM NH4Cl (total volume 190 µL). Experiments involving
DHBA-TiO2 nanoparticles contained 100 nM MtrC and DHBA-TiO2, ranging from 0 – 210 µg/ml
(total NP surface area of 0 - 10000 mm2) in 20 mM MOPS, 30 mM Na2SO4 buffer, pH 7.4 (total
volume 200 µL).
Samples were then incubated in room temperature for about 20 minutes and ultra-centrifuged
at 200,000 g, 6°C for 20 minutes using TLA-100 rotor (Beckman Coulter) in a tabletop
ultracentrifuge (Optima MAX-TL, Beckman Coulter). 180 µl of supernatant was then carefully
removed from the top and transferred to a 96-well plate (UV-star, Greiner Bio-One), where the
absorbance of non-sedimented (‘free’) MtrC or MtrCAB was measured from 300 - 450 nm,
step size 1 nm using Varioskan®Flash Spectral Scanning Multimode platereader operating SkanIt
Software 2.4.5 RE for Varioskan Flash (Thermo Scientific).
In order to assess the MtrC and MtrCAB co-sedimentation with a-TiO2, the amount of protein
present in supernatant was first measured using half-maximum of the haem peak absorbance (e.g.,
difference in absorbance between 413 nm and 423 nm or 412 nm and 423 nm). This method is
less sensitive to background scattering of any non-sedimented a-TiO2 particles. Then the relative
protein amount was calculated by dividing with the average half-height heam absorbance from the
control sample without a-TiO2.
Protein recovery
The protein recovery from co-sedimented a-TiO2 pellets was attempted using ammonium
bicarbonate (NH4HCO3). The carbonate ions (CO22 ) bind TiO2 surface, [127,128] and thus can be
used to replace MtrC / MtrCAB from the a-TiO2 surface. In order to do that, the ultra-centrifuged
a-TiO2 pellets (containing MtrC or MtrCAB) were dispersed in 180 µl 50 mM NH4HCO3 buffer
(pH  8). Resulting samples were then ultra-centrifuged at 200 000 g, 6°C for 20 minutes as
described before for co-sedimentation experiments. The supernatants containing the recovered
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protein were transferred to a 96-well plate and the haem absorbance of MtrC and MtrCAB was
measured as for co-sedimentation experiments. In addition, the absorbance of oxidised and
reduced haems of the recovered MtrC and MtrCAB was assessed spectroscopically, and showed
the same absorbance profile as the control, indicating that protein has not been damaged by
interaction with a-TiO2.
The amount of recovered protein was estimated relative to the initial protein amount used for co-
sedimentation experiments. The half-maximum of the measured heam absorbance was divided
with the average half-height heam absorbance from the control sample without a-TiO2 used for
co-sedimentation experiments. Then comparison of the amount of non-sedimented (’free’) and
the recovered MtrC/MtrCAB was made. This approach indicated that the amount of the recovered
protein is influenced by the a-TiO2 concentration. Thus a smaller fraction of the co-sedimented
protein was recovered from samples containing higher a-TiO2 concentration across all repeats.
This observation can be explained by an increase in a-TiO2 aggregation with increasing a-TiO2
concentration, leading to more protein being trapped within the aggregates.
2.4.2 X-ray assisted protein labelling with Mass Spectrometry
analysis (X-ray Footprinting Mass Spectrometry, XFMS)
Protein footprinting is a proteomics strategy where a change in the solvent accessibility of protein
backbone and residues (e.g., due to ligand binding) is monitored through their sensitivity to a
chemical modification or proteolytic or chemical cleavage. As the result, solvent exposed protein
areas become modified and chemically different from the native protein, and the imprint (or
footprint) of these modifications can then be analysed using mass spectrometry (MS). [129]
Different types of labelling can be used for protein footprinting, such as protease-cleavage
of exposed protein backbone, deuterium exchange of amide protons in the protein backbone
(hydrogen deuterium exchange, HDX), isotope-coded affinity tags to sample accessibility of
specific amino acids (e.g., cystein) as well as the use of oxidative hydroxyl radicals (YOH) to
label solvent exposed amino acid side-chains. [129–131]
In this study YOH labelling in used, as it provides non-specific (i.e., all exposed residues can
potentially be modified), fast and permanent modification, which allows greater flexibility in
subsequent sample processing and use of different proteases. [129, 132] In this study TiO2 NP
binding to the protein is expected to shield this protein interface from water, thus comparison
of peptide modification with and without TiO2 NPs allows identification of protein residues
involved in MtrC : TiO2 interface. In short, the sample conditions and buffer composition is
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optimised for radiolysis using a fluorescent dye, as described in X-ray irradiation dose-response
assay. Then, protein samples with and without TiO2 NPs are irradiated with X-rays. Water
ionization generates hydroxyl radicals that label water exposed amino acid side chains even within
buried protein cavities. [132] Resulting peptides typically contain covalent hydroxyl- (+16 Da
or +32 Da) modifications, which subsequently are detected by liquid-chromatography tandem
mass-spectrometry (LC-MS/MS). [129, 132, 133] The summary of XFMS approach is shown in
Figure 2.1.
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Figure 2.1: Overview of XFMS analysis. (a) Schematics showing main stages of XFMS
approach. (b) Example of XFMS illustrating the water (blue dots) radiolysis and generation
of hydroxyl- radicals (red dots), which then modify protein residues exposed to water. The
conformational differences between protein in state A and state B lead to selective labelling of
the identified phenylalanine (Phe). Protein is then digested with proteases and analysed using LC-
MS/MS. LC quantitatively separate the peptides at different retention times (RT), which are then
identified by the MS. MS/MS allows determination of the specific site of the modification. The
quantification of the fractions of the unmodified peptide over exposure time (dose-response plot)
allows determination of site-specific modification rate constants (k1). These rate constants are
then compared between different sample conditions and their ratios (R) are used to describe the
solvent accessibility changes due to any binding-interactions or conformational changes. The final
result is mapped onto available structures. Figure reproduced and modified after [131].
XFMS experiments involved two conditions (i.e., MtrC with and without a-TiO2). Samples from
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each condition were radiolysed for 5 different exposure times (e.g., 0, 12.5, 25, 50 and 75 ms).
MtrC from each sample was then proteolysed and the resulting native (i.e., unmodified) and
modified peptides were identified. Thus terms ’native’ and ’modified’ are used in regard to XFMS
to describe whether a XF hydroxyl- modification (+16 Da) is detected on a peptide residue, peptide
or protein. Then the amount and the distribution of hydroxyl- modifications were quantified
across the 5 exposure times to produce a dose-response plot for each detected modification.
A modification rate constants (k1) were then determined for each modification, which were
compared between conditions as the modification rate ratio (R) of MtrC and MtrC : a-TiO2
complex.
I performed the radiolysis experiments at the Beamline 3.2.1 at the Advanced Light Source (ALS)
in Lawrence Berkeley National Lab (LBNL) working together with Dr Sayan Gupta, Dr Corie
Ralston and Dr Caroline Ajo-Franklin as described in subsection on MtrC : a-TiO2 NP sample
radiolysis. The following LC-MS/MS analysis of modified proteins were performed by staff at the
Biomolecular Mass Spectrometry Facility of the University of Leeds as described in subsection
on Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. I analysed the
resulting MS data as described in subsection on XFMS data processing and analysis.
X-ray irradiation dose-response assay
A key step in XF experiments is water ionization by x-ray irradiation, which generates YOH
that modify the side chains of protein residues [133]. Thus protein labelling is related to YOH
concentration, which in turn depends on X-ray exposure time and the flux density of an X-ray
beam. [133] As the flux density of the X-ray beam is kept fixed, the dose of YOH concentration
is regulated by changing the duration of sample exposure. Many sample components such as
buffering agents (e.g., MOPS, Tris, HEPES), reducing agents and detergents used for membrane
protein solubilisation react with YOH (extrinsic radical scavengers) reducing the effective YOH
dose. [133] In addition, sample components (e.g., macromolecular assemblies) can also react with
YOH (intrinsic scavengers). [133] Therefore, the duration of sample irradiation often has to be
increased to overcome the radical scavenging processes [133], and the amount of YOH scavenging
was tested at the start of each radiolysis experiment.
The amount of hydroxyl radical formation and scavenging by different buffer and sample
components was estimated indirectly - observing bleaching of irradiated fluorescent dye (Alexa
Fluor 488), as reported in the supplementary information of [134] and in [133, 135]. Samples
containing 40 µM Alexa Fluor 488 hydrazide were prepared with 0.2 - 0.3 mg/ml a-TiO2 and/or
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0.2 - 0.5 µM MtrC in a buffer containing 5 mM NH4Cl (pH 8) or 50 mM phosphate buffer
(pH 7). 10 µl aliquots were then subjected to 0 - 50 msec X-Ray irradiation at Beamline 3.2.1
at Advanced Light Source (ALS) of Lawrence Berkeley National Laboratory (USA) using a fixed
stand set-up described in [136], where a microfuge tube containing the sample aliquot is placed
in the sample holder and exposed one at a time. Samples were then diluted in 50 mM phosphate
buffer (pH 7) and fluorescence (excitation at 496 nm, emission at 516 nm) was measured in a
portable fluorimeter (Turner Biosystems TBS-380). The rate of hydroxyl radical formation was
estimated from the dose-response plots, where fluorescence loss over x-ray irradiation time is fit to
a single exponential function as described in [135]. The fit was made using GraphPad and apparent
rate constants of the fluorophore modifications in various conditions were determined. Figure 2.2
provides an example of dose-response plots of MtrC with and without a-TiO2.
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Figure 2.2: Determining hydroxyl radical dose for XFMS using fluorescent dye Alexa
Fluor 488. (a) Example of a hydroxyl radical (YOH) dose-response plot of fluorophore
decay after exposure to ionizing radiation. Experiments involved 40 µM Alexa Fluor 488
in 5 mM NH4Cl buffer (pH 8) containing 0.2 µM MtrC with and without 0.2 mg/ml
a-TiO2 (black and red, respectively). The lines represent single exponential fit. Error
bars indicate standard deviation, n=2. (b) Chemical structure of Alexa Fluor 488
hydrazide. Image obtained from the website of the commercial supplier (ThermoFisher,
https://www.thermofisher.com/order/catalog/product/A10436#/A10436, accessed on 22/10/2019).
MtrC : a-TiO2 NP sample radiolysis
MtrC samples with and without a-TiO2 were radiolyzed by X-ray exposure at Beamline 3.2.1 at
ALS as previously described [133, 134]. 0.4 nmol MtrC (0.2 µM) with and without 2 nmol
a-TiO2 nanoparticles (0.2 mg/ml, 1.1 µmol NP per litre, µmol NP/l) were mixed together in
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5 mM NH4Cl buffer. Total volume per sample was 1.85 ml. Samples were split in two parts
and loaded in a flow set-up described in [133, 136] and irradiated with X-Rays for 0, 12.5, 25,
50 or 75 msec. Exposed samples were collected in a fresh tube containing 1M NH4HCO3 (final
concentration 50 mM). The collection tube of one set of MtrC control samples without a-TiO2
also contained 220 mM methionine amide (final concentration 11 mM) as a radical quencher to
prevent secondary oxidation reactions [136]. Methionine amide was not used for other control
samples and a-TiO2 samples to avoid increasing the solute concentration and thus slow the
a-TiO2 precipitation. The samples containing a-TiO2 were then immediately de-salted in 50
mM NH4HCO3 using Zeba™Spin columns (0.5 ml, 7k MWCO, ThermoFisher) according to
manufacturer’s instructions. Earlier sample turbidity measurements before and after the desalting
step showed that a-TiO2 binds to the de-salting column matrix (data not shown) and thus a-TiO2
was effectively removed in this step. All exposed samples were then concentrated to about 70 -
100 µl using a spin concentrator (Amicon Ultra 4, 30k MWCO). Finally, samples were snap-frozen
and kept at -80°C till LC-MS/MS analysis.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis
Samples were proteolysed and run through LC-MS/MS by Dr Rachel George at the Biomolecular
Mass Spectrometry Facility at the University of Leeds.
50 µL of sample was mixed with 50 µL SDS solubilisation buffer, which consisted of 5% sodium
dodecyl sulfate (SDS), 50 mM tetraethylammonium bromide (TEAB), pH 7.55. To reduce and
alkylate protein disulphide bonds, first DTT (dithiothreitol) was added to a final concentration of
20 mM and sample was heated to 95°C for 10 min with shaking. Then iodoacetic acid was added
to a final concentration of 40 mM and sample was kept at 20°C for 30 min with shaking. The
sample was acidified using 7.8 µL 12% phosphoric acid and 1200 µL of S-Trap binding buffer
(90% methanol, 100 mM final TEAB, pH 7.1). 2 µg of protease Glu-C (reconstituted in 50 mM
TEAB, Promega, UK) was added, and samples were transferred to a S-Trap™column (Protifi, NY,
USA). As the total sample volume was higher than the volume of the spin column, the sample was
loaded in parts onto the S-Trap column. The spin column was placed in a 2 mL Eppendorf tube
and spun in a centrifuge at 4,000 g for 30 minutes to ensure all of the solution had passed through.
The process was repeated until all of the sample had passed through the column and the protein
was trapped within the protein-trapping matrix of the column. The captured protein was washed
by adding 150 µL of S-Trap binding buffer (90% aqueous methanol containing 100 mM TEAB,
pH 7.1) and centrifuged. This step was repeated three times. The S-Trap™column was moved
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to a clean 1.7 mL sample tube then additional 0.5 µg of Glu-C in 25 µL of 50 mM TEAB was
added to the top of the column ensuring that no bubbles were formed in the process. The column
was capped loosely and incubated for 1 hr at 47°C in a thermomixer without shaking. Peptides
were eluted with 40 µL of both 50 mM TEAB and then 0.2% aqueous formic acid. Sample
was centrifugated for 30 seconds at 4,000 g. Hydrophobic peptides were eluted with 35 µL 50%
acetonitrile, 0.2% formic acid. Eluted peptides were dried before being resuspended with 50 µL
of 50 mM ammonium bicarbonate. 0.2 µg of protease ASP-N (reconstituted in water, Promega,
UK) was added to the sample and then incubated at 37°C with shaking for 18 hours. The second
digest reaction was quenched using 5 µL 1% trifluoroacetic acid (TFA). The sample was dried
down prior to analysis on the mass spectrometer.
Samples were reconstituted in 100 µL 0.1% TFA, and an aliquot of 10 µL was used for LC-MS.
LC separation of the peptide mixtures was performed on an ACQUITY M-Class UPLC (Waters
UK, Manchester). 1 µL of each sample was loaded onto a Symmetry C18 Trap Column (180 µm
inner diameter, 20 mm length) and washed with 1% acetonitrile/0.1% formic acid for 5 min at
5 µL min1. After valve switching, the peptides were then separated on a HSS T3 C18 analytical
column (75 µm inner diameter, length 150 mm; Waters UK, Manchester) by gradient elution of
1-60% solvent B in A over 30 min at a flowrate of 0.3 µL/min. Solvent A was 0.1% formic acid
in water, solvent B was 0.1% formic acid in acetonitrile.
The column eluant was directly interfaced to a quadrupole-orthogonal time of flight mass
spectrometer (Xevo G2-XS Q-TOF, Waters UK, Manchester) via a Z-spray nanoflow electrospray
source. The MS was operated in positive time of flight mode using a capillary voltage of 3.0 kV,
cone voltage of 40 V, source offset of 80 V, backing pressure of 3.58 mbar. The source temperature
was 80°C. Argon was used as the buffer gas at a pressure of 8.6   103 mbar in the trap and transfer
regions. Mass calibration was performed using [Glu]-fibrinopeptide (GFP) at a concentration of
250 fmol/µL. GFP was also used as a lock mass calibrant with a one second lock spray scan taken
every 30 s during acquisition. 10 scans were averaged to determine the lock mass correction factor.
Data acquisition was performed using data dependent analysis with a 0.2 s scan MS over m/z range
from 350-2000, which was followed by five 0.5 s MS/MS taken of the five most intense ions in
the MS spectrum. The applied collision energy was dependent upon charge state and mass of the
ion selected. Dynamic exclusion of 60 s was used.
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XFMS data processing and analysis
Peptides were de-novo sequenced and identified using PEAKS X software (Bioinformatics
Solutions Inc., Waterloo, ON, Canada). The peptides with oxidation modifications were identified
Figure 2.3: Example of protein coverage and detected +16 Da modifications (small red
squares) for unexposed MtrC control (without a-TiO2) sample. Protein coverage 77%. Blue
lines represent different identified peptides and are not a quantitative representation.
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searching for +15.99 Da and 31.99 Da mass additions on each residue. The false discovery rate
was set to 1%.
An example of obtained protein coverage and the identified +16 Da modifications of non-radiolysis
MtrC control sample is shown in Figure 2.3. This figure provide an initial qualitative insight in
the oxidation of MtrC by summarizing all different peptide versions identified across the protein.
The quantification of peptide modification was performed from extracted ion chromatograms
(EIC), which extract elution profiles for a specified single m/z value. The abundance of native (i.e.,
unmodified) and modified peptides were measured by integrating the peak area of the respective
extracted ion chromatograms (EIC) as described in [130,133,134]. This was done using MassLynx
v4.1 suite of software supplied with the mass spectrometer (Waters Ltd., Wilmslow, Manchester,
UK). EICs were generated by extracting the signal of the m/z values for a selected native or
modified peptides as a function of retention time (RT) for each observed charge state (e.g., z =
+2, +3 or +4). An example of EICs of a modified and unmodified peptide is shown in Figures 2.4
and 2.5. MS/MS data can then be used to identify the modified residues eluting at specific retention
times (RT).
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Figure 2.4: Example of XF labelling on peptide residues 73 - 83 (sequence:
DMPVIGLANLE). Overlaid extracted ion chromatograms (EIC) of the native peptide (black,
m/z 586.3, z=2) and +16 Da modified peptide (red, m/z 594.3, z=2). The intensity of native and
modified peptides are normalised relative to the RT of the most abundant peptide within each EIC.
EICs represent MtrC control sample (i.e., without a-TiO2) after 75 ms of radiolysis.
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Figure 2.5: Example of XF labelling on peptide residues 362 - 374 (sequence:
DLKTILPKVQRLE). Overlaid extracted ion chromatograms (EIC) of the native peptide (black,
m/z 518.32, z=3) and +16 Da modified peptide (red, m/z 523.65, z=3). The labelled peaks
represent identified peptide residues identified by MS/MS. Unlabelled peaks correspond to
peptides with similar m/z signature, but not identified to be from this protein region. The intensity
of native and modified peptides are normalised relative to the RT of the most abundant peptide
within each EIC. EICs represent MtrC control sample (i.e., without a-TiO2) after 75 ms of
radiolysis.
Some peptides, such as the one depicted in Figure 2.4 contained only a single XFMS modified
residue and the corresponding XFMS analysis was straightforward. However, data analysis of
other peptides was more convoluted. Figure 2.5 illustrates several common features of XFMS
data analysis. Firstly, most modified peptides had shorter RT than the native peptide. Secondly,
XF labelling of the same peptide residue can produce several oxidised products. For example,
multiple residues can be modified on a single peptide [132]. Furthermore, some residues can
be modified at different sites [129, 130] For example, the aromatic ring of phenylalanine can be
attacked by a hydroxyl radical at ortho, meta and para positions, converting phenylalanine into
three different stereoisomers of tyrosine [129]. Different oxidised products of the same native
peptide typically elute at different times (e.g., P368 and K364 in Figure 2.5). In some cases,
EIC peaks corresponding to different versions of the oxidised peptide were poorly resolved, such
as I366 and P368 with 12.6-13.1 min RT (peaks 2 and 3 in Figure 2.5), thus the quantification
of these had to be performed cumulatively. Finally, peak 5 in Figure 2.5 has the same RT as
the native peptide, which could be an in-source oxidation artefact formed during electrospray
ionisation [137] and as a precaution would generally be excluded from the analysis. In this case,
however, due to an overall overlap of peaks 4 and 5 in the EIC, peak area of both peaks were
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pooled and quantified together. A summary of identified XFMS modifications and the criteria
used to assign modified residues to individual EIC peaks are shown in Appendix, Table 1.
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Figure 2.6: Example of MS/MS identification of a peptide residues 362 - 374 (sequence:
DLKTILPKVQRLE). (a) Native peptide (1552.94 Da) was detected at 13.88 min retention time.
(b) XF labelled peptide (1568.93 Da) bearing a +16 Da modification on L367 eluted at 11.40 min.
Y-series ions (originate as MS/MS fragmentation of peptide’s C-terminus) are shown in red and
b-series ions (originate as MS/MS fragmentation of peptide’s N-terminus) in blue. The location of
XFMS modification is identified by observing +16 Da mass shift on peptides containing the L367
(i.e., y8 - yMax in y-series ions and b5, b6, bMax in b-series ions).
Figure 2.6 shows an example of a MS/MS identification of a native (a) and modified (b) version of
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the peptide from Figure 2.5. MS/MS fragmentation generates a nested set of peptide ions termed
Y- and b- series ions. Y-series ions originate from MS/MS fragmentation of peptide’s N-terminus
(i.e., appear to extend from the C-terminus), while b-series ions originate as MS/MS fragmentation
of peptide’s C-terminus. The location of XFMS modification is identified by observing +16 Da
mass shift on peptides containing the L367 (labelled in small caps and gold in Figure 2.6b). Thus
Y-series ions from y8 to Max and b5, b6, bMax of b-series ions are 16 Da heavier and appear
right-shifted compared to the ’native’ peptide (Figure 2.6a).
The modified fraction for each peptide (and residue, where the identification of the modified
residues was possible) was calculated as described in [132]. In short, the ratio was calculated
of the peak area corresponding to the modified peptide residue (or combined modification of a
peptide) to the collective area of native and modified peptides, i.e.,
Fr. modified  
PmodifiedPeak
native PmodifiedAll peaks
.
Then a site-specific modification rate constant (k s1) was calculated by first calculating fraction
of native site (i.e., peptide or residue-level) as follows:
Fr. unmodifiedsite   1  Fr. modified.
This was then plotted over the duration of radiolysis to obtain a dose-response plot and rate
constants (k1) of residue modification by a pseudo-first-order fit. [132] (Examples are shown in
Figure 2.7). The extent of the residue modification depends on the specific residue reactivity and
the local environment of the residue (e.g., solvent accessibility) [132, 133]. To simplify analysis
the changes in solvent accessibility (and hydroxyl-reactivity) of specific residues were estimated
by calculating R, the ratio of the k1 of free MtrC vs the k1 of MtrC bound to a-TiO2. Thus, in
the case of modified residues reported in Figure 2.7, M74 (Figure 2.7a) is relatively unprotected
by a-TiO2 (R=2.41.0), while residues L367, I366+P368 and K364+P368 are shielded by a-TiO2
(R=8.92.4, 6.61.3 and 11.04.1, respectively).
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Figure 2.7: Examples of changes in hydroxyl-radical reactivity for selected MtrC residues:
M74 (a), L367 (b), I366 with P368 (c), and K364 with P368 (d) with and without a-TiO2 (red and
black, respectively). Lines indicate a fit of a first order exponential (y   A  ekt) used to determine
the rate constants (k) of residue modification by hydroxyl-radicals. Error represents the standard
error from the fit.
2.5 Reduction of RR120 encapsulated in MtrCAB
proteoliposomes (Chapter 4)
Samples for photo-reduction experiments were assembled in nitrogen atmosphere (glovebox,
LABmaster, MBrown, O2 <0.01 ppm) to ensure anaerobic environment. MtrCAB proteoliposome
sample (section 2.2.1) was diluted 10-fold in 20 mM MOPS, 30 mM Na2SO4, pH 7.4 buffer
containing 50 mM sacrificial electron donor (EDTA). Appropriate amount of LHNP stock (27 µM
RuP-TiO2, 476 µM g-N-CD or 44 µM a-CD; mass of particles is estimated based on size
determined by EM and density of material) was added to 1 µmol LHNP/L final concentration.
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The cuvette was then sealed airtight and removed from the glovebox for UV-vis absorbance
spectroscopy (Cary 5000 UV-Vis-NIR, Agilent) fitted with an integrating sphere (Internal DRA-
900, Agilent). UV-vis absorbance spectra were measured after 10 sec, 50 sec, 60 sec, 120 sec or in
some cases 300 sec of sample illumination using a cold light source holding a 150 W, 4.5 cm (15 V)
halogen lamp (OSRAM) with a fibre optic arm (Kru¨ss KL5125). The sample was placed 10 cm
from the light source and illuminated from the side. The light intensity under these conditions
is approximately (450  40) mW/cm2 at 400 nm. Afterwards, the chemical reductant DT was
added (final concentration 27 mM) to monitor further possible reduction of RR120. Finally, Triton
X100 detergent was added (final concentration 0.045% v/v) to break the lipid vesicles and observe
reduction of any remaining RR120. Control experiments testing reduction by DT (i.e., without
LHNPs) were also performed. Photo-reduction control experiments with non-encapsulated RR120
were performed as above, but with 10 µM RR120, 50 mM EDTA and 1 µmol NP/L LHNPs in
MOPS buffer. The recovery yield of MtrCAB was observed to vary between proteoliposome
preparations. To account for this, comparisons of encapsulated RR120 (photo)reduction by DT
and LHNPs were made with proteoliposomes from the same preparation.
2.5.1 Treatment of UV-visible spectroscopy data
Spectroscopy data were corrected for sample dilution and for variations in background absorbance
(by setting absorbance at 750 nm as the zero for each spectrum). The changes in RR120
absorbance over time were monitored using absorbance at 539 nm, because it is less influenced by
the absorbance of reduced MtrCAB (α- and β- haem peaks at 552 and 522 nm).
In order to correct for the contribution of light scattering by (proteo)liposomes, the sample
absorbance was measured outside the RR120 absorbance peaks (i.e., 440 nm and 610 nm) and
used to estimate the optical density by comparing absorbance of intact and lysed (i.e., after addition
of TX) liposomes. I.e., Scattering440   A440finalDTspectrum  A440finalDTandTXspectrum, and
Scattering610   A610finalDTspectrum  A610finalDTandTXspectrum. The scattering contribution
at 539 nm was then estimated as an average of scattering at 440 and 610 nm. This estimate of light
scattering was then subtracted from all absorbance values at 539 nm values arising from liposome
photo-reduction and DT reduction. Relative absorbance values were calculated setting sample
absorbance at 0 minute as 100%.
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2.5.2 Observations of haem reduction state from the UV-visible
spectroscopy data
The absorbance spectrum of MtrCAB contains a heme Soret (γ) absorption peak centered at 410
nm, a visible-region peak at 531 nm and a shoulder at 560 nm. Upon haem reduction the Soret
(γ) peak shifts to 420 nm and two smaller α and β peaks can be distinguished at around 552 and
523 nm. [118] An example of MtrCAB absorbance spectrum is shown in Figure 2.8a.
Unfortunately, the other compounds (e.g. LHNPs, liposomes) present in MtrCAB proteoliposome
samples used for photoreduction experiments hinder the observation of haem absorbance. In order
to better observe the change in MtrCAB haem oxidation, a 1st derivative (i.e., A’) was calculated
for each spectrum. This allowed to observe presence of inversed peak (’dip’) of oxidised haems
at  416 nm, which gets shifted to  426 nm upon haem reduction. Figure 2.8b shows the A’
for purified MtrCAB. The haem reduction was assessed then by calculating the difference in A’
between the selected wavelengths (i.e., ∆A’ = A’418 - A’426)). In the case shown in figure 2.8b
∆A’ is -0.0035 and 0.02 for oxidised and reduced MtrCAB, respectively. The peak maximum
(and minimum) was determined for each condition containing different LHNP and MtrCAB
proteoliposome sample as shown in Figure 2.8c,d for g-N-CDs and RuP-TiO2. The calculated
∆A was then plotted over time, to show better the change from oxidised to reduced MtrCAB
haems.
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Figure 2.8: Observing reduction of MtrCAB haems using UV-vis spectroscopy. (a)
Absorbance spectrum of MtrCAB under oxidising aerobic conditions (black) and reduced by
dithionite (red). (b) The 1st derivative of MtrCAB absorbance (A’). Black – oxidised MtrCAB,
Red – MtrCAB reduced by dithionite. Dashed lines indicate wavelengths selected to assess haem
reductionby calculating the difference between them (i.e., ∆A’ = A’418 - A’426)). In this case
∆A’ is -0.0035 and 0.02 for oxidised and reduced MtrCAB, respectively.(c) Example of the
1st derivative taken of the absorbance spectra (A’) from g-N-CDs photoreduction of MtrCAB
proteoliposomes containing RR120. Oxidised and reduced haems have different signatures, and
the haem reduction is estimated by calculating the A’ difference at the wavelengths corresponding
the oxidised and reduced haem minima (416 nm and 426 nm, respectively). At the start of the
experiment MtrCAB is oxidised (dark red line) and gets reduced during illumination (dashed line);
Red line – reduced sample after addition of DT. DT – dithionite is included as indicator of fully
reduced haems. (d) Example of the 1st derivative taken of the absorbance spectra from RuP-
TiO2 photoreduction of MtrCAB proteoliposomes containing RR120. Although RuP absorbance
partially masks the signal of oxidised and reduced haems, the haem reduction was still estimated
by calculating the A’ difference at 416 nm and 426 nm. Coloured line segments indicate spectral
areas and the main chromophores responsible for the signal.
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2.6 H2 detection (Chapter 5)
2.6.1 Clark electrode setup and calibration
The hydrogen evolution was assessed by constant potential chronoamperometry (set potential
0.6 V vs Ag/AgCl, current sampled every second) using a Clark type electrode disc (Hansatech)
adapted for H2 measurements [138, 139]. The electrode system consisted of a Pt anode (2 mm
in diameter) and a concentric silver reference cathode connected via a thin layer of saturated
KCl electrolyte solution (Figure 2.9). The electrode system was enclosed and separated from
the reaction chamber with a polytetrafluoroethylene (PTFE) membrane (0.0125 mm x 25 mm x
 2 cm, Hansatech) held in place by an O-ring (Figure 2.9). The potential was regulated by a
potentiostat (PGSTAT30, Metrohm Autolab) controlled by Nova software (Metrohm Autolab).
The experiments were performed anaerobically placing the Clark type electrode in a Faraday cage
within the glovebox (LABmaster sp, MBraun, N2 atmosphere, <0.1 ppm of O2).
a) b)
Sample 
chamber
Electrode 
piece
c)
Cathode 
(Ag)
Anode 
(Pt)
Figure 2.9: The Clark electrode. a) A schematic of the Clark electrode used for H2 detection.
b) An image of the fully assembled system, where the electrode piece is fitted and sealed with O
rings below the reaction chamber. c) The electrode piece consists of a dome containing Pt anode,
surrounded by an Ag/AgCl counter electrode.
In this system, H2 as a non-ionized small molecule penetrates the PTFE membrane and is oxidised
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at the Pt anode. [140] The measured current is directly proportional to the concentration of
dissolved H2 and is limited to the rate of mass transport across the PTFE membrane, which in turn
is dependent on the H2 concentration in the sample chamber. [139, 140] Fresh PTFE membrane
was fitted daily and the Clark electrode was calibrated before each experiment using 5%-95%
H2 - N2 gas (BOC). The electrode calibration was performed by polarising the electrode at 0.6 V
vs Ag/AgCl for 10 minutes. Then 5% H2 calibration gas was flushed through the sample using
mass flow controllers (Sierra Instruments, accuracy  1%; typical flow rate 10 ml per minute) till
signal started to saturate. For practical considerations the duration of calibration was limited to
 10 - 20 min. The final measured value was considered to represent the sample saturated with
5% H2 gas. Finally, H2 was removed by flushing the sample with 100% N2 gas (BOC) using mass
flow controllers as before. A standard calibration curve is shown in Figure 2.10.
Capacitative discharge 5% H2 calibration N2  *
Figure 2.10: Calibration of the Clark electrode. First electrode is polarised for 10 min, then the
reaction chamber is flushed with 5% H2 calibration gas, followed by H2 removal by flushing the
sample with 100% N2 gas. The asterisk () indicates time period switching from H2 to N2 flush,
when H2 stream was stopped, but N2 had not been started yet. The measured electrochemical
current (scale on right) is converted into H2 concentration (scale on left) by approximating the
final calibration signal to represent the sample saturated with 5% H2 gas (i.e., 38µM).
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The H2 concentration of the sample saturated with 5% H2 was calculated using the Henry’s Law
constantHcp   7.9106  mol
m3Pa
   7.9104  molLatm. [141]H
cp was used for Henry’s volatility
KpcH defined as
KpcH  
p
ca
 
1
Hcp
,
where p is the partial pressure of H2 in the gas phase and Ca is the concentration of H2 in the
aqueous phase. [142] Thus the concentration of solution saturated with 5% H2 is:
ca  
p
KpcH
 
0.05 atm
1300 atmLmol
  3.8  105M  38µM.
This value was then used to convert the measured current into H2 concentration.
2.6.2 Chronoamperometry experiments
A typical experiment involved: Clark electrode calibration as described above, injection of a
catalyst containing solution (e.g., Pt NPs, Pt-Silica NPs, HydA1, liposomes) and injection of
an electron donor (typically 20 µL 0.57 M DT or g-N-CD as photosensitiser, followed by, for
example, addition of an electron mediator (methyl viologen, MV), a detergent to break lipid bilayer
(e.g., 1% v/v TX) or 50 µl 0.5 M OG or a sacrificial electron donor (50 mM EDTA) and sample
illumination. For the experiments assessing photocatalytic hydrogen evolution reaction (HER),
samples were illuminated using the same cold light source as for RR120 reduction experiments
in section 2.5. The light source contains a flexible fibre optic light conductor arm, which was
introduced within the Faraday cage and used to illuminate the sample sideways from about 10 cm
distance. Given the high variability of experimental conditions tested, the precise details are given
in the figure legend of each reported experiment.
2.6.3 Chronoamperometry data analysis
The measured current data was processed post-experiment to normalise it against changes in
sample volume (i.e., current was multiplied with sample volume in ml). In addition, data
corresponding to the time of chemical addition (up to 30 sec before and 60 sec after) has been
deleted to remove noise (spikes in current) caused by increased sample mixing. The catalytic
activity of the detected H2 evolution was assessed by fitting a line to the initial increase in signal.
The range for the linear fit was judged manually, to identify the longest available linear range of
the signal and limit such influences as current changes due to sample mixing or signal saturation.
In some cases, signal saturated so quickly that it was not possible to identify a reliable linear
activity. In these cases, data was used only for qualitative observation of H2 evolution activity.
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2.7 Trapping Ptsyn NPs into porous silica nanoparticles
(Chapter 5)
2.7.1 Trapping Pt nanoparticles into preformed commercial meSiO2
NPs
10 mg/ml meSiO2 stock solution in water was sonicated, centrifuged and resuspended to 80 mg/ml.
265 µl of Ptsyn nanoparticle solution was added to 50 µL of the 80 mg/ml meSiO2. Samples was
diluted to 500 µl in MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4) containing 2 mM MV.
Ptsyn and meSiO2 solution was incubated on a rolling shaker overnight (4°C). Samples were then
bath sonicated (Fisher Scientific) for 30 min and kept on rolling shaker till use.
2.7.2 Loading Pt nanoparticles while synthesizing gSiO2 NPs
Pt loaded bio-inspired ”green” SiO2 (gSiO2) NPs were synthesized with simultaneous loading
of Ptsyn nanoparticles in collaboration with Prof. Siddharth Patwardhan from the University of
Sheffield. [143] In short, 310 µL 94 mM pentaethylenehexamine (PEHA) solution was mixed
with 310 µL of 0.95 M sodium metasilicate (Na2OSiO2) and Ptsyn NPs (estimated concentration
0.6 mg/ml). Particles were formed after lowering the pH by adding 380 µL of 1 M HCl. Reaction
was carried out for 10 minutes. Particles were then washed by two cycles of sample centrifugation
(8000 g, 1min) followed by the pellet re-suspension in 2 ml of 1 M HCl to remove PEHA. Finally,
the particles were pelleted and the pellet was dried in oven (+ 40°C) overnight.
2.7.3 Forming supported lipid bilayer on SiO2 NPs
Lipid mixtures were mixed by dissolving and mixing lipids in chloroform, drying under a stream
of nitrogen and vacuum (for 2 hours) and finally storing dry aliquots in nitrogen atmosphere
as described in section 2.1. The lipid mixtures contained: fluorescently labelled lipids (e.g., 1%
wt/wt DGPE-CF or 0.4% Texas Red - DHPE) mixed with POPC, E. coli polar lipids, 2:1 E. coli
polar lipids : POPC and 5:3:1:1 E. coli polar lipids : POPC : POPG : POPE. Lipids were used to
form liposomes by rehydration by adding MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4)
at a typical concentration of 5 mg/mL. The lipid suspension was then extruded through a Mini-
Extruder (Avanti Polar Lipids), passing through a polycarbonate track-etched membrane (pore
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sizes 100 or 200 nm, Whatman) 11 times. 100 nm membrane was used for POPC, and 200 nm for
all experiments involving or comparing with lipid mixtures containing E. coli polar lipid extract.
Testing different lipid mixtures for forming supported lipid bilayer on meSiO2
Liposomes containing 1% wt/wt DGPE-CF combined with POPC, E. coli polar lipids, 2:1 E. coli
polar lipids : POPC or 5:3:1:1 E. coli polar lipids : POPC : POPG : POPE were mixed with
meSiO2 at a 12% wt/wt ratio of lipid bilayer to meSiO2. The lipid bilayer was then formed on
silica particles after protocol described in [144]. The lipid-silica sample was vigorously vortexed
for 2 min, followed by incubation on a rolling shaker for 1 h at 4°C. The nanoparticles were
collected by centrifugation (17 000 g, 1 min, 4°C). These were then re-suspended in buffer and
again subjected to another round of vigorous vortexing and incubation on rolling shaker for 1 h
at 4°C. Sample was then diluted 10x and transfered to a black 96-well plate (polystyrene, flat-
bottom µCLEAR®, Greiner Bio-One). The DGPE-CF fluorescence was measured using plate
reader (Hidex Chameleon, Driver Version: 4.48) by exciting fluorophore at 485 nm and reading
emission at 535 nm.
Forming supported lipid bilayer on Pt-loaded meSiO2 NPs
Ptsyn was trapped in meSiO2 as described in section 2.7.1. The resulting sample was mixed with
1 : 2 E.coli : POPC liposomes at a 17% wt/wt ratio of lipids to meSiO2 in the final volume of 130
µl MOPS buffer with 0.2 mM MV. The supported lipid bilayer was formed as described in [144]
and section 2.7.3. Prepared samples were tested for hydrogen production using Clark electrode
and the set-up described in section 2.6.
Forming supported lipid bilayer on gSiO2 NPs
Silica and silica/Pt NPs were suspended in the MOPS buffer and sonicated in bath sonicator for
about 30 - 40 minutes. Then liposomes consisting of POPC-1% DGPE-CF or POPC-0.4% DHPE-
Texas Red in MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4) were mixed with silica
particles at lipid:silica ratios ranging from 0 to 2 wt/wt. Samples were then sonicated at room
temperature in bath sonicator for about 10 minutes. Then samples were washed to remove free
liposomes by two cycles of sample centrifugation at 8000 g (18°C for 1 minute), removal of
the supernatant and re-suspention of the pellet in water. The fluorescence of lipids associated
Chapter 2. Materials and Methods 54
with gSiO2 and free liposomes was determined using black 96-well plate (polystyrene, flat-
bottom µCLEAR®, Greiner Bio-One) and a fluorescence microplate reader (Fluorostar optima
or VarioskanFlash) with excitation : emission at 485 : 517 nm for DOPE-CF labelled lipids and
595 : 615 nm for DHPE-Texas Red labelled lipids. Prepared samples were tested for hydrogen
production using Clark electrode and the set-up described in section 2.6.
55
Chapter 3
Interfacing inorganic nanoparticles
with conductive MtrC
3.1 Introduction
A key process for light-harvesting is electron transfer (ET) from one molecule to another. This
depends on multitude of parameters ranging from thermodynamic properties of electron donating
and accepting molecules, environmental conditions (e.g., temperature, pH) and the geometry
of the ET interface. [57, 145] One of the key ET interfaces for the liposomal light-harvesting
compartment introduced in Chapter 1 is between the LHNP and MtrCAB. This chapter aims to
map the molecular interface between TiO2 (common material used for light-harvesting in solar
cells and solar fuel cells) and the decahaem cytochrome MtrC, which forms the soluble part of
the MtrCAB conduit. This allows to identify the protein residues interacting with TiO2 at one
terminus of the MtrCAB conduit in the absence of other interfering compounds such as detergent
or liposomes, which are needed to stabilise the membrane region of MtrCAB. Previous research
has indicated binding interaction between MtrC and TiO2 NPs [146], but not much is known about
the binding interface. Identification of the protein residues at this binding interface will provide
basis for better understanding of the molecular interactions and forces between TiO2 particles and
MtrC. This can then pave ways to improve ET by directed site-specific protein and nanoparticle
engineering.
The chapter starts with a brief introduction in the current understanding of binding interactions
between MtrC(AB) and metal oxides (section 3.1.1), the binding interactions between TiO2 and
peptides (section 3.1.2) and the main methods used to probe interactions between biological
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and inorganic materials (section 3.1.3) and reasoning why an experimental technique termed
’protein footprinting’ was chosen to map the molecular interface between TiO2 and MtrC. This is
section follows with an introduction to the method (XFMS, X-ray footprinting Mass Spectrometry)
chosen for this study. Section 3.2 describes the considerations and experiments made for sample
optimization. The chapter then continues with the experimental results and a discussion.
3.1.1 Binding of MtrC to metal oxides
As described in Chapter 1, MtrCAB is a conductive, transmembrane protein complex isolated from
the bacterium Shewanella oneidensis. [90] The biological function of outer membrane protein
complexes such as MtrCAB is to support the anaerobic growth of the bacterium by shuttling
electrons out of the cell to extracellular electron acceptors, for example, insoluble iron and
manganese minerals, e.g., hematite (α-Fe2O3), goethite (α-FeO(OH) ), lepidocrite (γ-FeO(OH) )
etc. [90–92]. The final stages of ET to these minerals is supported by MtrC and the closely related
proteins MtrF and OmcA either by direct contact with the mineral or indirectly using soluble
electron mediators as flavins. [90] Figure 3.1 shows the structure of MtrC and the putative location
of MtrC within MtrCAB complex. Observations indicating active localisation of S. oneidensis
proteins (including MtrC and OmcA) at the mineral interface, suggest that MtrC is evolved to
specifically bind and exchange electrons with such metal oxides as iron minerals. [147]
Several studies have attempted to characterize in vitro the interaction between hematite and all
three closely related protein homologs: MtrC, OmcA and MtrF. [134, 147, 149] These studies
report of a stable and specific interaction between hematite and all three extracellular cytochromes.
[134,147,149] The redox state of the protein as well as the binding interaction can induce structural
rearrangements of OmcA and MtrC. [147,149,150] In addition, hematite binding to MtrC changes
between purified MtrC and MtrC in vivo. Thus, the binding affinity of MtrC in vivo was influenced
by both the redox state and the concentration of hematite particles, whereas purified MtrC showed
a constant binding affinity. [150] As for the location of hematite binding, MtrC and OmcA contain
a proposed hematite binding amino acid sequence (Ser/Thr-Pro-Ser/Thr) near their haem 10 (C-
terminus). [151] Such sequence, however is absent from MtrF, and the specific MtrF- hematite
binding has been attributed to complementary electrostatic interactions with protein region near
haems 6 and 7. [134] In this case, no large conformational changes were observed upon hematite
binding. [134]
As MtrC and OmcA have also been identified as involved in reduction of other metal ions such as
Mn(IV) and V(V) [152–154], it is possible that these proteins are adapted to accommodate a broad
Chapter 3. Interfacing inorganic nanoparticles with conductive MtrC 57
‘Front’ view ‘Back’ view
(rotated 180° around the y-axis)
Haem 5
Haem 10
C-terminus
N-terminus
I 
II
III IV
I II
III
IV
a) MtrC
b)
Figure 3.1: The structure of MtrC, which forms a soluble, conductive part of the MtrCAB
conduit. (a) A cartoon representation of MtrC structure (PDB ID: 4LM8 [148]). The 10 haems
are identified as yellow sticks, where the central iron atoms are shown as red spheres. In this
representation 4 protein regions (domains) are distinguished as primarily forming β-strands or
haem-containing α-helices. These are numbered and colour-coded according to their position
within the primary protein sequence, where blue corresponds to residues 44 to 175, green - from
176 to 331, orange - from 332 to 485 and purple - from 486 to 669. The beginning (first 43
residues) and end of the protein are absent from the published crystal structure. (b) Structure of a
full MtrCAB complex from a closely related bacterium species Shewanella baltica OS185 [94]. as
published in [94] and an insert showing the structure of MtrC (PDB ID: 4LM8). Figure modified
after [94].
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range of metal oxide materials. Thus it could be possible to interface these proteins to a range
of natural and engineered metal oxide surfaces. For example, light-active dye-sensitised TiO2
nanoparticles (RuP-TiO2) have been reported to bind OmcA and MtrC immobilised on a template
stripped gold electrode modified with a self-assembled monolayer, made up of various mixtures
of alkanethiols. [63, 146] The binding was estimated to occur at 1:1 ratio between the TiO2 NP
and MtrC. [63] In addition, these observations were accompanied with a decrease in electroactive
coverage of MtrC, which has been attributed to changes in the mobility and/or orientation of MtrC.
[63,146] The binding of TiO2 NP to immobilised monolayer of MtrC varied also among different
nanoparticles. Thus amino-capped TiO2 NP showed less binding compared to the ones capped
with carboxyl- groups (i.e., DHBA), whereas no binding was observed for the two commercial
TiO2 NPs. [146]
To summarize, MtrC seems to be able to bind several different metal oxides; but many questions
remain about the binding interactions and surface parameters, as well as the changes in MtrC
conformation and activity. The work described in this chapter aims to identify MtrC residues
involved in the binding interface with a commercial TiO2 NP and discuss any insights these could
provide about the forces governing the interface.
3.1.2 Binding of TiO2 to biological molecules.
TiO2 is found in several natural minerals, including rutile, anatase and brookite. [155] Numerous
experimental and theoretical molecular dynamics studies have been reported for interactions
between TiO2 surface and various small (bio)molecules. [155] These indicate that the nature of
bio-molecular interactions with TiO2 surface is primarily electrostatic. The surface of bare TiO2
normally reacts with water molecules, which results in surface hydroxylation, typically ranging
from 0.3 to 10 OH/nm2. [155] This surface hydroxylation then leads to hydrogen bonding with
water molecules and formation of an ordered water interface. [155]
Different types of surface hydroxyl groups are present on TiO2 surface (e.g., basic and acidic,
bridged and terminal OH groups), which determine the electrostatic interactions and adsorption
of amino acids. [155] Thus, charged amino acids (i.e., Arg/R, Lys/K, Glu/E, Asp/D) show the
highest affinity, followed by polar amino acids (i.e., Ser/S, Thr/T, Asn/N, Gln/Q, Tyr/Y), while
hydrophobic amino acids (i.e., Val/V, Leu/L, Ile/I, Phe/F) show limited or zero affinity. [155]
Charged and polar amino acids are also present within TiO2 binding peptides identified via phage-
display (e.g., RKLPDA, FATDSLIK, GHTHYHAVRTQT, CHKKPSKSC). [155,156] In addition,
peptides utilised for TiO2 precipitation and engineering of cell interactions with TiO2 surface
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(e.g., RGD and (RKK)4D8) also contain primarily charged amino acids. [155] The importance
of the charge of the amino acids, was tested in a point mutation study of the TiO2 binding
peptide CHKKPSKSC. [156] In this study, each individual amino acid residue was probed and
replaced by K, A or R. [156] Interestingly, the three lysines were essential for binding to TiO2, but
additional lysines actually lowered the binding affinity. Further theoretical exploration suggested
that the binding affinity is determined not only by the electrostatic interaction of the three Lys
residues, but also by the context of other surrounding amino acids, which can reduce the peptide’s
conformational flexibility and thus promote favourable binding interactions. [156]
Although several studies have explored TiO2 binding to small peptides, very little is known about
TiO2 binding interactions and interface with larger protein molecules. [155] Proteins contain
a range of different exposed amino acid residues, which can change with changes in protein
conformations. Furthermore, the surrounding environment (e.g., water and buffer molecules)
could also play role to modulate the binding affinity. [155] The answering of these questions
starts with understanding the interface between TiO2 and different proteins. Thus the aim of this
chapter - determining the molecular interface between TiO2 and MtrC- is a step towards building
a dataset for further exploration of forces and interactions within this bio-inorganic interface.
3.1.3 Structural studies of protein-NP interaction
Several techniques can be used to study protein interaction with inorganic nanoparticles.
These include absorbance and fluorescence spectroscopy, circular dichroism, dynamic light
scattering, surface plasmon resonance, TEM, chromatography, electrophoresis, isothermal
titration calorimetry, infrared spectroscopy, nuclear magnetic resonance (NMR), small angle
X-ray scattering, mass spectrometry (MS) based proteomics, as well atomic force microscopy
(AFM) and theoretical studies in silico. [147, 157, 158] Most of these techniques provide an
insight in the general characteristics of the binding event, but the structural resolution of the
molecular interface often is limited. For example, protein monolayers have been probed with
metal modified AFM-tips. [147] This allowed to estimate that the binding strength of OmcA-
hematite was about twice that of the MtrC-hematite bond and is strongly correlated to hematite
binding with the whole bacterial cell. Other techniques must be used to gain further molecular
and structural information about the binding interface. For example, information about broad
changes in protein secondary structure can be gained through circular dichroism spectroscopy
[150,157,158], whereas monitoring of finer structural details at the binding interface can be gained
with NMR (typically limited to small proteins, @35 kDa in size) and various MS based proteomics
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approaches. [129, 157]
The aim to locate TiO2 binding interface on the MtrC requires the of use techniques providing
high structural resolution. As MtrC is too big for standard NMR studies, proteomics approach
termed protein footprinting was used. Protein footprinting is a strategy where a change in the
solvent accessibility of protein backbone and residues (e.g., due to ligand or NP binding) is
monitored through their sensitivity to a chemical modification or backbone cleavage. As the
result, solvent exposed protein areas become modified and chemically different from the native
protein, and the imprint (or footprint) of these modifications can then be analysed using mass
spectrometry (MS). [129] Different types of labelling can be used for protein footprinting, such
as protease-cleavage of exposed protein backbone, deuterium exchange of amide protons in the
protein backbone (hydrogen deuterium exchange, HDX), isotope-coded affinity tags to sample
accessibility of specific amino acids (e.g., cysteine) as well as the use of oxidative hydroxyl
radicals (YOH) to label solvent exposed amino acid side-chains. [129–131] Each of these have
their own advantages and disadvantages. For example, proteases can be used in wide-range of
sample conditions, but often are specific to certain residues and are limited to protein areas that
are sterically exposed and accessible to a large enzyme. [129, 134] HDX assesses non-specific
protein backbone accessibility to solvent, but the nature of deuterium labelling is reversible, which
constrains options for further sample processing and handling. [129, 130, 132] The resolution
of isotope-coded affinity tags to sample accessibility of specific amino acids (e.g., cysteine) are
limited to the presence of these specific amino acids. [129] In this study YOH labelling was used, as
it provides fast, permanent and non-specific modification (i.e., all exposed residues can potentially
be modified), which allows greater flexibility in subsequent sample processing and use of different
proteases. [129, 132]
There are several methods to produce YOH in solution for oxidative footprinting. These include
methods involving specialised facilities, for example, electron pulse radiolysis, where electron
pulses are accelerated by a linear accelerator (LINAC) to megaelectronvolt scale and are able
to ionize water. [129] Similar process is synchrotron radiation footprinting, where radiolysis
of water is achieved using photons in the kilovolt X-ray range (x-ray footprinting, XF). [129]
Other reported strategies for YOH generation that involve facilities with easier access, are UV-
light laser photolysis of hydrogen peroxide (fast photochemical oxidation of proteins, FPOP),
use of chemical oxidants (e.g., Fenton-like reactions, tethered metal chelates, peroxynitrite) or
high voltage electrical discharge, which takes advantage of electrospray ion source used in mass
spectrometry. [129]
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Figure 3.2: Schematic representation of YOH footprinting. A protein and its complex with a
nanoparticle are exposed to hydroxyl radical source (e.g., synchrotron beam radiolysis). These
YOH radicals modify the side chains of the protein. Afterwards, the protein samples are digested
with proteases creating a pool of different peptides with and without modifications. MS is
then used to quantify the extent of modification through measuring the amount of modified and
unmodified peptides. This step allows to observe the solvent accessibility of each peptide in both
the isolated and complexed states. The exact modification sites are identified by tandem MS
(MS/MS). The dose-response example shows a slower rate of modification for the peptide in the
presence of NP compared to the condition of peptide in the absence of NP. This indicates that this
peptide contains reactive side chain residues, which have been shielded by the binding process.
Figure reproduced and modified after [129].
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X-ray Footprinting - Mass Spectrometry (XFMS) analysis
The work described in this chapter uses XF and was performed in consultation with Dr Caroline
Ajo-Franklin (Molecular Foundry), Dr Corie Ralston and Dr Sayan Gupta (Advanced Light
Source, ALS) from the Lawrence Berkeley National Lab (LBNL). I designed my experiments
based on their recent work mapping the MtrF binding interface with hematite [134] and I
performed XFMS experiments based on their extensive XFMS expertise and using their facilities
at the LBNL. Use of synchrotron radiation for YOH footprinting confers several advantages over
other YOH footprinting methods. In XF YOH radicals are generated in situ without addition
of chemical reagents (e.g, Fe-EDTA an H2O2), that could affect the protein conformation or
damage/unfold the protein. [132] In addition, the timescale of radical production is faster in XF
(milliseconds) than the microseconds used in laser photochemical methods such as FPOP. [132]
This advantage of speed allows to control the radical dose received by protein samples and limit
sample unfolding and conformational changes caused by residue modification and any secondary
radical oxidation reactions. [132]
In this approach protein samples from two conditions (i.e., with and without TiO2 NPs)
are irradiated with X-rays. Water ionization generates hydroxyl radicals that label amino
acid side chains exposed to aqueous environment even within buried protein cavities. [132]
Resulting protein typically contain covalent hydroxyl- (+16 Da or +32 Da) modifications, which
are subsequently detected by liquid-chromatography tandem mass-spectrometry (LC-MS/MS).
[129, 132, 133] The binding with TiO2 NP is expected to shield the bound protein interface from
water, thus comparison of peptide modification with and without TiO2 NPs allows identification
of protein residues involved in MtrC : TiO2 interface. The summary of XFMS approach is shown
in Figure 3.2.
3.2 Sample optimisation for XFMS
Hydroxyl radicals are a useful probe for protein footprinting because these provide fast, permanent
and non-specific modification of any exposed protein residues. [129] The modification rate of
a protein residue depends on the specific reactivity and the local context of that residue. For
example, cysteine, tryptophan, tyrosine and methionine react readily with YOH radicals, while
asparagine and glycine do not. [129] Challenge is to find sample conditions that permit generation
of optimal YOH dose and generate enough protein modifications to be later analysed with LC-MS.
This requires considerations of the sample composition, including, what buffer and how much
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protein and TiO2 NP to use and in what concentrations.
3.2.1 Buffer composition
A key step in XF experiments is water ionization by x-ray irradiation, which generates YOH
that modify the side chains of protein residues [133]. Thus protein labelling is related to YOH
concentration, which in turn depends on X-ray exposure time and the flux density of an X-ray
beam. [133] As the flux density of the X-ray beam is kept fixed, the dose of YOH concentration
is regulated by changing the duration of sample exposure. Many sample components such as
buffering agents (e.g., MOPS, Tris, HEPES), reducing agents and detergents used for membrane
protein solubilisation react with YOH (extrinsic radical scavengers) reducing the effective YOH
dose. [133] In addition, sample components (e.g., macromolecular assemblies) can also react with
YOH (intrinsic scavengers). [133] Therefore, the duration of sample irradiation often has to be
increased to overcome the radical scavenging processes. [133]
In light of this, the many common buffers (e.g., 20 mM MOPS, 30 mM Na2SO4) were not suitable
due to reported radical scavenging. [136] Unfortunately, other inorganic compounds commonly
used for XF experiments (e.g.,Na-KPO4 buffer, NaHCO3, NH4HCO3) were also not suitable,
as these have high affinity to TiO2 surface and would compete with protein binding. [159–161]
Instead, NH4Cl was selected as a buffering agent for the XF experiments.
3.2.2 Amount of MtrC and TiO2 nanoparticles
X-ray assisted protein footprinting requires quite large amounts of protein. Each sample must
contain enough protein for peptide detection with LC-MS/MS and to cover potential protein losses
during sample processing stage between sample radiolysis and the LC-MS/MS step. In addition,
multiple samples are required for each condition (i.e., with and without TiO2) to be able to measure
the rate of residue modification (i.e. the amount of residue modification has to be quantified
over increasing duration of radiolysis). The work described in this chapter used 0.3 mg MtrC
for a single experiment with 2 experimental conditions (with and without TiO2) and 5 different
radiolysis exposure times (i.e., 0, 12.5, 25, 50 and 75 ms).
High amounts of protein require even more TiO2 NPs. An excess amount of TiO2 is required in
these experiments to make sure that nearly all of proteins are bound to TiO2 nanoparticles. This
then simplifies the subsequent data analysis, where the fraction of modified versus unmodified
peptide is estimated for each modified residue in both control and +TiO2 conditions. To satisfy the
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requirement of having large amounts of TO2 NPs, XF experiments used commercial anatase TiO2
nanoparticles (a-TiO2). These nanoparticles have a similar size (5 nm) to the dye-sensitised TiO2
(i.e., RuP-TiO2; 6.8 nm in size) provided by Dr Reisner for the use as LHNP.
The caveat for using a-TiO2 is that these nanoparticles have different surface chemistry. The
differences in the nanoparticle surface is schematically illustrated in Figure 3.3. Commercial
a-TiO2 have no surface modification and thus likely have water hydroxylated TiO2 surface
(Figure 3.3a). In comparison, RuP-TiO2, which are used as LHNPs, are surface-stabilized with
DHBA (dihydroxy-benzoic acid) and photosensitized with RuP (Figure 3.3c). These particles
were first synthesized as DHBA-TiO2 (Figure 3.3b), which have been previously estimated to
contain 1.4 DHBA-molecules present per square nanometre of the DHBA-TiO2 surface. [63]
Then RuP was bound to the DHBA-TiO2 via the phosphate groups of RuP with an estimated
efficiency of 90 ± 20 nmol RuP per mg of DHBA-TiO2. [63]
To summarize the main difference in the surface chemistry of a-TiO2 and DHBA-TiO2 and RuP-
TiO2 is that the surface of a-TiO2 primarily contains hydroxyl groups resulting from interaction
with water molecules, whereas DHBA-TiO2 and RuP-TiO2 contain carboxylic acid functionality
(due to DHBA) and RuP-TiO2 also has the RuP complex. These differences in surface chemistry
are also going to cause differences in the interaction between MtrC (and MtrCAB) and the different
TiO2. For example, carboxyl-groups are more negative than hydroxyl groups, DHBA-TiO2 will
bind stonger to the positive amino acids such as Lys and Arg. This is an important caveat for
using a-TiO2 compared to the use of the light-harvesting RuP-TiO2, which unfortunately were
not available in the quantities required for the XF experiments.
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Figure 3.3: The surface differences between TiO2 nanoparticles. (a) The bare surface of a-
TiO2 gets hydroxylated in aqueous solutions. Panel modified after [155]. (b) DHBA-TiO2 NPs
are surface-functionalised with DHBA to increase the solubility of nanoparticles. (c) RuP-TiO2
NPs are DHBA-TiO2, which have been additionally light-sensitized with RuP dye. Panels (b) and
(c) have been modified after [63]. The chemical structure of DHBA was obtained from the internet
(https://www.chemspider.com/Chemical-Structure.71.html; accessed on 03/05/2020).
The lack of surface modifications make a-TiO2 more prone to aggregation as was seen in DLS
(Figure 3.4), where introduction of NH4Cl resulted in particle aggregation. Further addition
of similar amounts of MtrC seemed to slow the a-TiO2 aggregation, resulting in stable particle
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aggregates of 100-200 nm in size. In order to minimise the effect of particle aggregation, a-TiO2
NPs were added to the buffered protein sample immediately before experiments.
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Figure 3.4: DLS of a-TiO2 nanoparticles in water (MQW, black), in 5 mM NH4Cl (pH8,
dashed red line) and in 5 mM NH4Cl with 50 nM MtrC (blue line). Approximately 11 µg
(70 nmol NP/ml) a-TiO2 NPs were used. Error bars represent standard deviation, where nC3.
3.2.3 Estimating the binding ratio of MtrC and TiO2 NPs.
A key feature for XFMS is to determine the optimal concentration and ratio of MtrC and a-TiO2.
As mentioned earlier, a-TiO2 should be in excess so that all (or nearly all) of MtrC would be
interacting with the surface of a-TiO2. In order to do that, the binding stoichiometry between
MtrC and a-TiO2 was characterised using co-sedimentation assay as described in section 2.4.1.
Protein was mixed with different amounts of a-TiO2 NPs and incubated at room temperature for
about 20 min. Bound proteins were then pelleted together with TiO2 NPs by ultracentrifugation,
and the amount of non-sedimented (‘free’) protein was determined optically by measuring the
absorbance of supernatant (Figure 3.5 a and b). Then ammonium bicarbonate (NH4HCO3) was
added to the MtrC-TiO2 pellet. In this case, the binding of carbonate ions (HCO2 and CO
2
2 )
to a-TiO2 is exploited to displace MtrC from the a-TiO2 surface. [127, 128] The a-TiO2 was then
removed again by ultracentrifugation as described in section 2.4.1. The amount of MtrC recovered
from a-TiO2 was again measured optically (Figure 3.5 c and d).
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Figure 3.5: MtrC binding to and recovery from a-TiO2 nanoparticles. (a) Representative
example of a co-sedimentation assay showing a decreasing concentration of free MtrC (initial
concentration 160 nM) in supernatant after protein sedimentation with increasing concentration
of a-TiO2 (0 – 120 µg/ml) in 5 mM NH4Cl buffer, pH 8. (b) Co-sedimentation of a-TiO2 with
MtrC in 5 mM NH4Cl, pH 8. Error bars represent standard deviation, where nC3. (c) The amount
of MtrC bound and pelleted together with a-TiO2 (blue) is compared to the amount of recovered
MtrC (grey) displaced from a-TiO2 by carbonate ions. MtrC amount is shown relative to the initial
amount of protein present in sample before co-sedimentation and recovery assays. n=3 (d) The
haem absorbance of oxidised (red) and reduced (blue) MtrC exhibit identical characteristics before
(’control’) and after binding a-TiO2 (’Recovered MtrC’).
These experiments demonstrate 100% MtrC binding, when the total a-TiO2 surface area was
around 3000 mm2 (Figure 3.5b) and particle ratio was about 2:1 a-TiO2 : MtrC (50% MtrC binding
at 1:1 particle ratio). (For convenience, the condition when all (or half) of the initial MtrC was
sedimented is described as ’100%’ (or ’50%’ ) MtrC binding.) Thus, a particle ratio higher than
2:1 should be used for XFMS experiments to ensure conditions that nearly all MtrC are bound to
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a-TiO2.
It has been reported before that protein interactions with nanoparticles can lead to changes in
protein structure and even protein unfolding [155, 157, 158, 162]. Experiments on MtrC recovery
from co-sedimented MtrC : a-TiO2 pellets aimed to test if MtrC binding to a-TiO2 leads to
irreversible protein conformation changes. The amount of recovered protein was estimated relative
to the initial protein amount used for co-sedimentation experiments. Figure 3.5c compares the
amount of recovered protein to the estimate of the fraction of MtrC sedimented as MtrC :a-TiO2
complex. This approach indicated that the protein recovery is influenced by the concentration of
a-TiO2 during co-sedimentation (seen in Figure 3.5c, where the blue bars indicate how much MtrC
was co-sedimented with a-TiO2, and the overlapping grey bars indicate the amount of subsequently
recovered MtrC). Thus all co-sedimented MtrC was recovered from the experiment involving a-
TiO2 with the total surface area of 700 mm2 (1:2 particle ratio of a-TiO2 :MtrC), whereas only
a fraction of MtrC was recovered from samples containing higher a-TiO2 concentration. This
could be explained by an increase in a-TiO2 aggregation at higher a-TiO2 concentration leading
to protein entrapment within the a-TiO2 aggregates. It is also possible that MtrC gets not only
entrapped but also damaged and unfolded at higher a-TiO2 concentrations.
Protein absorbance of the recovered MtrC was measured (Figure 3.5d) under oxidative and
reductive conditions, and showed the same absorbance profile as the control, indicating that the
interaction with a-TiO2 did not cause changes in the local haem environment. As the 10 haems of
MtrC span the whole protein, this is a strong indication that the recovered MtrC have maintained
structural integrity. This is important because following x-ray irradiation, the protein must be
recovered and separated from a-TiO2 for further sample processing and MS analysis.
Exploring interaction between MtrC and TiO2 NPs in broader context.
So far binding interaction and ratio has been explored only between MtrC and commercial a-
TiO2 in 5 mM NH4Cl. In order to estimate how this interaction relate to the full membrane
protein complex, another set of co-sedimentation assays was performed with MtrCAB solubilised
in detergent (LDAO) (Figure 3.6). MtrCAB showed similar binding to a-TiO2 as MtrC, showing
50% and 100% binding at approximately 2:1 and 1:1 MtrCAB : a-TiO2 ratios, respectively. The
observation of similar affinity between a-TiO2 and both MtrC and MtrCAB, suggests that MtrC
interaction with MtrAB does not change MtrC binding capacity to a-TiO2. A less likely scenario
would be that MtrAB does shield some of MtrC binding interface with a-TiO2, but in that case
MtrAB provides complementary interactions with a-TiO2.
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Figure 3.6: Detergent solubilised MtrCAB binding to a-TiO2 nanoparticles. Co-
sedimentation of a-TiO2 with MtrCAB in 5 mM NH4Cl, 5 mM LDAO, pH 8. Error bars represent
standard deviation, where nC3.
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Figure 3.7: MtrC binding to DHBA-TiO2 nanoparticles. (Co-sedimentation of DHBA-TiO2
with MtrC in 20 mM MOPS, 30 mM Na2SO4, pH 7.4. Error bars represent standard deviation,
where nC3 with the exception of sample containing 2000 mm2 DHBA-TiO2 in (d), where n =2.
Another set of experiments was performed to gain an insight how binding interaction might
change with TiO2 NPs with different surface modifications. For this a co-sedimentation assay was
performed with DHBA-TiO2 NPs (Figure 3.7. DHBA-TiO2 were chosen as these are precursor
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NP for the light-harvesting RuP-TiO2 NPs. RuP-TiO2 were not suitable for this assay due to the
spectral overlap of the absorbance of the photosensitiser dye (RuP) and MtrC haems.
The data in Figure 3.7 indicate that almost all MtrC was co-sedimented with DHBA-TiO2, when
the total TiO2 surface area was around 1100 mm2. This equates to particle ratio of about 1:1
DHBA-TiO2 : MtrC and observation that 50% of available MtrC were sedimented at around 1:3
particle ratio. This relatively high MtrC : DHBA-TiO2 ratio suggests that several MtrC molecules
might be able to bind to a single DHBA-TiO2. Comparison of these results to a-TiO2, it can be
noted that MtrC has lower binding affinity to a-TiO2 than DHBA-TiO2. This is most likely due
to the different surface chemistries between these particles, where a-TiO2 should have exposed
hydroxyl groups, whereas DHBA-TiO2 contain exposed carboxyl groups (see Figure 3.3). This
observation of change in binding affinity due to difference in particle surface chemistry might
hint that this particle interface is at least partly governed by electrostatic interactions. One
caveat to comparing these co-sedimentation experiments between a-TiO2 and DHBA-TiO2 is that
experiments with DHBA-TiO2 were performed in a buffer with higher ionic strength. In order to
estimate the effect that increased charge screening due to higher ionic strength has on MtrC binding
to these different TiO2 particles, it would be useful to perform co-sedimentation experiments with
DHBA- TiO2 in 5 mM NH4Cl (or co-sedimentation with a-TiO2 in the MOPs buffer, 20 mM
MOPS, 30 mM Na2SO4, pH 7.4).
3.2.4 Estimation of the required x-ray irradiation dose.
After considering the initial sample conditions (i.e., buffer, TiO2 NPs, the ratio of MtrC and a-TiO2
NPs), these experimental conditions were tested at the synchrotron beamline. The influence of
different sample components on YOH dose is commonly estimated indirectly - observing bleaching
of irradiated fluorescent dye (Alexa Fluor 488), as reported in section 2.4.2. Figure 2.2 provides an
example of dose-response plots of MtrC with and without a-TiO2. The apparent rate constants of
the fluorophore decay in various buffer and a-TiO2 conditions are summarised in Table 3.1. These
results indicate that MtrC was not scavenging YOH, whereas a-TiO2 appeared to scavenge YOH in
5 mM NH4Cl. Interestingly, the YOH scavenging was not influenced by a-TiO2 concentration as
the rate constant was essentially the same for samples containing 0.2-3 mg/ml a-TiO2. Upon closer
investigation, it was noticed the fluorescent dye (Alexa Fluor 488, Figure 2.2b) has a carboxylic
and hydrazide groups, which could interact with a-TiO2 surface. The resulting binding between
fluorophore and a-TiO2 could lead to enhanced fluorophore protection from oxidative YOH. To
test this hypothesis, a similar YOH dose-response assay was performed in 50 mM phosphate buffer
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with and without a-TiO2 (see Table 3.1). In this case, phosphate ions (similarly to carboxyl-
groups used for MtrC recovery from co-sedimentation experiments) bind the a-TiO2 surface and
prevent binding of the fluorescent Alexa dye. The result showed no YOH scavenging by a-TiO2 in
phosphate buffer. Thus, it was concluded that these sample components (i.e., 5 mM NH4Cl, MtrC
and a-TiO2) were not significant scavengers of YOH. The estimated rate of 30 s1 indicates that
sample could be effectively radiolysed and modified with YOH radicals using x-ray exposure times
ranging fom 0 to 70-80 ms (determined by Dr. Sayan Gupta based on his extensive experience
with XFMS).
Initially, XFMS analysis of detergent solubilised MtrCAB complex interaction with a-TiO2 were
also intended. Unfortunately, this proved to be impractical as the YOH scavenging of the detergent
(5 mM LDAO) was too high (Table 3.1).
Table 3.1: Summary of YOH modification rate constants from fluorophore dose-response assays
Buffer Protein a-TiO2 Rate  SD (s1) n
5 mM NH4Cl - - 35  6 2
5 mM NH4Cl 0.2 µM MtrC - 31  2 2
5 mM NH4Cl 0.2 µM MtrC 0.2 mg/ml 11  1 2
5 mM NH4Cl - 0.3 mg/ml 8 1
5 mM NH4Cl - 3 mg/ml 10 1
50 mM Pi buffer - 3 mg/ml 23 1
50 mM Pi buffer - - 26 1
5 mM NH4Cl, 5 mM LDAO - - 12 1
5 mM NH4Cl, 5 mM LDAO 0.4 µM MtrCAB - 11 1
5 mM NH4Cl, 5 mM LDAO - 0.3 mg/ml 10 1
Pi - phosphate buffer; n - number of experimental repeats
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3.2.5 Summary of sample conditions derived for XFMS experiments.
The previous few sections list a number of considerations and experiments aimed to optimize
sample conditions for XFMS. The final conditions and the reasoning for them are summarized
below:
1. 5 mM NH4Cl buffer:
(a) NH4CL does not bind a-TiO2 and is not scavenging YOH;
(b) low concentration to minimise a-TiO2 aggregation;
2. 0.3 mg MtrC used per a single XFMS experiment (2 experimental conditions, i.e., with and
without TiO2, and 5 different radiolysis exposure times):
(a) enough to detect peptides by LC-MS/MS despite large potential losses during sample
processing;
(b) large sample volume to keep MtrC in concentration comparable to conditions in co-
sedimentation experiments (i.e., 0.2 µM);
3. commercial a-TiO2:
(a) available in bulk to satisfy the requirements for large amounts of TiO2 NPs;
(b) main caveat is the difference in surface chemistry to the light-harvesting RuP-TiO2
NPs;
4. particle ratio of 5:1 between a-TiO2 and MtrC:
(a) higher than 2:1, to make sure that all (or almost all) MtrC is bound to a-TiO2;
(b) increased even more to compensate a-TiO2 aggregation in buffer, which effectively
reduce the particle ratio between a-TiO2 and MtrC;
(c) the excess of a-TiO2 over MtrC might lead to higher prevalence of non-specific
binding and will have to be accounted for during XFMS data analysis;
5. radiolysis exposures ranging from 0-70-80 ms:
(a) determined from Alexa fluorophore dose-response rate constant assay results by Dr.
Sayan Gupta.
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3.3 MtrC : a-TiO2 XFMS analysis
MtrC : a-TiO2 samples in 5 mM NH4Cl were radiolysed at ALS based on work published in
[133, 134] as described in section 2.4.2. Resulting proteins were then proteolysed and analysed
using LC-MS/MS analysis at the Biomolecular Mass Spectrometry Facility of the University of
Leeds as described in section 2.4.2. The summary of XFMS approach is shown in Chapter 2
Figure 2.1 and for convenience is reproduced here as Figure 3.8.
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Figure 3.8: Overview of XFMS analysis. (a) Schematics showing main stages of XFMS
approach. (b) Example of XFMS illustrating the water (blue dots) radiolysis and generation
of hydroxyl- radicals (red dots), which then modify protein residues exposed to water. The
conformational differences between protein in state A and state B lead to selective labelling of
the identified phenylalanine (Phe). Protein is then digested with proteases and analysed using LC-
MS/MS. LC quantitatively separate the peptides at different retention times (RT), which are then
identified by the MS. MS/MS allows determination of the specific site of the modification. The
quantification of the fractions of the unmodified peptide over exposure time (dose-response plot)
allows determination of site-specific modification rate constants (k1). These rate constants are
then compared between different sample conditions and their ratios (R) are used to describe the
solvent accessibility changes due to any binding-interactions or conformational changes. The final
result is mapped onto available structures. Figure reproduced and modified after [131].
XFMS experiments involved two conditions (i.e., MtrC with and without a-TiO2). Samples
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from each condition were radiolysed for 5 different exposure times (e.g., 0, 12.5, 25, 50 and
75 ms). MtrC from each sample was then proteolysed and the resulting native (i.e., unmodified)
and modified peptides were identified. Thus terms ’native’ and ’modified’ are used within this
chapter to describe whether a XF hydroxyl- modification (+16 Da) is detected on a peptide
residue, peptide or protein. Then the amount and the distribution of hydroxyl- modifications
were quantified across the 5 exposure times to produce a dose-response plot for each detected
modification. A modification rate constants (k1) were then determined for each modification,
which were compared between conditions as the modification rate ratio (R) of MtrC and MtrC : a-
TiO2 complex.
3.3.1 Protein coverage.
Overall, MS/MS identified peptide fragments covering around 68% of the MtrC sequence
(Figure 3.9) across exposed samples from both conditions (i.e., with and without a-TiO2). The
missing peptides are generally located at the beginning and the end of the MtrC sequence, as
well as the areas containing haem-groups. The 10 haems of MtrC are covalently attached via two
cysteines in a CXXCH polypeptide motif, where X denotes unconserved amino acid within the
motif [163] and are depicted red in Figure 3.9. It has been noted before that haem-containing
fragments are more difficult to identify by MS/MS due to such properties as differing charge
state of the haem iron and atypical peptide fragmentation. [164] De novo peptide sequencing by
MS/MS also identified which peptides and peptide residues contained hydroxyl- modifications.
The examples of obtained protein coverage and the identified +16 Da modifications of XF modified
MtrC with and without a-TiO2 are shown in Figure 3.10. This Figure provide an initial qualitative
insight in the differential XF labelling of samples with and without a-TiO2 (i.e., Figure 3.10 a
and b, respectively) by summarizing all different peptide versions identified across the protein.
For instance, it is easily observed that more modifications (and more different peptide versions)
are detected in the exposed MtrC control sample (without a-TiO2) in peptides corresponding
to residues 300-480 (highlighted with the yellow frame in Figure 3.10. Interestingly, the 0 ms
radiolysis MtrC control sample (data shown in Chapter 2, Figure 2.3) shows that some peptides in
unexposed control also contain oxidised residues. These are at or near Trp (W), Tyr (Y), Met (M),
Phe (F) and His (H), which are among the most reactive amino acid residues towards YOH, thus
likely represent protein oxidation during sample storage and handling. [129]
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Figure 3.9: Average coverage of identified peptides in MtrC sequence. Protein areas covered
by MS/MS identified peptides are in bold. Grey indicates peptides found in majority of samples
(across different exposures and conditions). Orange indicates areas that were identified in at least
two exposures within each condition (i.e., control and with a-TiO2). Red ’CXXCH’ motifs indicate
location of the covalently-bound haems.
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3.3.2 XFMS results
Overall about 41 peptides have been identified as showing potential +16 Da modifications caused
by XF. The peptides eluting at specific retention times (RT) were identified by MS/MS and the
quantification of peptide modification was performed from extracted ion chromatograms (EIC)
as described in section 2.4.2. A summary of peptides with identified XFMS modifications and
the criteria used to assign these modifications to specific modified amino acid residues are shown
in Appendix, Table 1. The extent of the residue modification depends on the specific residue
reactivity and the local environment of the residue (e.g., solvent accessibility) [132, 133]. To
simplify analysis the changes in solvent accessibility (and hydroxyl-reactivity) of specific residues
were estimated by calculating R, the ratio of the k1 of free MtrC vs the k1 of MtrC bound
to a-TiO2. Thus, M74 is relatively unprotected by a-TiO2 (R=2.41.0), while residue L367 is
shielded by a-TiO2 (R=8.92.4). The summary of the progress and results of XFMS modification
processing and analysis to the date of writing this thesis is shown in Appendix, Table 1. Although
the majority of data has been processed, a fraction of identified peptides remains unanalysed due
to time constrains of this PhD. This work is intended to be continued by a postdoc or a future PhD
student within the Jeuken lab.
The results of processed XFMS data analysis were evaluated in the context of MtrC structure
published as PDB entry 4LM8 (shown earlier in Figure 3.1) [148]. The analysed XFMS peptides
are shown in Figure 3.11.
The protein surface area is coloured according to the presence of detected YOH modifications (i.e.,
grey, blue to yellow and red) and the areas of lack of information (black) due to undetected peptides
and peptides that to date of writing this thesis have yet to be processed. In this type of studies,
1.5-3 fold increase (or decrease) of modification rate is regarded as significant identification of
increased residue protection (or increased solvent accessibility). [132–134, 165, 166] Here, the
difference of residue modification between condition with a-TiO2 and the control is indicated
using a colour scale from blue (no difference) to yellow (some residue protection by a-TiO2) and
dark red (strong residue protection from modification by a-TiO2). As XFMS experiments used
a-TiO2 in excess, some of the detected modifications might represent non-specific binding events.
These are expected to show lower fold increase of modification rate than areas of specific binding
and would be shown in Figure 3.11 lighter (e.g., light yellow to light orange).
To the date of writing this thesis majority (but not all) of the modified peptides have been analysed
and is shown in Figure 3.11. In some cases, it was impossible to identify the precise location of
the modified residue, thus peptide sequences corresponding to the closest reliable localisation of
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‘Back’ view‘Top’ view ‘Bottom’ view
‘Left’ view ‘Right’ view
R ≤ 1.5
1.5 < R ≤  3
3 < R ≤  5
Inconsistent
Not modified
5 < R ≤  7
7 < R ≤ 10  
10 < R ≤  15
15 < R 
𝑅 =
𝑘𝑀𝑡𝑟𝐶+𝑇𝑖𝑂2
𝑘𝑀𝑡𝑟𝐶
(k - modification rate)
Proposed hematite
binding site 
(Thr-Pro-Thr)
No data
Figure 3.11: The available XFMS results mapped onto the surface of MtrC structure
(PDB ID: 4LM8 [148]). Haems are shown as yellow sticks with green spheres as the central
irons.+16 Da modified residues are coloured according to the ratio (R) of residue modification in
MtrC control sample vs. sample with a-TiO2. Residues modified similarly with and without a-
TiO2 (low R) are dark blue. Higher R (i.e., residue modification are increasingly different between
+/- a-TiO2) is shown as progressive colour change from light blue to yellow, orange and dark red.
Thus, dark red indicates residues showing highest detected shielding from YOH radicals by a-
TiO2. Magenta - inconsistent modifications (i.e., data too noisy for a reliable fit or error A60%).
Grey - residues with no detected modifications. Black - protein areas with no information due to
missing peptides or peptides not analysed within the timeframe of writing this thesis. ’Left’ and
’Right’ view indicate sideways rotation of the structure in ’Front’ view -90°and 90°around the y
axis. The ’back’ view is 180°around the y axis. Similarly, ’top’ and ’bottom’ views are -90°and
90°rotation around the x axis. Yellow circle indicates a proposed hematite binding sequence (Thr-
Pro-Thr). [90, 151]
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the detected modification are shown. More detail of each identified residue (or peptide area)
are found in the Appendix, Table 1. The regions with peptides not detected in LC-MS/MS
are shown black in Figure 3.11. Unfortunately, these correspond to areas around all 10 haems
and the C-terminus of the peptide, which has been suggested to play role in protein orientation
on self-assembled monolayer modified gold electrode [146]. The region around haem 10 has
been identified as involved in binding to α-Fe2O3 (hematite) nanoparticles in MtrF (a closely
related protein homologue of MtrC). [134] In addition, MtrC contain a proposed hematite binding
sequence (Thr-Pro-Thr, yellow circle in Figure 3.11) near its haem 10 (residues 559-661) [90,151].
In current study the peptide containing these residues did not carry any detected modifications,
which might be influenced by the low coverage of the entire domain IV. It is possible that the
amounts of modified peptides at this region was present in not high enough amounts and thus was
not picked-up with the tandem MS/MS. Further experiments probing the missing protein areas are
required to provide better comparison between binding sites of a-TiO2 and hematite, the natural
binding partner of MtrC.
Most detected modifications are located primarily on the same haem-facing (’Front’) side of the
MtrC, with very few modifications in the ’Back’. This is unexpected because hydroxyl radicals
should be able to modify all water accessible areas. It is possible that most modifications on
the ’Back’ of MtrC are located in the missing peptide areas. Alternatively, protein might be
self-assembling in a structure, sequestering its back from the aqueous environment. Further
experiments using different proteases or protein footprinting probes might help to address these
possibilities. Overall, modification showing low or no difference between conditions with and
without a-TiO2 are present on the membrane-interfacing protein domains (domains I and II, see
Figure 3.1). In few cases, data was too noisy for a reliable fit of exponential decay and these
residues were marked inconsitent (magenta in Figure 3.11). Often these cases involved tryptophan
(e.g., W104, W272, W440), which showed high levels of oxidation modifications even in control
samples without exposure to X-ray irradiation. Tryptophan is the second most reactive residue
(after cystein) to be modified by hydroxyl radicals. [129] As, some of these residues were buried
within the protein structure, these residues seem to be in some way more susceptible to oxidation.
Further work is needed to test if these residues in their oxidised or reduced form play any specific
role (e.g., as a safety mechanism for radical quenching).
The most a-TiO2 protected residues (having larger R and coloured intensive orange, red and dark
red) are located on top of domain III and in the areas where domains I, II and III interface the
largely missing domain IV. Interestingly, one modification (i.e., Ile376, Ser389) is located near
haem 7 among on domain III and near the interface with domain IV. These residues show no
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difference with and without a-TiO2 despite being surrounded by other a-TiO2 protected areas. In
this case, the LC-MS/MS identification of the modified Ser389 was ambiguous (see assignment
criteria in Appendix, table 1) due to poor peptide fragmentation in MS/MS. Ile376 in turn is
located in a buried cavity, thus water present within the cavity would be able to modify the residue
irrespective of presence of a nearby a-TiO2. In contrast, Ser389 is a surface exposed residue
and surrounded by areas protected by a-TiO2, which seems contradictory for a residue with no
contact with a-TiO2. Given the ambiguous identification of this residue by LC-MS/MS, analysis
of additional XFMS samples and repeats is required to confirm the status of this modification.
If this residue is indeed not-associated with a-TiO2, this might be an indication for structural
conformation changes caused by a-TiO2 binding, such as potential rotation of the loop containing
Ser389 to bury Ser389 within the same cavity as Ile376.
3.4 Discussion
To the time of writing this chapter the majority (but not all) of the collected XFMS data has
been processed. It has been possible to identify multiple protein residues showing different
modification rates with YOH in conditions with and without a-TiO2 (Figure 3.11). These can
be used to hypothesize on putative a-TiO2 binding sites and the properties leading to the binding
interaction. The current understanding of MtrF binding to hematite [134] and several peptide
binding to TiO2 suggest a role of electrostatic interactions and a contribution of 3D peptide
conformation [155, 156]. To address these in the context of MtrC, the properties of protein
surface surrounding the residues identified in XFMS were examined (Figure 3.12). Although,
a-TiO2 protected residues are scattered around the MtrC, I focus on three areas showing highest
residue protection by a-TiO2 (i.e., highest R and coloured more intensely red in Figure 3.12).
This approach allows to disregard areas of possible non-specific a-TiO2 binding events caused by
the a-TiO2 in excess. More detailed analysis for each detected modification together with further
acquisitions of XFMS data and data refinement is necessary for better and more thorough data
interpretation.
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b) Location of  charged/polar and flexibility limiting peptide residues
Area 1: top
(domain III, near haem 7)
Area 2: front 
(top of domain I and II)
Area 3: top of domain I
a) XFMS data
c) Surface charge
Figure 3.12: MtrC properties of three putative a-TiO2 binding areas: area 1, near haem 7
(left), area 2, in near haem 1 (middle) and area 3, ’top’ of the domain I (right). (a) XFMS data
mapped on MtrC structure (PDB ID: 4LM8 [148]), coloured as described in Figure 3.11, where
haems are identified as yellow sticks with green spheres. Modified residues are coloured according
to the ratio (R) of residue modification, where low, moderate or high shielding by a-TiO2 is shown
as progressive colour change from blue to yellow to orange and red. Grey - non-modified residues.
Black - areas where XFMS information is absent. (b) Location of polar and charged residues, as
well as bulky residues, which increase local peptide rigidity. Blue - positive residues (i.e., K and
R), Green - charged (i.e., E, D) and polar (i.e., S, Q, N, Y) residues, Olive - T (polar and bulky
residue), Orange - bulky residues (i.e., P, W, L). Yellow sticks represent haem groups with the
iron coloured as red sphere. (c) The surface charge of MtrC calculated using the APBS plugin
within the Pymol. [167,168] Colour transition from red to blue identifies surface charge from -5 to
+5 kT/e (130 mV). Yellow sticks represent haem groups. Yellow circle highlights the boundaries
of XFMS areas 1, 2 or 3.
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The three areas selected for this initial data interpretation are: 1) ’top’ of MtrC (domain III) and
near heam 7 (further referred as Area 1), 2) an area in ’front’ of MtrC near haem 1 (top of domains
I and II around Lys243 - Thr246; further referred as Area 2) and a closer look on area on the ’top’
of protein domain I (residues from P41 to L48; further referred as Area 3). Although area 1 mostly
belong to an individual domain (domain III in Figure 3.12), these are all located near the domain
interface with domain IV.
The panel c in Figure 3.12 shows distribution of electrostatic charge on the MtrC surface. No clear
common properties can be seen between the three areas, as Area 1 is mostly positively charged,
Area 2 contains both positively and negatively charged residues and Area 3 is mainly neutral. It
is well-accepted that charged and polar amino acids have the greatest affinity for adsorption to
TiO2. [155] These include positive residues (Lys and Arg) that have been observed as essential
for peptide binding to TiO2 [156] In addition, the rigidity of peptide is also reported to promote
interactions with TiO2 [156] and other minerals as quartz, calcium carbonates [169,170] and pure
Ti [171]. Panel in Figure 3.12 aims to provide a summary of the distribution of charged and bulky
amino acids within areas 1, 2 and 3. Thus positively charged residues (Lys, Arg) are shown blue,
other charged and polar residues (Glu, Asp, Ser, Asn, Gln, Tyr) are green, Thr, which is both
polar and bulky, is olive, but the distribution of bulky residues ( Pro, Trp, Leu) restricting the local
peptide conformation are shown as orange. In this context, it can be observed that Area 1 contains
charged residues, including several positively charged Lys lining a pocket near haem 7. This
pocket in turn is surrounded by several bulky amino acids restricting the conformational flexibility
of the protein, and potentially facilitating a contact with a-TiO2. Area 2 contains a charged Lys243
and Thr246, and the bulky Thr246 is located right next to another rigid residue - Pro245. The right
side of area 2 (top of domain I) is closer observed as Area 3, which consists of charged and polar
residues surrounded by positive residues and a bulky threonine, which might help to orient the
charged residues towards a-TiO2 surface. Thus, no single property can be identified as being
common for all three MtrC areas explored in detail. They all contain charged residues able to
form complementary electrostatic interactions with the hydroxylated surface of a-TiO2 surface. In
addition, presence of protein flexibility limiting amino acids is also observed, which could promote
the stability of a complex formed by complementary electrostatics. Further experiments using
mutations to replace the identified Lys and Pro/Leu/Trp/Thr at these interfaces could help to clarify
how these amino acids and their properties affect the binding affinity. In addition, computational
studies could be carried out to see how the flexibility and surface charge of MtrC in areas 1, 2 and
3 compare to other areas identified in contact or in absence of contact with a-TiO2.
Another aspect of identifying the interface of MtrC binding to a-TiO2 is to think about the
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dimensions of both particles and how this interface would help or hinder electron transfer from a-
TiO2 and MtrC. Both particles are similar in size, where the diameter of a-TiO2 is about 5 nm and
the size of MtrC is approximately 8 nm × 7 nm × 4 nm [93]. Thus it is likely that the binding
interface might also span large areas of MtrC. In fact, all tree areas explored in Figure 3.12
seemingly surround domain IV, where, unfortunately, the peptide coverage detected by MS/MS
was very low. Nevertheless, one might speculate that a-TiO2 forms a large interface with the ’front’
side of MtrC’s haem containing domain IV. In a way, this is supported by the current knowledge of
the structural orientation of MtrC, where MtrC is suggested to form a membrane facing interface
with MtrAB via the ’bottom’ side of domains I and II (see Figure 3.1) [93]. In this scenario, the
closest haems to the interface with MtrA would be either haem 2 or haem 5, and other terminal
haems (i.e., haem 7 and 10) would be positioned away from the membrane and closer to external
electron acceptors. Such arrangement would also provide interpretation for the observation that
both MtrC and MtrCAB had very similar binding affinity to a-TiO2 in the co-sedimentation assays.
This can be explained as follows, metal binding occurs through exposed MtrC areas near haem 7
ad domain IV, which are also accessible within detergent-solubilised MtrCAB, and that MtrAB do
not have additional metal binding sites.
All of the three MtrC areas explored in detail in Figure 3.12 are located close to a haem
group, which could lead to a direct ET between MtrC and a-TiO2. For instance, area 1 is near
haem7, area2 - near heam 1 and area 3 is not too far from haem 10. Similar areas have also
been identified in the binding interface between hematite and the MtrC-homolog MtrF. [134]
Fukushima and colleagues attributed the binding being governed by complementary electrostatic
interaction between negatively charged hematite and positively charged pocket near haem 7 (i.e.,
corresponding to area 1 of MtrC). In addition, mutational studies of residues located within this
pocket lead to changes in the binding affinity to hematite. [134] The fact that MtrC also has a
similar positively charged binding pocket near haem 7 could suggest a more universal binding
strategy between these cytochromes to a range of metal oxide minerals. In addition, haem 7 has
the highest redox potential of all haems (i.e., 0.07 V for haem 7, the second highest potential being
0.01 V for haem 5, while the lowest redox potential is -0.28 V for haem 9) as has been identified in
a molecular dynamics simulation. [172] These observations highlight a possibility that the haem 7
could be the main route for direct ET out of the cell and to the mineral. Unfortunately, lack of MtrC
coverage and resolution in the current XFMS study limits our abilities to address these questions.
One way to further explore these questions is to perform a wide range of protein footprinting
assays. For example, different sent of proteases could be used to gain peptide coverage of the
missing domain IV. In addition, these XFMS assay could be coupled with FPOP and HDX assays
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to probe changes in the solvent accessibility of protein and, perhaps, further increase the resolution
of protein footprinting. Other assays such as mutational analysis coupled with electrochemical
assays are required to assess how mutations in protein around haems 1, 7 and 10 change electron
transfer properties within MtrC and between MtrC and a-TiO2.
The original question for the work described in this chapter was to map where and how MtrC binds
to a-TiO2. This was done to identify protein areas and strategies how these areas or particles could
be modified to optimise ET from a-TiO2 to MtrC. Unfortunately, XFMS experiments yielded
incomplete protein coverage with many crucial protein areas being missing (i.e., surrounding
haems). Nevertheless, the available data identify multiple peptide residues scattered around the
protein, with highest protected areas being nearby haem 1, 7 and 10. The scattered results of X-
ray footprinting also reinforce assumption that this binding interface is relatively non-specific
and guided by complementary electrostatic interactions. Thus particles with different surface
modifications (e.g., a-TiO2, DHBA-TiO2 and RuP-TiO2 ) will have different binding properties
to MtrC. This was indeed observed in co-sedimentation experiments comparing binding between
MtrC and a-TiO2 and other TiO2 modified with DHBA. DHBA-TiO2 showed superior binding
affinity and were able to bind 50% of MtrC with half as much TiO2 particles as a-TiO2 (50%
binding of a-TiO2 occurred at 1:1 particle ratio). A key question for future work is to understand
how the current results of a-TiO2 binding interface with MtrC relate to the interface with dye-
sensitised light-harvesting version of TiO2 particles (e.g., RuP-TiO2). As the work described in
this chapter identified protein areas similar to those identified by Fukushima et al. [134] using
MtrC homolog protein MtrF and hematite nanoparticles, it is possible that the interface between
these decahaem proteins and inorganic nanoparticles is qualitatively similar irrespective to the
differences in particle surface. Further experiments are needed to address this and could involve
measuring and mapping the MtrC binding interface and affinity with TiO2 NPs of different sizes
and with different surface modifications, as well as comparing the MtrC binding affinity for a-
TiO2 to that of hematite. In addition, other assays including mutational analysis, molecular
dynamics simulations and circular dichroism spectroscopy could be used to probe changes in
protein structure and potential binding interactions between a mineral and the protein. This would
also clarify the contrasting observations where structural rearrangements of OmcA and MtrC
were reported for binding with hematite, though no major structural changes were observed upon
binding of MtrF and hematite. [134, 147, 149, 150]
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3.5 Conclusion and future work
The work described in this chapter explores the interaction between MtrC and a-TiO2, identifying
particle binding within 1:1 and 3:1 binding between MtrC and a-TiO2 and DHBA-TiO2,
respectively. The main question was to identify the interface of MtrC and a-TiO2 nanoparticles.
Overall these aims were achieved only partially due to incomplete MtrC coverage in XFMS
analysis. Despite this several MtrC areas were identified to be involved in the binding interface
with a-TiO2. Closer analysis of the protein structure and the protein surface charge within these
areas did not provide conclusive insights into the nature of the interaction, but adds to the growing
evidence suggesting the necessity of complementary electrostatic interactions and the role of bulky
and rigid peptide residues able to facilitate beneficial conformation of the peptide binding site.
The chosen approach of protein footprinting provided a ’map’ for protein areas interacting with
the a-TiO2, however this approach must be coupled with other functional assays to determine
the strength of interaction. In this work, co-sedimentation assays provided insight in some of
these aspects (e.g., indicating higher affinity to DHBA-TiO2 than a-TiO2). Futher experiments
using other techniques (e.g., isothermal titration calorimetry, quartz crystal microbalance with
dissipation) are required.
This work illustrates the power protein footprinting approaches have to gain understanding of the
interface between biomolecules and metal oxide material. These interfaces are of great importance
for many applications involving ET, such as protein-electrode and microbial-electrode interfaces
used to explore strategies for light-harvesting, improving microbial fuel cells or advancing such
fields as microbial synthesis. [57,59,80,97,159,173] Similar interfaces are also relevant to medical
settings, where nanoparticles could be used for different therapeutic and diagnostic applications,
as well as assessing the environmental impact of nanoparticle pollution, created by increasing use
of nanoparticles in cosmetics, textiles, paints, coatings and food packaging. [174] Understanding
the interplay of physical forces and interactions behind these bio-mineral interfaces can lead to
further engineering of both nanoparticles and proteins, which in turn could promote more effective
and safer use of these nano-materials. However, in order to achieve detailed understanding of
these bio-mineral interactions, complementary experimental assays and theoretical simulations
should be used, such as protein footprinting to identify the binding interface together with assays
quantifying the binding affinity (e.g., co-sedimentation, isothermal titration calorimetry, quartz
crystal microbalance with dissipation (QCM-D), DLS etc.) and mutational assays to validate
hypothesis formed through these observations.
The next chapter focuses on next steps the couple light-harvesting TiO2 (e.g., RuP-TiO2) with full
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MtrCAB protein complex and to construct light-harvesting compartment.
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Chapter 4
MtrCAB as a transmembrane
molecular electron conduit for
compartmentalized photocatalysis
4.1 Chapter introduction
Chapter chap1 introduced the vision for demonstrating and liposomal compartment for solar
energy capture. Figure 4.1 a provides a recap of the envisioned system, where light energy
is captured by a light-harvesting nanoparticle (LHNP) located externally from liposomes. This
energy is then used to excite an electron, which is then transferred across the membrane to the
final electron acceptor (e.g., catalyst producing fuel). This chapter introduces such compartment
(Figure 4.1 b), where electrons from three different LHNPs are transferred across the membrane
via integral membrane protein MtrCAB and used to reductively bleach an encapsulated red azo
dye, Reactive Red 120 (RR120). The work behind this chapter aimed to demonstrate and assess
the photo-electron transfer across the membrane using MtrCAB as an electron-conductive ’wire’
(conduit) across the membrane. More specifically, it was aimed to test two key assumptions: 1) the
ability to improve electron separation fom LHNP by using MtrCAB as a route for electron relay
away from LHNP; 2) the ability to use the environmental separation by liposomes (i.e., interior
and exterior environment) to optimise such light-harvesting oxidation-reduction reactions.
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Figure 4.1: Schematic of light-driven electron transfer across the lipid membrane in the
envisioned compartmentalised bio-mimicking system (a), and as presented in the model
system in this chapter(b). a) External electrons are supplied photo-chemically from a light-
harvesting nanoparticle (LHNP), which is regenerated by a water-oxidising catalyst (CAT).
Electrons are relayed across the membrane to a catalyst (CAT) leading to fuel generation within the
compartment. b) Electron transfer across the lipid bilayer is ensured via transmembrane protein
complex MtrCAB and monitored following reductive bleaching of an internalised red azo-dye,
Reactive Red 120 (RR120). SED – sacrificial electron donor. Figure adapted from [67].
In the envisioned compartment, electrons are transferred via MtrCAB to the liposome lumen,
where they could generate fuel (such as hydrogen) by a fuel-generating catalyst. This chapter
focuses on the proof-of-concept compartment, where the electron transfer across the membrane is
optically monitored at 539 nm by a destructive reduction of an encapsulated azo dye, Reactive Red
120 (RR120, Figure 4.2). [175–177] RR120 contains two azo bonds (R–N=N–R’), each of which
requires a transfer of four electrons in order to be cleaved to a colourless (pale yellow) product
(Figure 4.2 c), i.e., 8 electrons per RR120. [176] The optical signatures revealing the redox status
of MtrCAB haems (Figure 4.3) are also monitored.
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Figure 4.2: Characteristics of the RR120 azo-dye and its reactivity. The chemical structure of
RR120 (a) and absorbance spectrum of 15 µM RR120 (b in MOPS buffer (20 mM MOPS, 30 mM
Na2SO4, pH 7.4). (c) Schematics of the reduction reaction of an azo group.
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Figure 4.3: MtrCAB absorbance (a) and the 1st derivative of MtrCAB absorbance (b). Black
– oxidised MtrCAB, Red – MtrCAB reduced by dithionite. Dashed lines indicate wavelengths
selected to assess haem reductionby calculating the difference between them (i.e., ∆A’ = A’418 -
A’426)). In this case ∆A’ is -0.0035 and 0.02 for oxidised and reduced MtrCAB, respectively.
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4.1.1 Summary of previous work, which led to the optimisation
and creation of the MtrCAB compartment described in this
chapter.
The work described in this chapter builds on the long-term collaboration and work with between
previous members of the Jeuken group (i.e., Dr Ee Taek Hwang, Dr Theodoros Laftsoglou),
members of Prof. Julea Butt’s group in the University of East Anglia (i.e., Dr Emma Ainsworth,
Dr Samuel Rowe and Sam Piper), and members of Prof. Erwin Reisner’s group in the University
of Cambridge. Many of the decisions concerning material selection and experimental procedures
were thus taken based on conversations and meetings between these groups and building on the
previous published and unpublished work. A lot of this work resulting from close collaboration
between Dr Ee Taek Hwang and Dr Emma Ainsworth is described in the doctoral thesis of
Dr Emma Ainsworth (see reference [85]). This dissertation describes studies of MtrC, OmcA
and MtrCAB photoreduction using various different types of photosensitisers (e.g., ruthenium
complexes, Eosin Y, fluorescein, flavins) as well es experiments designing and optimising protocol
for simultaneous liposome formation and MtrCAB incorporation through rapid dilution. This
work also included testing encapsulation of various potential compounds that could be used as
internal redox indicators and identified RR120 as a suitable indicator, which can be encapsulated in
optimal amount within the liposomes and optimisation of lipid composition choosing to use E. coli
lipids over chicken egg phosphatidylcholines, as E. coli lipids yielded better liposome formation
in the presence of RR120. [85] This resulting protocol has been used for work presented in this
chapter with minor modifications as described in section 2.2.1. The main reported difference
is to exclude liposome extrusion step, which involves passing liposomes through nanoporous
membrane (e.g., pore size of 200 nm) to improve the homogeneity of liposome samples (i.e.,
making liposomes to be more uniform in their size). This decision was made as a precaution as
liposome extrusion might lead to temporary damage to liposome membrane and increase leakage
of the encapsulated content and after experiments comparing liposome concentration and size
distribution using nanoparticle tracking analysis (NTA) showed no meaningful difference between
samples undergoing extrusion or without it (data not shown).
In terms of choosing LHNPs, I would also like to emphasize work by Dr Ee Taek Hwang, who
tested electronic coupling between MtrC protein film and various TiO2 NPs (see reference [63,
146]). This work led to identification of RuP-TiO2 as a good candidate for light-harvesting step.
And as it is discussed in the previous chapter (Chapter 3), TiO2 nanoparticles seem to be able to
directly bind MtrC, thus facilitating a close contact required for electron transfer from RuP-TiO2
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to MtrCAB. In addition, Prof. Erwin Reisner’s group came to synthesize carbon dots showing
promising light-harvesting properties and excellent water dispersion properties. [86, 88, 89] Two
of these carbon dots, i.e., amorphous carbon dots (a-CD) [86] and graphitic carbon dots with core
nitrogen doping (g-N-CDs) [88,89] were tested in experiments described in this chapter. As these
carbon dot particles show excellent water solubility, it is assumed here that they do not form stable
complexes with MtrCAB. However, the nature of this interaction still remains to be characterized
(e.g., by quartz crystal microbalance with dissipation (QCM-D) analysis or isothermal titration
calorimetry).
4.2 Characterization of MtrCAB liposomes
MtrCAB proteoliposomes loaded with the dye RR120 were prepared as described in section 2.2.1.
This proteoliposome protocol is based on spontaneous, stochastic liposome formation, where
detergent-solubilised lipids and MtrCAB are injected in a higher ( 50x) volume solution to rapidly
dilute the detergent below its critical micelle concentration (i.e., concentration, where detergent
forms self-assembled micelles within solution, which are able to solubilise lipid structures). As
this is stochastic process every liposome preparation will yield a batch-to-batch variation due to
small differences in the sample injection step and even small differences in lipid and detergent
concentrations. These could be attempted to minimise by constructing a robotised version for the
protocol, but that was beyond the scope of this project. The highest variation was for samples
containing MtrCAB, where the success of MtrCAB reconstitution within liposomes varied from
one reconstitution to another. Thus all the liposome estimates (e.g., average liposome size and
volume, amount of MtrCAB per liposome, amount of LHNP per liposome, speed of RR120
reduction) were calculated and compared within each liposome preparation. Only then the results
which were independent of amount of MtrCAB (or had been normalised against variation in
MtrCAB reconstitution) were compared between different liposome preparations.
(Proteo)liposomes from each preparation were characterized to determine their size,
concentration and amount of reconstituted MtrCAB and encapsulated RR120 as described in
sections 2.2.1 and 2.3. Although the size of MtrCAB proteoliposomes showed some batch-to-
batch variation, the majority of proteoliposomes were consistently between 100 and 200 nm in
diameter (Figure 4.4). The reconstitution protocol generated about 1013 liposomes/mL and thus
an estimated total lumen volume in the order of 10-30 µL per mL of sample. Approximately
43% (SD = 13%, n =3 different liposome preparations) of initial MtrCAB was present in the
reconstituted proteoliposomes with an estimated ratio of 10-50 MtrCAB proteins per liposome
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(depending on liposome size) assuming an even distribution across the liposomes.
Estimation of the amount of RR120 encapsulated in MtrCAB proteoliposomes was performed
spectroscopically using optical absorbance at 534 nm ( 534nm = 31.83 mM1cm2 was determined
using titration). It was estimated that, on average RR120 concentration in liposome lumen was 10
mM, i.e., the same order of magnitude as during liposome formation.
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Figure 4.4: Size distribution of liposomes without MtrCAB (control) and liposomes with
MtrCAB (a, c and b, d, respectively) determined from nanoparticle tracking analysis (NTA)
(a,b) and dynamic light scattering (DLS) (c, d). Shaded area in NTA data represents the standard
error for each sample, whereas the error bars in DLS represent the standard deviation (n=3) for
each sample. Bin size for NTA is 0.5 nm. Repeats 1 - 3 represent liposomes from three separate
sample preparations.
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4.3 MtrCAB provides electron transfer across the
bilayer
The ability of MtrCAB to transfer electrons across the membrane and reductively degrade RR120
was confirmed using an excess chemical reductant (dithionite, DT; Figure 4.5). DT (Em  -0.41 V
vs SHE at pH 7.4) [178] reduced MtrCAB (haem potential window ranging from -0.45 to 0 V
vs SHE) [179] within the time resolution of the experiment (< 20 s), as indicated by a shift of
MtrCAB Soret peak due to haem absorbance (from 410 to 420 nm, Figure 4.5 b). This is followed
by a slower (minutes) decrease of RR120 absorbance (450-570 nm, RR120 becomes reductively
bleached at B -0.4 V vs SHE [180]), confirming the destructive reduction of the encapsulated
RR120. Only 10% of RR120 was reduced in control experiments using liposomes without
MtrCAB, indicating that RR120 is protected from reductive bleaching when inside liposomes
and that reduction of encapsulated RR120 proceeds only if MtrCAB is present (Figure 4.5 a). As
a positive control, detergent (Triton X100, TX) was added at the end of the experiment to lyse
the liposomes. This is followed by the immediate reductive bleaching of any remaining and now
released RR120 (Figure 4.5 a and b, green lines). The rates of reduction of encapsulated RR120
were observed to vary between MtrCAB proteoliposome preparations, likely due to the fact that
MtrCAB recovery yields varied (see section 4.2). For this reason, (photo)reduction of encapsulated
RR120 by different reductants (i.e., DT, LHNPs) was compared using proteoliposomes from the
same preparation. In such studies the relative rates of RR120 reduction by the different LHNPs
are as reported by the representative data. The chemical reduction using DT was used as indicator
for the rate of electron transfer across the membrane, where electron supply to MtrCAB is not
limited.
As mentioned earlier, the amounts of MtrCAB incorporated within liposomes varied between
different liposome preparations. As MtrCAB is key for electron transfer across the membrane
(and thus the reduction of encapsulated RR120), this batch-to-batch variability limited options
to quantitatively and reliably compare the chemical reduction of RR120 between samples from
different liposome preparations. Thus the data shown in Figure 4.5 is a representative example.
For this same reason, reduction of encapsulated RR120 by different reductants (i.e., DT, LHNPs)
was compared primarily using proteoliposomes from the same preparation. In addition, Figure 4.5
also includes an exponential (y=eAx) and a linear (y=kx+b) fit to the data, which are primarily
meant to be guides for the eye. Having said this, these could also be used as very primitive data
representations of the RR120 absorbance decay over time. In such case these fits can be use
to extract a rate constant for RR120 decay, which in turn could be normalised to the amount of
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MtrCAB per sample and lead to data, which could be compared across liposome samples from
different MtrCAB proteoliposome preparations. This approach will be further discussed later in
section 4.4.1.
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Figure 4.5: A representative example of chemical reduction of encapsulated RR120 by
sodium dithionite (DT) in control liposomes without MtrCAB (a) and with MtrCAB (b)
Reduction is followed optically by monitoring absorbance of MtrCAB haems (oxidised peak at
410 nm, reduced peak at 420 nm) and RR120 (oxidised 450-570 nm region). Black – oxidized
sample; Blue – intact liposomes after addition of sodium dithionite; Green - sample after disruption
of proteoliposome bilayer by detergent (Triton X100, TX). Time points indicate the time passed
since the addition of DT. (c) Decrease of RR120 absorption (λ = 539 nm) over time using
liposomes with and without MtrCAB. Yellow and black lines show exponential (y=eAx) and
linear (y=kx+b) fits to the data, respectively. These fits serve primarily as guides to the eye and
are very primitive data representations of the RR120 absorbance decay over time.
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4.4 Photoreduction across the membrane
Three different photosensitisers, i.e., RuP dye sensitized TiO2 nanoparticles (RuP-TiO2) [63],
amorphous carbon dots (a-CD) [86] and graphitic carbon dots with core nitrogen doping (g-
N-CDs) [88, 89], were tested for photoreduction of RR120 encapsulated in liposomes with and
without MtrCAB (Figure 4.6). All LHNPs have been previously shown to have sufficiently
low reducing potential (< -0.45 V vs SHE) [57, 89] to be able to reduce methyl viologen, and
thus MtrCAB and RR120. Consistent with the data above, in the absence of MtrCAB, the
majority (> 70%) of RR120 was protected from photoreduction inside the liposome compartments
(Figure 4.6 a). However, subsequent addition of DT to all samples showed that slightly more
RR120 was reduced in samples exposed to g-N-CD and RuP-TiO2 compared to ’DT only’ control
(compare black open circles to blue data points in Figure 4.6 a). This could suggest that small
amounts of RR120 are released from liposomes due to interactions between RuP-TiO2/g-N-
CD and the liposomes. To further quantify this, well-established vesicle leakage assays were
performed using a self-quenching dye, carboxyfluorescein (see publication on this method in
reference [181]). No significant leakage was observed upon addition of any of the LHNPs,
indicating no or very limited damage is incurred to the vesicles by the LHNPs (data not shown).The
association of RuP-TiO2 and liposomes was also probed using cryo-TEM (Figure 4.7), which
indicated that RuP-TiO2 particle self-agglomeration within the liposome sample without clear
association with liposome in the presence and absence of the MtrCAB.
In the presence of MtrCAB, all three LHNPs photo-reduced the encapsulated RR120 (Figure 4.6
b). As before, photoreduction of encapsulated RR120 by different LHNPs was compared using
proteoliposomes from the same preparation to limit influence of the variations of the amount
of MtrCAB being reconstituted in different liposome preparations. The following discusses
the example dataset presented in Figure 4.6 b). These experiments used 1 µM LHNPs, with
an estimated ratio of 45  2 LHNP per MtrCAB. RuP-TiO2 and g-N-CD showed the fastest
photoreduction, but with a rate lower compared to DT. Both g-N-CDs and a-CD showed a short
1–2 min delay from the start of irradiation till the onset of RR120 photoreduction. This delay
is further referred as the ’lag phase’ throughout this chapter. The name of the ’lag phase’ is a
reference to term used to describe bacterial growth characteristics, where cells are metabolically
active and adapting to environmental conditions, but do not multiply. This is then followed by the
active growth phased called ’log phase’, when cells numbers grow in exponential fashion. Here, I
use the term ’lag phase’ to describe observed lack of initial photo-activity of carbon dots defined as
period of time from the onset of sample illumination till the first signs of RR120 photoreduction.
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Figure 4.6: Photoreduction of RR120 encapsulated in control liposomes without MtrCAB
(a, error bars indicate standard deviation for liposomes without MtrCAB from 3 different
preparations), in MtrCAB proteoliposomes (b, representative sample using liposomes from
the same preparation), and in control sample without liposomes and MtrCAB (c, error bars
represent standard deviation, n=3). RR210 photoreduction is followed by a decrease in the
RR120 absorbance at 539 nm. Squares – g-N-CD; Upward triangles – a-CD; Downward triangles
– RuP-TiO2; Red – sample after irradiation; Blue – sample after addition of DT; Black circles –
chemical reduction using DT added at t=0 and without irradiation. Time points indicate cumulative
time of irradiation. In case of DT, the time of DT addition is arbitrarily set to 50 and 30 min for
(a) and (b), respectively, and following time points indicate time passed since addition of DT. (c)
Direct photo-reduction of 10 µM RR120 in solution by LHNPs. White rhombus – irradiation of
RR120 without LHNPs.
Chapter 4. MtrCAB as a transmembrane molecular electron conduit for
compartmentalized photocatalysis 97
+MtrCAB-MtrCAB
Figure 4.7: Cryo-TEM of E. coli liposomes without reconstituted MtrCAB (control) and with
reconstituted MtrCAB mixed with RuP-TiO2 NPs. RuP-TiO2 agglomerates formed within 2-5
min after transfer from water to liposome sample.
Such initial period of carbon dot inactivity has been also observed by our collaborators in Prof.
Erwin Reisner’s lab, where they attribute this to surface heterogeneity or contamination that must
be first reduced before achieving full activity of carbon dots (information shared through verbal
communication).
The quantification of MtrCAB haem photoreduction by all three LHNPs was also attempted.
Unfortunately, haem difference spectra could not be used due to spectral overlap with changes
in RR120 and DT absorbance. Instead the first derivatives of all spectra were used as this is
less sensitive to the background absorbance (Figures 4.3 and 4.8). This approach showed that
DT immediately and fully reduces MtrCAB (4.8 a). Most MtrCAB is photoreduced by RuP-
TiO2 within the first minute of irradiation (4.8 b). In case of g-N-CDs and a-CD (4.8 c and d,
respectively), it appeared that MtrCAB became reduced after several minutes, a time that coincides
with the initial ’lag phase’ of RR120 reduction (i.e., initial carbon dot inactivity). After the lag
phase, MtrCAB appeared to be fully reduced by g-N-CDs, whereas only partial MtrCAB photo-
reduction seem to be observed by a-CDs. This suggest that with a-CD, photo-reduction of RR120
is in part rate-limited by the photo-reduction of MtrCAB. Thus the data shown in Figure 4.8 allows
to observe the electron transfer function of MtrCAB in action, showing that electron supply to
MtrCAB from RuP-TiO2 and g-N-CDs is sufficient and the rate of RR120 reduction depends
mainly on the number of MtrCAB present and the electron transfer from MtrCAB to RR120. In
contrast, a-CDs were not able to fully reduce MtrCAB and further work on optimising the photo-
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Figure 4.8: Reduction of MtrCAB haems and RR120 by DT (a), RuP-TiO2 (b, g-N-CD (c)
and a-CD (d)). (a - d) Photoreduction of MtrCAB haems as observed by changes in the 1st
derivative of haem absorbance (scale on the left, black) and photoreduction of RR120 encapsulated
in MtrCAB proteoliposomes (scale on the right, red). Time indicates duration of total illumination.
DT – dithionite is included as indicator of fully reduced haems.
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activity of a-CDs and the interaction (i.e., binding) between MtrCAB and a-CDs could help to
improve electron transfer from a-CDs to MtrCAB.
Finally, photo-reduction of RR120 in the MtrCAB proteoliposomes was compared to the
direct photo-reduction of non-encapsulated RR120 (Figure 4.6 c). RuP-TiO2 showed faster
photoreduction compared to the MtrCAB proteoliposomes, clearing > 90% in less than 2 min,
in line with conclusion that reduction in proteoliposomes is rate limited by the interaction between
RR120 and MtrCAB. In contrast, g-N-CDs and a-CDs took significantly longer to directly photo-
reduce RR120 compared to MtrCAB proteoliposomes, i.e., about 20 minutes for g-N-CDs and for
a-CDs it took more than 40 min to reduce even 50% of RR120. Both LHNPs also showed longer
and more variable kinetics, with lag phases up to 5 min for g-N-CDs and 10-20 min for a-CDs.
These variations in photo-reduction could reflect heterogeneity within carbon dots, as observed
before. [182, 183]
4.4.1 Fitting and comparison between different liposome
preparations
As discussed earlier the major limitation for comparing experimental data across samples is the
high variation of MtrCAB reconstitution from one preparation to another. One way to overcome
this is to estimating the rate of RR120 reduction by approximating the data of RR120 absorbance
decay over time to a mathematical model (fitting data). An example of this is shown in chemical
reduction of RR120 encapsulated in MtrCAB proteoliposomes as seen in Figure 4.5 c. In this case
RR120 reduction via MtrCAB proteoliposomes was estimated to proceed as simple exponential
decay (y=AAx). The control sample without MtrCAB showed slow linear decrease (y=b-kx) in
RR120, which is likely due to passive RR120 leakage out of the liposomes. Although this approach
works for the chemical reduction of MtrCAB proteoliposomes (i.e., assay using excess amount of
DT as electron source), this can not be extrapolated easily to the photo-reduction experiments
involving LHNPs, as these are more complex processes which do not reliably follow the rules of
simple exponential decay. This is due to the RR120 photo-reduction reaction being influenced by:
• RR120 reduction being potentially limited by electron availability at 3 different stages: 1)
photo-electron generation at LHNP; 2) electron transfer from LHNP to MtrCAB; 3) electron
transfer from MtrCAB to RR120 (requires 4 electrons per azo-bond; 2 bonds per molecule);
• heterogeneity within carbon dot stock. Although the data was corrected for different ’lag
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phases’, it was observed that carbon dots exhibiting longer ’lag phase’ were also photo-
reducing RR120 slower;
• increased RR120 leakage from liposomes using RuP-TiO2 and g-N-CD (as observed in
control liposome experiments without MtrCAB);
• presence of some non-encapsulated RR120 on the outside of liposomes;
• liposome heterogeneity, where MtrCAB distribution per liposome was observed to vary
between 10 and 50 (across different preparations) and a sub-population of liposomes might
lack any MtrCAB;
• changes in RR120 reduction reaction by depletion of RR120 and accumulation of RR120
reduction products.
Given the complexity of the underlying process for RR120 photo-reduction, it was beyond the
scope of this PhD to come up with a reasonable mathematical model to fit the data. Instead,
I decided to estimate the initial rate of RR120 reduction using linear fit to the longest linear
range after the onset of RR120 reduction (i.e., after any determined ’lag phases’ of carbon dots).
This allows to estimate the initial rate of electron transfer from electron source (DT, LHNP) to
MtrCAB and RR120 under optimal conditions for the reaction (e.g., maximum electron supply and
RR120 present in abundance). The results from control samples (i.e., control liposomes without
MtrCAB and direct photoreduction of RR120) were then directly compared across different
sample preparations (see Table 4.1). The initial rate estimates for MtrCAB proteoliposome
samples were then normalised to the number of MtrCAB present per liposome (calculated for
each sample preparation) and then multiplied to the average amount of MtrCAB per liposome
across all sample preparations (27 17; SD, n=3). This approach provided a relatively simple way
to compare initial RR120 reduction rate across different sample (and liposome) preparations and
electron sources. The main caveat for this approach is that this method is itself error-prone as it
imposes fitting a line to a subset of data which is not linear. This is seen in the error estimates
for the final RR120 reduction rates (relative errors reach 70 and even 80%). The resulting data is
shown in Table 4.1.
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Table 4.1: Initial rate of RR120 reduction (%/min) using with MtrCAB proteoliposomes, control
liposomes without MtrCAB and directly in control samples without MtrCAB and liposomes.
Electron source MtrCAB
proteoliposomes
(%/minSD)
Control
liposomes
(%/minSD)
Direct reduction in
solution (%/minSD)
Dithionite (DT) 1813 0.350.28 n/a (too fast to measure;
@30 sec)
RuP-TiO2 6.4 4.2 1.350.10 6012
g-N-CD 8.36.8 0.760.35 8.41.7
a-CD 2.71.8 0.240.19 0.930.39
n = 3; number of experimental repeats (different liposome prepations)
The estimates of the initial RR120 reduction rate in Table 4.1 neatly summarize what has been
discussed before. RuP-TiO2 showed the fastest direct RR120 photo-reduction, followed by g-N-
CD and a-CD. However none of the LHNP were able to achieve as efficient reduction of MtrCAB
as by chemical reduction with DT. This indicate that this system could potentially be optimised
further by engineering better interaction between LHNPs and the MtrCAB. In addition, data on
RR120 reduction control liposomes without MtrCAB in Table 4.1 confirms that RuP-TiO2 does
interact with the integrity of liposomes and seem to increase the leakiness of RR120. g-N-CD also
increase the leakiness of liposomes, but does it half-as much as RuP-TiO2.
4.5 Discussion
In plant photosynthesis, a lipid membrane is used as a scaffolding to arrange and spatially
separate photosynthetic components between the different environments of thylakoid lumen and
stroma. [50] In this chapter, liposome based nanocompartments are used to mimic such physical
separation and show a biomimetic photo-reduction across an insulating lipid membrane, where
energy generated by external LHNP is transferred across the lipid membrane via MtrCAB conduits
to reduce electron acceptors located in the lumen of liposomes.
This system has several inter-facial electron transfer steps: 1) LHNP to MtrCAB, 2) MtrCAB to
RR120 and 3) SED to LHNP (Figure 1.6 c). All experiments used excess amounts of SED (50
mM EDTA) and it has been previously shown that the SED is not rate limiting for photo-reduction
of MtrC by RuP-TiO2. [63] As MtrCAB provided the electron relay across the membrane,
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the observed rate of RR120 reduction within liposomes will be dependent on the amount and
distribution of MtrCAB within the liposome population. Chemical reduction of MtrCAB with
DT was fast and instantaneous with respect to the time resolution of the experiments reported
here. MtrCAB reduction by DT thus represent the fastest possible RR120 reduction within each
liposome sample. The photoreduction by all three LHNPs was slower than reduction by DT,
confirming that the overall rate of RR120 reduction was at least partly limited by the electron
supply from LHNP to MtrCAB. However, for RuP-TiO2 and g-N-CD, MtrCAB was almost fully
reduced during the photo-reduction experiments, suggesting the reductive bleaching kinetics of
RR120 were also rate limited by reduction of RR120 by MtrCAB. It is possible that electron
transfer across the MtrCAB itself is influenced by the electron supply and demand on both sides
of the membrane. MtrCAB orientation in liposomes is not known and likely random, possibly
further complicating the observed kinetics.
TiO2 has high affinity for Glu/Asp protein residues [184–186], and RuP-TiO2 has been shown
before to bind strongly to MtrC and MtrCAB [97]. In addition, RuP-TiO2 showed the best
direct photo-reduction of non-encapsulated RR120. Despite this, photoreduction of RR120 in
MtrCAB liposomes with RuP-TiO2 was slower compared to chemical reduction with DT. The
faster photoreduction of non-encapulated RR120 is likely due to improved interaction between
RuP-TiO2 and RR120, where RR120 can interact with the whole surface area of RuP-TiO2,
which forms the interface for intermolecular transfer of light-excited electrons. In addition, RR120
contains several sulphate groups, which are known to bind to TiO2 surface [187], thus RuP-
TiO2 and RR120 can establish close proximity facilitating intermolecular electron transfer. In the
MtrCAB preteoliposome system electron transfer to RR120 occurs through the limited number
of MtrCAB present in the liposomes (on average 27 MtrCAB per liposome; SD=17, n=3). (For
context, LHNPs were in excess with 1206 LHNP per liposome; SD= 819, n=3.) In addition,
RuP-TiO2 self-agglomerate or aggregate within buffered solutions, as observed with cryo-electron
microscopy analysis (Figure 4.7). Hence, the particle ratio and interaction between MtrCAB and
RuP-TiO2 might have been impaired further.
In contrast, the interaction between MtrCAB and both g-N-CDs and a-CDs is likely to be
transient as no aggregation was detected upon mixing of the particles with MtrCAB liposomes.
Nevertheless, for both carbon dots, relaying the electrons via MtrCAB improved total bleaching
time of RR120 remarkably, which took up to four times faster in MtrCAB proteoliposomes
compared to the direct photoreduction of RR120. This was also seen in the comparison between
the initial RR120 photo-reduction rates shown in Table 4.1. As described earlier light-excited
electrons are transferred from LHNP to other molecules (e.g., RR120 or MtrCAB) from the surface
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of LHNP, thus introduction of MtrCAB compartment limits the routes of electron transfer through
the available amount of MtrCAB (as opposed to anywhere from LHNP surface; on average there
were 50 times more LHNPs than MtrCAB). Interestingly, g-N-CD showed pretty much the
same initial RR120 reduction rate in direct photo-reduction as with MtrCAB proteoliposomes
(i.e., 8.41.7 and 8.36.8, respectively). This suggests that MtrCAB improves the reaction rate
to the levels that offset the MtrCAB ’bottleneck’ within the electron flow path. a-CD, in turn,
showed about 3 times more efficient RR120 photo-reduction within MtrCAB proteoliposomes
than directly in solution. Encapsulation of RR120 at mM concentration in the small lumen of
the liposomes (compared to 10 µM RR120 in the control experiments with direct photoreduction)
will enhance reduction kinetics by MtrCAB and, indeed, reduction of RR120 by MtrCAB was not
observed to be rate limiting for a-CD (where MtrCAB haems were partially reduced throughout
the illumination, Figure 4.8). The enhanced photobleaching kinetics in the proteoliposome are
thus due to a faster reduction of MtrCAB (at concentrations P 10 µM) compared to free RR120.
This enhancement is likely due to the MtrCAB conduit, which can accumulate multiple electrons
on its 20 haems, improving the rate of the multi-electron reduction required to bleach each RR120
molecule. In this respect, MtrCAB is able to stabilise the charge separated intermediate for the
photo-reduction of RR120, mimicking the role of the chlorophyl/pheophytin/QA electron relay of
the natural photosystems I and II.
4.6 Chapter conclusion
This chapter demonstrated and assessed the proof-of-concept of using the transmembrane MtrCAB
conduit for compartmentalized photo-reduction. The initial aims behind this work were to assess:
1) the ability to improve electron separation from LHNP by using MtrCAB as a route for electron
relay away from LHNP and 2) the ability to use the environmental separation by liposomes
(i.e., interior and exterior environment) to optimise such light-harvesting oxidation-reduction
reactions. Both of these aims were assessed testing three LHNPs. All three LHNPs showed
efficient photo-reduction of a liposome-encapsulated dye using MtrCAB as an electron relay.
Furthermore, MtrCAB improved the rate with which a-CD photo-reduced the encapsulated dye
in the liposome system (as opposed to the non-encapsulated system). This example demonstrated
how incorporation of a scaffolding material to separate photo-oxidation and reduction reactions
can be beneficial for overall efficiency of solar energy harvest both in terms of using MtrCAB as
electron relay (and accumulate electrons for such multi-electron reactions as reduction of RR120
azo-bonds) and using liposomal compartments for creating separate environments (and separate
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and concentrate incompatible reactants of the reaction). In particular, it can be proposed that
MtrCAB can aid in the stabilisation of the charge separated state, improving quantum efficiency.
Such component could be beneficial to further advance artificial photosynthesis strategies and
other (bio)nanocatalysis applications.
This bio-mimetic compartment for solar energy capture was intended to explore features of
photosystem (e.g., providing route for electron relay and environmental separation across the
membrane) and proved to be able to change the dynamics of the photo-reduction reaction. Thus
it is important to further explore strategies on how to physically arrange molecules and materials,
which is not a simple task. Evolution has taken many billion years to perfect the composition of
natural photosystems. The work described in this chapter illustrates some of the difficulties and
the increasing complexity for assembling this system and assessing interactions between different
molecular partners. Each of the molecular partners have their own properties, which can negatively
interfere with the system. For example, RuP-TiO2 tends to agglomerate and increase liposome
leakiness. In contrast, both carbon dots were better for liposome membrane integrity, but also very
soluble and thus are suspected to interact with MtrCAB only transiently.
The next step for exploring the potential use of MtrCAB conduit and nano-compartments is to test
MtrCAB compartments for photosynthetic production of solar fuels or solar chemicals. In this
case, a catalyst can be encapsulated in the liposomes, which enables a PS/LHNP to function in a
separate environment from the fuel-generating catalyst. Chapter 5 summarizes work on trying to
encapsulate such catalysts to produce hydrogen.
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Chapter 5
Towards encapsulation of hydrogen
evolving catalyst in lipid compartments
5.1 Chapter introduction
Chapter 4 describes how light energy is used to drive photo-electron transfer across the membrane
for reductive bleaching of the encapsulated dye RR120. In short light energy was used to excite
electrons at LHNPs. Then these electrons were transferred across a membrane via MtrCAB
conduit and used to reduce an encapsulated azo-dye RR120 (Figure 5.1 a). The next step for
demonstrating genuine compartmentalised photocatalysis within the lumen of the compartment is
to change the final electron acceptor from RR120 (i.e., using photo-excited electrons to reduce azo-
bonds in the dye) to a fuel-producing catalyst (Figure 5.1 b). Such catalyst is required to complete
the energy transformation from photons through photo-induced electron transfer to storing these
electrons into chemical bonds of a synthesized compound such as producing gaseous H2 as was
discussed in the Chapter 1, section 1.5.3. In this case electrons transferred by MtrCAB reduce
hydrogen/hydronium ions which are present within the lumen of the liposome due to the self-
ionization of water (i.e., 2HO XH3O OH) .
The aim of this chapter is to demonstrate a compartmentalised photo-catalysis of hydrogen
production. In order to attempt this three different hydrogen evolving catalysts (HEC) were
used: two types of platinum nanoparticles (i.e., Ptsyn and Ptcom) and a hydrogenase HydA1. As
introduced in Chapter 1, section 1.5.3, both Pt and hydrogenases are currently the benchmarks for
showing the highest activity for hydrogen evolution. This chapter starts by determination of the
catalytic and photocatalytic activity of the selected catalysts. The catalytic activity was measured
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b)a)
H2RR120
2 H+/H3O
+
+2e-
HEC
Figure 5.1: Schematic of light-driven electron transfer across the lipid membrane as was
demonstrated in Chapter 4 (a) and as intended for work in this chapter(b). a) External
electrons are supplied photo-chemically from a light-harvesting nanoparticle (LHNP) and then
transferred across the lipid bilayer via transmembrane protein complex MtrCAB. This reaction
is monitored following reductive bleaching of an internalised red azo dye, Reactive Red 120
(RR120). b) Electron electrons are relayed across the membrane via MtrCAB to a hydrogen
evolving catalyst (HEC) leading to reduction of hydrogen/hydronium ions (present by self-
ionization of water) and generation of gaseous H2 within the compartment. SED – sacrificial
electron donor. Figure adapted from [67].
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using dithionite (DT) as chemical reductant and the photocatalytic activity was achieved after
sample illumination with g-N-CD LHNPs. These experiments also tested how the H2 evolution
activity changes over time and whether addition of an electron mediator (e.g, methyl viologen,
MV) improves or hinders the electron transfer from the electron source (i.e., DT or g-N-CD) to
the catalyst resulting in production of more H2.
The chapter then describes the results for two different strategies employed to encapsulate HEC
within the interior of liposomes. At first, liposomes are prepared by rapid dilution by adapting
a liposome preparation protocol that was used previously for RR120 experiments in Chapter 4.
This method of liposome formation by rapid dilution creates liposomes, reconstitutes MtrCAB
and simultaneously encloses HEC catalysts present within the surrounding solution. However,
rapid dilution is a stochastic process, thus it is difficult to control and reproduce the amount of
catalysts that are encapsulated.
In order to gain better control over the catalyst loading within the compartment, a different strategy
was explored using porous support material. In this case, HECs are trapped within a porous
material (e.g., porous silica), which is then enclosed by a supported lipid bilayer. This approach
could provide higher control over catalyst loading (e.g., the amount and reproducibility) by
opening up the chemical space for manipulation (e.g., pH, temperature, manipulation techniques)
before introducing the fragile biological components to the system. Many studies have explored
the use of silica as a solid support for such cargoes as chemical catalysts and pharmaceuticals.
[188] Similarly, HEC could be trapped within silica nanoparticle, after which the HEC could
be encapsulated by self-assembly of a membrane around the entire silica (SiO2) nanoparticle.
[18, 188, 189] Formation of a supported lipid bilayer containing functional membrane proteins
has also been reported. [144, 190] In fact, Nordlund and colleagues have reconstituted functional
cytochrome c oxidase in supported lipid membrane on porous silica and established proton-tight
electrochemical gradient across these membranes. [190] This chapter explores use of two different
types of supporting silica material. First, I test loading of Pt NPs into pre-formed commercial NPs.
Then, I test the potential to achieve higher loading of Pt NPs by incorporating these during the
synthesis of silica NPs.
Finally, the chapter concludes with a discussion of the results and the diversity of challenges that
must be overcome to achieve reliable encapsulation of HECs within MtrCAB liposomes.
Chapter 5. Towards encapsulation of hydrogen evolving catalyst 108
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
F
ra
c
ti
o
n
 o
f 
s
a
m
p
le
Bin Center (nm)
a) b)
Figure 5.2: A representative TEM image (a) and the size distribution (b) of Ptsyn NP
observed by the TEM. n = 289, bin width = 0.5 nm, was chosen as a compromise between
keeping sensitivity to the different sizes of NPs present in the sample and limiting the human error
while performing manual particle measurements. (In these TEM images, 0.5 nm was around the
level of reliable resolution by eye of Ptsyn NPs vs. the background.)
5.2 Catalyst characterisation
5.2.1 Characterisation of the Pt NP size
Two types of Pt NPs were obtained - commercially purchased Pt NPs (Ptcom) and in-house
synthesized Pt NPs (Ptsyn).The Ptcom consists of 99.9% pure Pt and have an average particle
size of 3 nm (specified by the manufacturer). Ptsyn were synthesized as described in section 2.1
following previous work by Eklund and Cliffel, where glutathione was used as a capping agent to
inhibit particle overgrowth and aggregation, and yield soluble NPs with an average size of about
2.5 nm. [111]
Both Ptcom and Ptsyn were imaged by the TEM as described in section 2.1. Ptsyn are well dispersed
particles with an average particle size of 2 nm (i.e., diameter was measured for two different
synthesis batches by TEM as 2.2  0.3 nm, n=157 and 2.0  0.3 nm, n=289; Figure 5.2).
TEM of the Ptcom sample was performed by Dr Sunjie Ye. TEM revealed that although the
individual particle size is 3 nm as specified by the manufacturer, many particles are present in
much larger agglomerates (Figure 5.3 a). DLS of Ptcom water dispersion confirmed the presence
of particle aggregates between 100 - 200 nm (Figure 5.3 b).
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Figure 5.3: A representative TEM image (a) and the size distribution (b) of Ptcom NPs
determined by DLS.
5.2.2 Characterizing the activity of Hydrogen evolution reaction
(HER)
H2 evolution of both Pt NPs and HydA were tested using a Clark-type electrode set-up as described
in section 2.6. In brief, H2 diffuses from the reaction chamber across a plastic (PTFE) membrane
and is oxidised at the Pt anode (not to be confused with Ptcom/Ptsyn) kept at a constant potential
of 0.6 V vs Ag/AgCl. [140] The resulting current is proportional to the concentration of dissolved
H2.
The activity of Ptcom was observed using excess amount of DT as the reductant (Figure 5.4).
No current was observed from Ptcom until DT was added, which led to an immediate increase
in current indicating H2 production (Figure 5.4a). HER activity was estimated by a linear fit
to the initial current increase and was recorded as 0.2 µmol H2 min1 mg1 Ptcom. Over
time, the current indicating H2 evolution saturates and starts to decline. This might indicate
poisoning of Ptcom surfaces by reaction by-products. It is well-known that Pt can be poisoned
by CO and sulphur compounds such as SO2, COS and H2S. [107, 191] The products of dithionite
decomposition contain HS and various sulphur-oxoacid salts, which could adsorb onto Ptcom.
[192] Figure 5.4b explores how the activity of Ptcom changes upon adding electron mediator
(methyl viologen, MV), which could further improve electron transfer from DT to Pt surface
and improve H2 production. And indeed, the presence of electron mediator (MV) increases the
initial ”burst” of activity, but it also leads to much quicker saturation and subsequent decline of H2
evolution, suggesting that increased HER might lead to quicker accumulation of the Pt poisoning
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by-products.
Pt DT + MVa) b)
Pt DT
Figure 5.4: HER activity of Ptcom NPs using excess DT as electron source. Dashed lines
indicate time-points when PtNPs, dithionite (DT) or methyl viologen (MV) were added to the
reaction chamber. All experiments used 1 ml of 20 mM MOPS and 30 mM Na2SO4 buffer (pH
7.4) and 0.04 mg Ptcom . a) Experiment used 29 mM DT. b) Experiment involved 13 mM DT and
2 mM MV as additional electron mediator.
Pt DT
Figure 5.5: HER activity of Ptsyn NPs using excess DT as electron source. Dashed
lines indicate time-points when PtNPs or dithionite (DT) were added to the reaction chamber.
Experiments used 1 ml of 20 mM MOPS and 30 mM Na2SO4 buffer (pH 7.4) and  0.02 mg Ptsyn
with 11 mM DT.
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The activity of Ptsyn was determined as described above and is shown in Figure 5.5. Ptsyn showed
lower HER activity (i.e., 0.09 µmol H2 min1 mg1 Ptsyn) than Ptcom, which is likely a trade-
off for using glutathione as a capping agent to increase particle solubility and to prevent particle
aggregation, and while doing so blocking the surface-active sites of Pt. [106] As seen with Ptcom,
the H2 evolution by Ptsyn also saturated and started to decline over time, indicating poisoning of
Ptsyn surface. In order to test whether this surface poisoning depends on the activity of Ptsyn NP
themselves or is purely influenced by the reaction conditions (e.g., concentration of the breakdown
products of DT), an experiment of stepwise addition of Ptsyn was performed (Figure 5.6). This
showed that once H2 evolution starts to saturate, it is not recovered by more Pt NPs indicating that
the surface of freshly added Pt NP becomes immediately poisoned. In addition, further addition
of even more electron source (DT) also did not help to restore HER even for short-term. Thus
detection of the HER activity of Pt NPs using DT as an electron source is time sensitive and
perhaps only reliable as a qualitative but not a quantitative method.
DT DTPt Pt Pt Pt Pt
Figure 5.6: HER activity of increasing amounts of Ptsyn. The blue bar indicates increasing Pt
amount corresponding to 0, 2.5, 3.5, 4.5, 5.5 and 6.5 arbitrary units of Pt. The precise amounts
of Pt were not determined in this case, as the synthesized particles were subjected to additional
cleaning step of particle precipitation using 1 : 2.5 v/v ethanol and re-suspension in water without
measuring final amount of recovered Pt. Dashed lines indicate time-points when Pt NPs or
dithionite (DT) were added to the reaction chamber. DT was added in two increments of 20 µl,
0.57 M resulting in concentrations of 11 mM and 19.5 mM. Experiment used 1 ml of 20 mM
MOPS and 30 mM Na2SO4 buffer (pH 7.4)
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HydA1DTMV*
Figure 5.7: HER activity of HydA1 hydrogenase using excess DT as electron source
and methyl viologen (MV) as electron mediator. Lines indicate time, when stated reaction
components were added to the reaction chamber. The experiment involved 0.5 ml of 100 mM
K-Pi buffer (pH 7.4), 10 mM MV, 100 mM DT, 4 nM HydA1. The asterisk indicates removal of
some buffer.
The activity of HydA1 was observed using excess amount of methyl viologen (MV) and DT as
an electron mediator and the electron donor, respectively (Figure 5.7). MV is typically used for
measuring activity of hydrogenases, as the electron mediator often helps to ensure electron supply
to the buried catalytic centre of the enzyme. [68, 107, 193] No H2 was recorded after addition of
MV and DT alone, until the addition of the HydA1. HER started as a slower initial phase (14
minutes), followed by a long linear increase. The region of this linear increase was used to estimate
the catalytic activity of HydA1 as 13.07.8 µmol H2 min1 mg HydA11 (n = 2). The recorded
activity is about an order of magnitude lower than the activity reported for this particular protein
batch received from Dr. Gustav Berggren (160 µmol H2 min1 mg HydA11 measured at 28°C,
120 rpm, 10 mM methyl viologen, 100 mM Na-DT in 100 mM KPi pH 6.8, 15 minutes after Na-
DT addition). This particular batch of HydA1 preparation had itself lower specific HER activity
than was previously obtained by Dr. Gustav Berggren (700 - 800 µmol H2 min1 mg1) [112]. The
lower activity most likely represents the difficulties to transport and preserve HydA1 in conditions
that provide sufficient shielding from O2 in the buffers, containers and atmosphere that might come
in contact with the protein, as well as exposure to residual oxygen present in the experimental
equipment (e.g., the electrode set-up or solutions) despite working within the glovebox (O2 @ 0.01
ppm). The decreased catalytic activity might also be influenced by the lower temperature (room
Chapter 5. Towards encapsulation of hydrogen evolving catalyst 113
temperature vs. 28°C used by Dr. Berggren group) and protein loss during sample transportation.
The photocatalytic activity of HECs
The photocatalytic activity of all three HECs were tested using the same electrochemical set-
up supplemented with a light source as described in section 2.6 (Figure 5.8). g-N-CD was the
most active LHNP in RR120 photo-reduction experiments in Chapter 4, and thus was selected for
measuring photocatalytic HER by both Pt NPs and the HydA1 hydrogenase. All experiments used
surplus g-N-CD and the initial HER activity (i.e., before addition of MV or other components) was
used to estimate the specific catalyst HER activity as 0.02, 0.005 and 2 µmol H2 min1 mg HEC1
for Ptcom, Ptsyn and HydA1, respectively. Thus the HydA1 had the highest activity and, as noted
previously, Ptcom was more active than Ptsyn. In these experiments electrons for H2 evolution
are supplied by g-N-CD, and to account for varying concentration of g-N-CDs the observed
photocatalytic HER activity was estimated as 1, 0.07 and 200 µmol H2 min1 mg HEC1 mg g-
N-CD1 for Ptcom, Ptsyn and HydA1, respectively. Due to time constraints, full characterisation
and optimisation of the reaction kinetics was not performed (i.e., optimisation of particle ratios
between HEC and g-N-CD, determination how quickly Pt surface gets poisoned, determination if
inclusion of electron mediator, e.g., MV, improves or hinders HER initially and/or in long term).
Some of these aspects are illustrated in Figure 5.8. Panel b attempts to observe change in the
hydrogen evolution activity of Ptsyn after addition of electron mediator (MV), which did not seem
to influence the activity significantly. The more Ptsyn and more g-N-CD were added, which did
seem to result in a marginal increase in the rate of H2 production (i.e., steepness of the slope).
MV was also tested for photo-catalytic HER by HydA1 (Figure 5.8 c). Presence of electron
mediator (MV) also led to marginal increase in H2 production, which is likely due to MV being
able to improve electron transfer between g-N-CD and the catalytic site of HydA1. Overall, these
observations confirm that photocatalytic HER is thermodynamically possible by combining these
catalysts with g-N-CD as LHNP.
Illumination of the Clark electrode also generates a photocurrent, observed as an increase in
the detected current, which then saturates (Figure 5.8, d). The observed photocurrent varies
between repeated illuminations and experiments in terms of both the slope (average increase of
0.32 nA/min, SD 0.2 nA/min, n = 21) and duration of the current increase (6.3 min, SD 3.7 min,
n = 21). This complicates data analysis of photocatalytic HER, as any detected increase in signal
has to be higher or has to demonstrate longer increase in current than the one of the photocurrent.
The following sections of this chapter describe attempts to encapsulate HECs (Pt NPs and
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EDTA gNCD HydA1 MV
*
c) d)
EDTA**
Figure 5.8: Photocatalytic HER activity of Ptcom (a), Ptsyn (b) and HydA1 hydrogenase
(c), using carbon dots (g-N-CDs) as LHNPs and a control photo-current of the electrode
(d). Lines indicate time, when stated reaction components were added to the reaction chamber.
Yellow bars indicate sample illumination, and grey bars indicate time periods immediately after
illumination. All experiments were performed in about 0.5 ml of 20 mM MOPS, 30 mM
Na2SO4 (pH 7.4) buffer and 50 mM EDTA. a) Experiment involved 2 µM g-N-CD, 20 µg
Ptcom (0.11 nmol NP). b) Experiment involved 2 µM g-N-CD, 19 µg Ptsyn (0.34 nmol NP).
1© - addition of 0.2 µM MV, 2© - addition of 15 µg more Ptsyn and more g-N-CD NPs (end
concentration: 4 µM g-N-CD), 3© - addition of more g-N-CD NPs (end concentration: 6 µM g-
N-CD). c) Experiment involved 1 µM g-N-CD, 4 nM HydA1 (2 pmol HydA1), 1 mM MV. The
asterisk indicates noise due to loose electrode connection. d) The double asterisk () indicates a
removal of some buffer, before addition of EDTA.
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HydA1) in compartments (liposomes and silica nanoparticles). To determine encapsulated catalyst
qualitatively, DT was used as the electron source.
5.3 Attempts to trap HECs in liposome compartment by
rapid dilution
The simplest way to attempt introducing a fuel-producing catalyst within the lumen of a
compartment presented in Chapter 4 is to modify the existing protocol by substituting the RR120
for a HER catalyst. The main advantage for this approach is the ability to simultaneously
encapsulate the catalyst and reconstitute MtrCAB while forming liposomes. The main
disadvantage for this approach is the large volume sample gets diluted to, thus resulting in very
low theoretical yields of HEC encapsulation.
Encapsulation of all three catalysts by rapid dilution was studied. Liposomes were prepared as
described in section 2.2.2 and HEC activity was observed electrochemically as before. Liposomes
were mixed with DT as a reducing reagent and H2 evolution was monitored. In case of
successful encapsulation, no changes in the recorded signal should be recorded as the DT cannot
diffuse through the lipid membrane and proton permeability is low. However, once the the lipid
bilayer is solubilised by a detergent (e.g., Triton X100), an increase in detected current (and H2
concentration) should be recorded, .
The liposome sample with Ptcom showed a significant H2 evolution even before the detergent was
added (Figure 5.9). This indicates that most of the Pt NPs are present on the outside of liposomes.
The TEM of the Ptcom showed that most NPs are aggregating and these aggregates are likely
being sedimented together with the reconstituted liposomes during the ultra-centrifugation step
used for liposome recovery. In addition, the Ptcom agglomerates are comparable in size with the
lipsomes (100 - 200 nm), making them less likely to be trapped within a liposome. It is also
possible that Pt NPs interact with the liposomal membrane as this has been observed for other
metal nanoparticles. [189] Attempts to separate liposomes and Ptcom using gel filtration (e.g.,
Illustra NAP-5 column) were unsuccessful.
Ptsyn nanoparticles are more soluble than their Ptcom counterparts, and thus it should be easier
to trap these within liposomes. Figure 5.10 shows a liposome sample showing a promising
response for a successful encapsulation of Ptsyn. No increase in H2 concentration was observed
for liposomes without MtrCAB until detergent was added, and the liposome membrane was
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solubilised. The same liposomes were also tested for photocatalytic HER using g-N-CD as a
LHNP, however the amount of encapsulated Pt NPs was not enough to distinguish a photocatalytic
HER from background photocurrent (Figure 5.10 c). Unfortunately, encapsulation of Ptsyn by
rapid dilution showed very low reproducibility (i.e., positive encapsulation was only confirmed
for 18% of preparations, n = 11) and thus was discontinued. Perhaps, the amount of the trapped
Pt NPs was too small to see any signal, especially taken into account that the Ptsyn had the lowest
catalytic activity out of all three catalyst tested. Furthermore, a few times (3 preparations) H2
production was observed before the lysis of the lipid membrane, indicating that Pt NPs were
sometimes also present on the outside of the liposomes.
LDT + MV TX DT + MV
Figure 5.9: HER activity of E. coli polar lipid and 1% DOPE-CF liposomes (L) after an
attempted encapsulation of Ptcom nanoparticles by rapid dilution. Excess dithionite (DT) was
used as an electron source, methyl viologen (MV) as electron mediator and Triton X100 (TX) to
solubilise the lipid bilayer. Lines indicate time, when stated reaction components were added to
the reaction chamber. The experiment involved 1 ml of MOPS buffer (20 mM MOPS, 30 mM
Na2SO4, pH 7.4), 2 mM MV, 14 mM DT, 0.1% v/v TX.
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Figure 5.10: HER activity of E. coli polar lipid liposomes after encapsulation attempts of
Ptsyn by rapid dilution. (a) Control liposomes without MtrCAB, (b) MtrCAB proteoliposomes.
(c) photoactivity of MtrCAB proteoliposomes+Ptsyn (red) and control liposomes+Ptsyn (black),
using carbon dots (g-N-CD, 2 µM) as a LHNP. Yellow bar indicate sample illumination. (d)
A representative experiment of unsuccessful Ptsyn encapsulation in liposomes by rapid dilution.
Lines indicate time, when stated reaction components were added to the reaction chamber. L -
liposome samples, DT - dithionite (57 mM), OG - octyl glucoside (50 mM), EDTA - sacrificial
electron donor (55 mM. All experiments were performed in  0.5 ml of 20 mM MOPS, 30 mM
Na2SO4 (pH 7.4) buffer.
Finally, an attempt was made to encapsulate HydA1 using rapid dilution (Figure 5.11).
Unfortunately, no HER activity was associated with the liposomes before or after addition of
the detergent. This might be due to lack of success to trap any HydA1 within the liposome cavity,
or lack of success in keeping sample protected from oxygen, which is the main challenge working
with this extremely oxygen sensitive enzyme. The work was carried out in collaboration with
Samuel Piper from the University of East Anglia and is currently continued here in Leeds by Dr
Huijie Zhang.
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Figure 5.11: HER activity of E. coli polar lipid liposomes (L) with attempted encapsulation of
HydA1 by rapid dilution. Excess dithionite (DT) was used as an electron source, methyl viologen
(MV) as electron mediator and Triton X100 (TX) to solubilise the lipid bilayer. Lines indicate
time, when stated reaction components were added to the reaction chamber. The experiment
involved 0.5 ml of MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4), 1 mM MV, 11 mM
DT, 0.1% v/v TX (0.11% v/v after second addition of TX).
5.4 Attempts to trap Ptsyn in porous silica nanoparticles
Two types of silica were used for testing catalyst encapsulation and the formation of supported
lipid bilayers in this study. First, commercial mesoporous silica nanoparticles (meSiO2, 200 nm
particle size, pore size 4 nm) were obtained, and tested for Pt NP loading within the pre-formed
pores of the silica (Figure 5.12 a). Secondly, bio-inspired silica (gSiO2) were synthesized in
collaboration with Prof. Siddharth V. Patwardhan from the University of Sheffield. Patwardhan
and colleagues have developed a rapid, environmentally friendly way to form silica nanoparticles
by silica precipitation using small amine polymers such as pentaethylenehexamine (PEHA) and
diethylenetriamine (DETA). [194,195] Their designed method allows trapping of Ptsyn within the
porous gSiO2 NP during particle synthesis (Figure 5.12 b).
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Figure 5.12: A diagram of formation of liposome compartment using porous silica support.
a) Commercial silica nanoparticles (meSiO2 ) are mixed with Pt nanoparticles, which enter the
porous meSiO2. b) Alternatively, Ptsyn are trapped within the porous gSiO2 NP during particle
synthesis. Ptsyn are mixed with the silica precursor and amine. The solution then gets acidified,
which causes precipitation of the silica nanoparticles. c) Silica nanoparticles containing Pt catalyst
are then mixed with liposomes, which form supported lipid bilayer around these particles, as
shown in d).
5.4.1 Characterisation of the silica particles
The size distributions of both meSiO2 and gSiO2 NPs (Figure 5.13) were measured by nanoparticle
tracking analysis (NTA) and also by imaging particles with the TEM as described in section 2.1.
Both meSiO2 and gSiO2 ranged in size from 50 - 400 nm. In addition, Pt-loading did not seem to
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significantly change the size distribution of gSiO2. The TEM revealed that commercial meSiO2
NPs were present as uniform spherical particles with a dense lattice-like structure, whereas the
shape of the gSiO2 NPs varied significantly. TEM of gSiO2 NPs also indicated heterogeneous
Pt loading, where some particles contained large clusters of Ptsyn and others had fewer and more
dispersed Pt. This could be due to interaction of Ptsyn with the PEHA amine, resulting in exchange
of Pt surface ligands from glutathione to PEHA. The resulting amine capped Pt NPs would also
have a higher tendency to agglomerate. [196]
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Figure 5.13: Representative size distributions and TEM images of meSiO2 (a,b) and gSiO2
NPs (c,d). a) NTA analysis of meSiO2 NP dispersion based on analysis of 33083 tracked particles.
c NTA analysis of gSiO2 NPs loaded with Pt (Pt-gSiO2) and without (n = 2987 Pt-gSiO2 NPs and
1030 gSiO2 NPs). NTA was performed in MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4)
and the size distribution is represented using a bin size of 0.5 nm.
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5.4.2 Supported lipid bilayer on porous silica support
The work in Chapter 4 used E. coli polar lipids to mimick the lipid mixture present in the outer
membrane of the S. oneidensis and thus the native environment for the MtrCAB. Most reports on
the formation of supported lipid bilayers, however, use synthetic lipids (e.g., POPC, 1-palmitoyl-
2-oleoyl-sn-glycero- 3-phosphocholine and DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine)
and mixtures of these such as 9:6:4:1 DOPE:DOPC:DOPG:CA (where DOPE stands for 1,2-
Dioleoyl-sn-glycero-3-phosphoethanolamine, DOPC - 1,2-dioleoyl-sn-glycero-3-phosphocholine,
DOPG - 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) and CA - cardiolipin). [18,144,190]
In fact, there has been reports indicating difficulties to form supported lipid bilayer from
E. coli total extract lipids, which could be partially solved by using 68:32 molar ratio of
E. coli : POPC lipids. [197] Thus several lipid combinations were tested for supported lipid
bilayer formation on meSiO2 . These were 100% POPC, 100% E. coli polar lipids, 68%-32%
E. coli polar lipids- POPC and 5:3:1:1 E. coli polar lipids : POPC : POPG : POPE (where POPG
stands for 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoglycerol and POPE - 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoethanolamine). All 4 lipid mixtures also contained 1% w/w fluorescent
carboxyfluorescein-conjugated DOPE (DOPE-CF). The supported lipid bilayers were formed as
described in section 2.7.3, washed by centrifugation and the fluorescence of the pellet (lipids
associated with the silica) and the supernatant (free liposomes) was recorded (Figure 5.14). These
experiments were performed using 12% wt/wt ratio of lipid to meSiO2 (rough estimate of 2:1 lipid
bilayer to silica surface ratio) as has been reported in [144]. The data confirms that out of the 4
tested lipid compositions POPC was the best at forming supported lipid bilayers, whereas pure E.
coli polar lipids showed the least association with silica. Both mixtures containing  30% POPC
showed  60% of the association of meSiO2 seen for 100% POPC. Thus these lipid mixtures
show a potential to both mimic the lipid composition of the bacterial outer membrane and to
enclose silica. In addition, the dependency of lipid (POPC) concentration on the formation of
supported lipid bilayers on gSiO2 was also tested (Figure 5.15). These results show that particles
get saturated with lipids already at 0.5 - 1 relative w/w ratios. Similar experiment, comparing the
lipid concentration dependency on the formation of supported lipid bilayers on meSiO2, were not
performed, but would be advantageous to better estimate success of lipid bilayer formation.
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Figure 5.14: Formation of the supported lipid bilayer on meSiO2 using different lipid
compositions. Blue, 100% POPC; Orange, 68% E. coli polar lipids - 32% POPC, Grey, 5:3:1:1
E. coli polar lipids : POPC : POPG : POPE (EcPcPgPe); Yellow, 100% E. coli polar lipids. All
lipid mixtures contained 1% w/w DOPE-CF and the recorded fluorescence values were normalised
against the fluorescence of the original lipid sample. The experiment used 12% wt/wt ratio of lipid
to meSiO2 (rough estimate of 2:1 bilayer to silica surface ratio) in MOPS buffer (20 mM MOPS,
30 mM Na2SO4, pH 7.4).
Figure 5.15: Formation of supported lipid
bilayer on Pt-gSiO2 NPs using increasing
concentrations of POPC liposomes containing
1% w/w DOPE-carboxyfluorescein. Red - Pt-
SiO2 sample with the supported lipid layer, Blue
- non-attached liposomes separated from the
reported Pt-SiO2 samples, Black - lipid control.
0.0 0.5 1.0 1.5 2.0
0
5000
10000
15000
20000
25000
30000
35000
 Lipid control
 Free liposomes
 Pt-SiO
2
 + lipids
F
lu
o
re
s
c
e
n
c
e
Lipids:Silica w/w
Chapter 5. Towards encapsulation of hydrogen evolving catalyst 123
5.4.3 Trapping PtNPs in porous silica particles
Current attempts to load catalyst within porous silica tested only Ptsyn as these were smaller and
better dispersed than their commercial counterparts. Ptsyn also allowed experimentation in aerobic
conditions, which would not be possible if HydA1 was used. Ptsyn loaded meSiO2 and gSiO2
with attempted supported lipid bilayer were formed as described in section 2.7.3. The resulting
particles were tested for H2 evolution and were compared to lipid-free control samples using the
same Clark-electrode type system as before (Figure 5.16).
*
DT TXSi* DT Si TX
b)a)
Figure 5.16: HER activity of Ptsyn loaded meSiO2 (a) and gSiO2 (b) covered with a supported
lipid bilayer and using excess dithionite (DT) as the electron source. Black - lipid-free control
sample, Red - sample with supported lipid bilayer. Si - addition of Pt-loaded SiO2 nanoparticles;
TX - Triton X100 detergent. Lines indicate time, when stated reaction components were added
to the reaction chamber. The time data of the compared experiments (black and red) have been
modified so that time and the signal changes associated with adding the stated components would
be the same. The asterisk indicates removal of some buffer. Both experiments were performed in
MOPS buffer (20 mM MOPS, 30 mM Na2SO4, pH 7.4). a) Experiments involved 1 ml sample
containing 0.4 mg meSiO2 loaded with Ptsyn and 0.2 mM MV, 68% E.coli polar lipid - 38%
POPC liposomes, 11 mM DT and 0.1% v/v TX. b) Experiments involved 0.5 ml sample containing
0.4 mg gSiO2 loaded with Ptsyn, liposomes containing 99.6% POPC - 0.4% Texas red labelled
DHPE lipids (DHPE, 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine), 57 mM DT and
0.1% v/v TX.
Both lipid-free controls showed clear change in HER upon introduction of the reducing agent
(DT). Thus both silica NPs contained sufficient amounts of Ptsyn. The HER activity with gSiO2
was significantly higher than meSiO2. Regretfully, no clear difference was seen between silica
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with supported lipid bilayers and the corresponding control samples. This is most likely an
indication of an incomplete encapsulation of the silica by the supported lipid bilayers. All
experimental conditions were estimated to contain surplus lipids. The experiments with gSiO2
used 1.5 w/w lipid to silica ratio, which has been shown to saturate gSiO2 particles in Figure 5.15.
The experiments with meSiO2 used 17% w/w ratio of lipids to meSiO2 (rough estimate of 3:1
bilayer to silica surface ratio). Interestingly, Ptsyn loaded meSiO2 with supported bilayer showed
reduced HER activity compared to the lipid-free control. Lipid solubilisation by the detergent
(TX) caused a ”jump” in H2 concentration, suggesting that some fraction of the meSiO2 NPs
might have been successfully encapsulated. This however is a very low change in the recorded H2
concentration and should be optimised in future work.
5.5 Discussion
In this chapter, a study on encapsulation of three different catalysts (Ptcom, Ptsyn and HydA1
hydrogenase) within liposomes and in lipid-bilayer coated silica is described. The work was
carried out with the ultimate goal of encapsulating the catalyst within separate compartment that
would be coupled to an external light-harvesting nanoparticle by the membrane haem protein
MtrCAB. This would create a first proof-of-concept system for demonstrating compartmentalized
photo-catalysis. Unfortunately, none of the attempted methods so far have provided robust and
reproducible results for successful catalyst encapsulation within lipid covered compartment. Main
difficulties lie in combining the different materials (i.e., lipids, protein, inorganic nanoparticles),
whose properties restrict the range of methods available to assemble the compartment and gain
spatial control over the assembly.
First, catalyst encapsulation was attempted with simultaneous MtrCAB reconstitution and
liposome formation by rapid dilution. Although this approach was successful for experiments
with RR120 azo-dye (reported in Chapter 4), it has limitations when dealing with larger and more
valuable cargoes such as precious metal nanoparticles like Pt, and sensitive-enzymes like HydA1.
Liposome formation by rapid dilution is a stochastic process, trapping only a small fraction
of the relatively large sample volume within the liposome lumen (i.e., cumulative liposome
volume of 10 µl in 50 ml). Further difficulties arise, if the cargo to be encapsulated (i.e., Pt
NPs) itself form large agglomerates as was observed with Ptcom. Stochastic encapsulation of
well-dispersed nanoparticles (3 nm in size) within 100-200 nm large liposomes is easier than
encapsulation of particle agglomerates ranging in size of 100-200 nm. These Ptcom aggregates
are very diverse in shape, which further impairs formation of continuous lipid bilayer around
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them. Ptsyn are more water-soluble than Ptcom and remain small (2 nm), because their surface
is modified by glutathione. Thus, it is more likely to encapsulate Ptsyn than Ptcom within
MtrCAB proteoliposomes. And indeed, successful though unreliable encapsulation of Ptsyn was
observed. However, the improved water solubility of Ptsyn comes at a catalytic cost, as the surface
modification by glutathione also reduce the available Pt surface for H2 evolution. As the result
Ptsyn had half the catalytic activity as Ptcom. HydA1 seemed as the most suited catalyst for
encapsulation by rapid dilution as it showed superior catalytic activity than both Pt NPs and is also
very soluble. Unfortunately, the catalytic centre of HydA1 is extremely oxygen sensitive, which
makes it very difficult to provide sufficiently anaerobic environment and work with this enzyme.
This also makes it difficult to discriminate whether lack of HER activity is due to unsuccessful
encapsulation of HydA1 or whether the enzyme has lost its activity.
Another issue upon observing HER activity was that the activity of both Pt NPs were time-limited
by what appeared to be Pt surface poisoning with the end products of dithionite (DT) reduction.
This meant that any enquiry of the catalytic activity of Pt NPs with chemical reductant (DT) as
electron source was time-sensitive. In addition, a build-up of reaction by-products might even
mask HER activity, when trying to determine whether any Pt NPs have been encapsulated within
liposomes or not. Liposome assays relay on the assumption that no HER signal should be observed
of liposomes with encapsulated catalyst till the liposome bilayer is solubilised by a detergent.
The experiment in Figure 5.6 showed that addition of catalyst after the initial saturation of H2
evolution reaction did not yield any increase in the observed signal. If this is caused by build-up of
DT by-products that poison the catalytic Pt surface, than similar build-up might occur during the
observation of liposome samples. In this situation, subsequent release of Pt NPs from liposomes
by detergent would not yield any signal as Pt might get immediately poisoned by DT by-products.
Thus it might be a better strategy to use LHNPs and photo-reduction as the electron source as it
seemed to provide a less time-sensitive observation of HER activity.
The attempts to encapsulate the chosen HER catalysts (i.e., Ptcom, Ptsyn and HydA1) exposed
some of the challenges to be overcome. Firstly, sufficient amounts of catalyst have to be loaded
within liposomes to record a clear signal. Secondly, the testing conditions for the catalytic activity
should be optimised to prevent catalyst deterioration (e.g., oxygen sensitivity, surface poisoning
of Pt). Thirdly, greater control over the liposome preparation is required to achieve robust
and reproducible liposome loading. Rapid dilution is a stochastic process with respect to HEC
encapsulation. Increasing the concentration of catalyst should increase the catalyst loading within
the liposomes. However, increasing the concentration of catalyst can also cause complications
such as Pt NP aggregation, as well as raise the concentration of non-encapsulated catalyst in
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the final sample. Thus, the liposome preparation mechanism should include a step to efficiently
remove non-encapsulated catalyst from the exterior of liposomes. This could be based on size
separation (e.g., size exclusion, gel filtration, differential centrifugation) or employment of a
catalyst specific approach. For example, Pt NPs could be precipitated (e.g., by increasing salt
concentration, which, in turn, can subject liposomes to osmotic shock) or nickel-nitrilotriacetic
acid (Ni-NTA) resin can be used to bind the His-tag of non-encapsulated HydA1. Any potential
preparation or cleaning step, however, has to be compatible with the fragile nature of liposomes
and proteins (e.g., MtrCAB and HydA1, if used). Thus, the space for sample manipulation
is constrained to low and mild temperatures, neutral pH and strictly anaerobic environment
in case of HydA1. Perhaps, further liposome engineering is required to expand the range of
available methods and facilitate sample preparation. For example, another membrane protein
(such as aquaporin [45] or self-inserting α-haemolysin [6]) engineered to have an affinity tag
could be introduced and used to isolate purified liposomes. Other methods could be used to form
liposomes and encapsulate catalysts. Edwards et al. encapsulated small tetraheme cytochrome
(STC) by rehydrating within lipid membranes followed by sample sonication and freeze-thaw
cycles. [93] This approach allows use of smaller sample volumes (and thus hopefully better yield
of encapsulation), but it also exposes sensitive proteins (i.e., HydA1 and MtrCAB) to harsher
conditions, such as sonication and temperature changes. Additional washing steps to remove non-
encapsulated catalyst are also still required.
A different approach would be to trap catalyst within a support material. This chapter describes
work on loading Ptsyn in silica NPs (i.e., meSiO2 and gSiO2), which loaded silica with Pt NPs
during sample preparation allowing more flexibility of chemical conditions before the formation
of solid supported lipid bilayers (SLB) in later steps. Thus the range of chemical approaches
for material manipulation and catalyst loading can be expanded. For the work reported in this
chapter, preformed meSiO2 NPs were loaded with Ptsyn using extensive sonication, while Ptsyn
were entrapped within gSiO2 during the synthesis of gSiO2. As the result, the gSiO2 showed
better catalyst loading than meSiO2. Both meSiO2 and gSiO2 showed better and more reliable
catalyst loading compared to previous catalyst encapsulation within liposomes formed by rapid
dilution. Unfortunately, this approach was then stalled by observation that formation of supported
lipid bilayers resulted in limited or only partial silica enclosure with both silica materials. Further
work is required to optimise silica surface and lipids for the formation of SLB.
Solid-supported lipid bilayer formation on silica has been studied in detail [198–200] and is
believed to proceed in stepwise mechanism: first, liposomes adsorb onto the surface of silica,
which induce liposome deformation (Figure 5.17). The liposomes then either rupture and form a
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SLB patch, which grows by fusion of other liposomes (self-spreading process), or reach a critical
coverage of adsorbed liposomes, where rupture of one liposome triggers rupture of neighboring
vesicles and a fusion of SLB patches (vesicle fusion). [198]
Figure 5.17: Diagram showing SLB formation by vesicle fusion. SLB formation proceeds in a
stepwise mechanism: at first, liposomes adsorb onto the surface of silica, which induce liposome
deformation. The liposomes then either rupture and form a SLB patch (a), which grows by fusion
of other liposomes (self-spreading process), or reach a critical coverage of adsorbed liposomes,
where a liposome rupture triggers rupture of neighbouring vesicles and a fusion of SLB patches
(vesicle fusion)(b). Liposomes might also just adsorb onto silica without rupturing, but forming
adhesive vesicular layer (c). Figure from reference [198].
Multiple parameters such as the physical and chemical composition of silica, liposomes and
the environment (e.g., temperature, pH, ionic strength of buffer) can influence lipid interactions
with silica, and thus the formation of SLB. [198–200] This was briefly explored in experiments
assessing the choice of lipids between E. coli polar lipid extract, pure POPC and various lipid
mixes (Figure 5.14). In addition, membrane proteins within proteoliposomes can also affect the
formation of SLBs, as been seen by Grane´li et al., where the hydrophilic domains of a membrane
protein hindered SLB formation. [201] Thus, further work optimising the electrostatic interactions,
Van der Waals forces and surface hydrophilicity/hydrophobicity is required to achieve a proton
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tight SLBs on a porous silica support as reported by Nordlund et al. [190, 202]
5.6 Chapter conclusion
The work described in this chapter aimed to demonstrate a compartmentalised system for photo-
catalytic evolution of H2. Several strategies were attempted to trap Pt NPs and HydA within
lipid-shielded space and to mimic the spatial separation aspect of natural photosynthesis. In
order to achieve this catalytic and photo-catalytic performance of HER was assessed, showing that
photo-catalytic evolution of H2 is thermodynamically possible using g-N-CDs as photo-electron
source. In addition, it was observed that the chemical electron source (DT), which is commonly
used for reduction experiments, might lead to Pt poisoning and thus should only be used for
initial, qualitative observation of catalytic activity. The catalyst encapsulation itself is technically
very challenging. This study explored two strategies: liposome formation by rapid dilution and
catalyst-loading within porous silica, which then could be covered with a supported lipid bilayer.
Both strategies were met by issues caused by material incompatibility. For example, as liposome
formation by rapid dilution is a very stochastic process, which yields very variable results. Its
success is further limited by nanoparticle aggregation as seen by Ptcom and difficulties to ensure
sufficiently anaerobic environment during rapid dilution, which is required for encapsulation of
HydA1. Due to the high variability and unpredictably of the encapsulation process via rapid
dilution, other methods for liposome preparation should be explored instead. In contrast, catalyst
loading within silica showed more promising results in terms of control over catalyst loading
within the supporting material (especially, for Pt loading during synthesis of gSiO2). This strategy,
however, highlighted a different challenge to gain control and achieve reproducible formation and
complete coverage of gSiO2 by supported lipid bilayers. This should be addressed by gaining
better control on the shape and surface of the synthesised silica particles, as well as the lipid
composition of liposomes used for supported lipid bilayer.
Although the completion of the original aim has not been successful so far, this chapter illustrated
some of the challenges that must be addressed to gain spatial control over the compartment
assembly. Further work is needed to design strategies to combine and manipulate different
materials (e.g., lipids, membrane proteins, organic and inorganic fuel-evolving catalysts etc.).
Many of the highlighted issues could be addressed by developing new synthetic analogues to
such labile bio-materials as lipids and proteins. Future work building on ongoing progress within
fields focused on polymer self-assembly, microfluidics and nanoparticle engineering should help
to address these challenges.
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Discussion and Future work
Micro- and nano-compartmentalization provides a framework to explore the role molecule
organization plays in a wide variety of biological, chemical and physical processes. As such
it supports a very interdisciplinary environment, where bottom-up synthetic compartments are
used as model systems for cellular processes and engineering concepts (e.g., interfacing different
biological and inorganic materials, localising chemical reactions), as well as the resulting practical
applications (e.g., drug delivery in medicine and development of chemical microreactors). The
work described within this thesis focuses on establishing an electron transfer (ET) functionality
within a biomimetic lipid compartment for compartmentalised photo-catalysis, and thus in
itself brings together several fields including solar fuels, molecular interactions and material
engineering.
A key aspect for the envisioned compartment is efficient electron transfer between molecules:
LHNP (light-harvesting nanoparticles), MtrCAB and HEC (hydrogen-evolving catalysts). Each
of these molecular components is already known individually for their ability to harvest light
energy for photocatalysis purposes (LHNP, dye-sensitized TiO2 [82, 203, 204] and carbon dots
[86, 88, 89]), to transfer electrons across membrane (MtrCAB [91, 173, 179]) and to use electrons
for fuel synthesis (HEC, Pt [76, 205], HydA1 hydrogenase [107, 112]). Therefore, the main
challenge for this study was to assemble these within a compartmentalised system and ensure
electron transfer from one component to the other, where MtrCAB helps to transfer electrons
across the membrane. It has also been indicated previously, that the rate of electron transfer across
MtrCAB is more likely to be limited by electron transfer to and from MtrCAB than electron
transfer between the MtrCAB haems [91, 94, 163]. Optimal electron transfer between different
molecules requires both molecules to be in close proximity. Thus it is important to study and
optimise the molecular interactions leading to photo-electron transfer from LHNP to MtrCAB
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and to the reductive reaction within the compartment. For most of the components used in this
study, their interactions and electron transfer are presumed to be governed by diffusion. However,
it was known that TiO2 nanoparticles can bind MtrC [146], and this interaction was further
explored in Chapter 3. This showed how structural biology approaches like protein footprinting
can be used to identify the molecular interfaces between MtrC and a-TiO2. These results also
added to the growing evidence about the role complementary electrostatic interactions and protein
structure play to facilitate interaction between MtrC and TiO2. This knowledge can now be used to
further study molecular mechanisms for biological and metal binding (e.g., nature of interaction,
localisation of key residues and mutations) and be used to inform how to engineer direct contact
between MtrC and TiO2 nanoparticles (i.e., by protein mutations, different surface modification of
TiO2 nanoparticles).
As the binding between MtrC and TiO2 NPs is based on complementary electrostatic interactions,
it is very likely to be affected by such environmental conditions as temperature, pH, ionic
strength of buffer. [206] Thus a vast array of different buffers and conditions could be screened
to improve electron transfer from TiO2 to MtrCAB. Such screening of wider buffer conditions
could also help to identify conditions, where aggregation of dye-sensitized TiO2 NP would be
reduced. Improvement of particle stability in sample buffer is likely to improve NP interaction
with MtrCAB proteoliposomes by increasing the effective ratio between available TiO2 NP
and MtrCAB in proteoliposomes. In fact, the MtrCAB and RR120 proteoliposomes, which
were demonstrated in Chapter 4, could be used as a simple indirect optical screening system
to determine whether changes in buffer conditions result in improved electron transfer and thus
reduction of RR120 by MtrCAB or not. In addition, use of MtrCAB proteoliposomes would allow
to test electron transfer through the whole protein complex of MtrCAB and not just MtrC as was
done for the protein footprinting assay.
Chapter 3 focused on the molecular interface between TiO2 and MtrC, but the envisioned
compartment for photo-catalysis contains other types of electron transfer interfaces, which
could be explored similarly. These include: interface between both types of carbon dots and
MtrCAB and the interface between MtrCAB and HECs (i.e., Pt NPs, HydA1 and Pt loaded
silica nanoparticles). In the context of the light-harvesting nanocompartments demonstrated in
Chapter 4, no stable interaction has been observed between MtrCAB and both light-harvesting
carbon dots. Thus engineering of complementary interactions between MtrC and a-CDs or g-N-
CDs could be exploited to optimise ET from these LHNPs to MtrCAB. Both of these particles
showed better reduction of RR120 within the MtrCAB proteoliposomes than directly in solution.
The mechanism for this improvement in RR120 reduction could also be probed by engineering a
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binding interaction between both types of CDs and MtrCAB. This would help to answer questions
how does MtrCAB proteoliposome improve the reaction efficiency. For example, is MtrCAB
driving the reduction of RR120 by accumulating electrons from several different CDs or helping
to reduce charge-recombination from individual carbon dots? Or maybe the improved efficiency
of RR120 reduction by CDs using MtrCAB proteoliposoms, is purely due to RR120 concentration
within smaller compartmentalised spaces? Finally, interface of MtrCAB and fuel-generating
catalysts should also be studied and engineered. This study focused primarily on the challenges
leading to catalyst encapsulation within lipid coated compartment (see Chapter 5). Thus no
experiments were performed to assess electron transfer from MtrCAB to HECs. Nevertheless,
the electron transfer interface should be studied using similar methods to the protein footprinting
used in Chapter 3, as also other instrumentations like quartz-crystal microbalance and isothermal
titration calorimetry.
Ability to understand and engineer this interface could also help with the challenge to gain control
for reliable nano-assembly of all the components (as described in Chapter 5). For example,
nano-assembly of the photo-catalytic compartment could be improved by tethering catalyst to
close proximity of MtrCAB, which could facilitate catalyst incorporation within the liposomal
cavity. This could help to improve the catalyst loading and reproducibility using and exploring
various methods for liposome formation. Chapter 4 and 5 relied on liposome formation by rapid
dilution, however other methods could also be tested. For example, Edwards et al. encapsulated
small tetraheme cytochrome (STC) by rehydrating within lipid membranes followed by sample
sonication and freeze-thaw cycles. [93]
Similar strategy could be used to engineer interaction between MtrCAB proteoliposomes and
porous silica, that could help with forming proton-tight supported lipid bilayer around the silica
nanoparticle. Nordlund et al reports that formation of a proton tight SLBs on a porous silica
support could be improved by optimising the electrostatic interactions, Van der Waals forces and
surface hydrophilicity/hydrophobicity between silica and lipid bilayer [190, 202]. Another way to
minimise the effect of the silica substrate properties could be by forming a tethered lipid bilayer,
where linker molecules (such as covalently bound polymers or avidin interacting with biotinylated
lipids) are used to bind the support material with lipid bilayers. [198] Alternatively, silica could
be replaced by other supporting materials, such as polyelectrolyte coacervates, which have been
used to trap functional enzymes (e.g., glucose oxidase and horseradish peroxidase) in polymer-
stabilized compartments. [207,208] Recently, coacervates have also been coated by lipid vesicles,
which did not however fused to form a continuous bilayer. [209]
Other approaches for encapsulating catalysts within compartments use polymersomes and
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microfluidic devices. Enzyme encapsulation within polymersomes has been reported for such
biocatalysts as superoxide dismutase, horse-radish peroxidase, catalase, glucose oxidase, urease
and hemoglobin. [210–214] Generally, these approaches are similar to liposome preparations,
where lipids are substituted to polymer blocks. For example, polymersomes have been formed
by rehydration of polymer film followed by sample extrusion through a polymer membrane
[211, 213]. Other preparations use polymersome formation by injection of polymer dissolved
in organic solvent (e.g., tetrahydrofuran or ethanol), followed by solvent removal (e.g., by
dialysis). [210, 212, 214] The main advantages for these approaches arise from substituting
lipids for chemically more controlled and stable polymers, which would extend the life-time of
the compartment as well as permit use of harsher conditions for polymersome recovery. For
example, polymersomes could survive being subjected to higher osmotic shock to precipitate non-
encapsulated Pt NPs. Main foreseeable challenges for using polymersomes to build the MtrCAB
compartment for light energy harvest as envisioned in this PhD thesis, are necessities to further
develop these techniques for reconstituting membrane proteins (such as MtrCAB) in the thicker
non-native polymer membranes. In addition, many polymersome preparations still rely on a rather
stochastic entrapment of the catalyst inside the polymersome lumen.
Microfluidic devices aim to provide higher control over sample loading within compartments, as
the aqueous catalyst-containing phase is mixed with oil emulsions, and the droplet interface is
stabilised by surfactants or polymers. This approach was used by Peng et al. to load Pt NPs within
a polymersome cavity [215] and similar principles have been used to encapsulate proteins such
as benzaldehyde lyase [80] and even protein expression systems demonstrating GFP production
[39]. However, further improvements are necessary to build photo-synthetic compartments as
the ones aimed in this chapter. First, methods for incorporating membrane proteins within these
microfluidic water-oil-water emulsion systems have to be developed. Possible solutions could be
developed inspiring from work by Kawano and colleagues, who demonstrated use of the osmotic
pressure to promote fusion of pre-made proteoliposomes in droplet chamber [216] or by Biner and
colleagues, who used charge-mediated fusion of proteoliposomes and preformed target liposomes
for liposome functionalisation with membrane proteins [217]. The main challenge here then
lies in liposome fusion without breaking and releasing the encapsulated catalyst from the target
vesicles. Another feature of the current microfluidic devices is that they generally produce large
cell-sized vesicles termed giant unilamellar vesicles (GUVs) [39, 218–220], where the bulk mass
transport within the vesicle could limit the potential gains of using membrane-bound compartment
for bringing together light-harvest nanoparticles and fuel generating catalysts.
Observations made within this thesis have significance to research areas outside the field of bio-
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compartments. For example, mapping of the MtrC areas binding TiO2 adds on the available
information of protein-inorganic interfaces, which can help to design tools for determining and
predicting processes at bio-inorganic interfaces. These in turn could aid the development of
nanoparticles for diagnostic and therapeutic applications, or help to estimate the role of NP
pollution within the environmental and biogeochemical processes. [174] Besides, indication of
a putative conserved mineral-binding interfaces (i.e., area 2 in MtrC and MtrF), can augment
the biochemical understanding of metabolic processes within the Shewanella oneidensis, which
serves as a model organism for microbial electrochemistry and biogeochemical reactions. [97,
163] In addition, quantitative and mechanistic understanding of electronic coupling between
light-harvesting materials and S. oneidensis are relevant for such applications as microbial
electrosynthesis and microbial fuel cells, which involve coupling between bacterial cells and an
electrode. In case of microbial electrosynthesis, electricity is used to drive specific chemical
conversions within microbial metabolism, whereas microbial fuel cells use microbial metabolic
activity for generating electricity. [97, 148, 221]
Finally, such physical and engineering concepts and the knowledge how spatial arrangement can
be used to modulate molecular interactions (e.g., protein binding to LHNP) or processes (e.g.,
electron transfer) can also help in the development and the scale-up of synthetic industrial systems,
such as optimising physical arrangement of molecular components for more efficient solar cells
and solar-fuel generators. Results in Chapter 4 provide an insight into how control over the nano-
device organization and assembly can be used in artificial photosynthesis and solar-fuel catalyst
design to enhance catalytic efficiency and the external quantum efficiency (i.e., measuring how
much of the applied light energy results in the final reaction product [57]). This adds to the
ongoing research in which the organisation of different photosynthetic components is exploited
for (bio-)nanocatalysis. [58] For example, stacked multilayers of lipid membranes containing
PSII [83] have been shown to increase production of ATP due to highly efficient exchange of
substrates, while limiting diffusion of photo- and catalytic centres. Besides lipid membranes,
various other template materials such as viruses, graphene and peptide fibres have been used to
gain control over precise physical distribution of porphyrin PSs and catalytic reaction centres (e.g.,
Pt, TiO2 and IrO2 clusters). [222–227] A 10-times higher yield for selective CO2 conversion into
methanol was reported using hollow graphene-doped nanofibers (G-fibers). [227] In this case,
multiple enzymes required for methanol generation were confined within the nanofibers, and the
photo-excited electrons were transported through the graphene fibers from photosensitizers located
on the outside. [227] In a similar approach, photo-oxidation was separated from photo-reduction
reactions by employing hierarchical cobalt oxide – silica core-shell nanotube arrays, where
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water oxidation and photo-reduction was confined to the inner and outer surface of nanotubes,
respectively. [228]
6.1 Summary of directions for future research
Several directions were discussed within this chapter on how to take this research further. These
are summarized below:
• exploration and engineering of the molecular interface between LHNP and MtrCAB;
• exploration and engineering of the molecular interface between MtrCAB and HydA1;
• using molecular anchoring to encapsulate HEC or fully cover porous silica nanoparticles
containing Pt;
• forming MtrCAB proteoliposomes using microfluidics approach (main challenge lies in
reconstitution of membrane proteins and the resulting size of liposomes);
• building synthetic analogue compartments to MtrCAB proteoliposomes using chemically
more stable materials (e.g., polymerosomes instead of liposomes).
135
Appendix
A Peptide fragments analysed using XFMS
Appendix 6.1 136
Appendix 6.1 137
Ta
bl
e
1:
L
is
t
of
pe
pt
id
es
id
en
tifi
ed
to
ha
ve
X
FM
S
m
od
ifi
ca
tio
ns
an
d
th
ei
r
su
bs
eq
ue
nt
an
al
ys
is
.
(P
ep
tid
es
w
ith
ou
t
+1
6,
+3
2
or
+4
8
m
od
ifi
ca
tio
ns
ar
e
no
t
in
cl
ud
ed
.)
Pe
pt
id
e
N
at
iv
e
pe
pt
id
e
M
od
ifi
ed
pe
pt
id
e
R
at
e
co
ns
ta
nt
k
SE
(s

1
)
R
at
io
po
si
tio
n
Pe
pt
id
e
m
/z
∆
m
as
s
(D
a)
∆
R
T

SD
(m
in
)a
A
ss
ig
nm
en
t
A
ss
ig
nm
en
tc
ri
te
ri
a
M
tr
C
co
nt
ro
l
+
a-
Ti
O
2
(M
tr
C
/M
tr
C
:a
-T
iO
2
)
37
-5
0
D
G
G
E
PA
G
SI
Q
T
L
N
L
68
6.
34
(2
+)
+1
6
-0
.5
9

0.
07
PA
G
SI
Q
T
L
(1
)O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
1.
1
0.
2
0.
04
2
0.
00
7
25

7
(2
)M
S/
M
S
na
rr
ow
s
do
w
n
to
PA
G
SI
Q
T
L
,f
ur
th
er
id
en
tifi
ca
tio
n
no
tr
el
ia
bl
e
51
-5
8
D
IT
K
V
SY
E
no
ta
na
ly
se
d
ye
t
51
-7
1
D
IT
K
V
SY
E
N
*G
A
PM
V
T
V
FA
T
N
E
11
44
.0
4
(2
+)
+1
6
-2
.0
3

0.
06
M
63
1)
M
S/
M
S
na
rr
ow
s
do
w
n
to
PM
V
11

1
12

2
1.
0
0.
2
76
3.
02
(3
+)
2)
M
et
is
13
x
an
d
10
x
m
or
e
re
ac
tiv
e
to
Y
O
H
th
an
Pr
o
an
d
V
al
,r
es
pe
ct
iv
el
y.
[1
29
]
51
-7
2
D
IT
K
V
SY
E
N
*G
A
PM
V
T
V
FA
T
N
E
A
no
ta
na
ly
se
d
ye
t
52
-7
1
IT
K
V
SY
E
N
*G
A
PM
V
T
V
FA
T
N
E
no
ta
na
ly
se
d
ye
t
59
-7
1
N
*G
A
PM
V
T
V
FA
T
N
E
no
ta
na
ly
se
d
ye
t
59
-7
2
N
*G
A
PM
V
T
V
FA
T
N
E
A
no
ta
na
ly
se
d
ye
t
72
-8
3
A
D
M
PV
IG
L
A
N
L
E
no
ta
na
ly
se
d
ye
t
73
-8
3
D
M
PV
IG
L
A
N
L
E
58
3.
30
(2
+)
+1
6
-2
.5
3

0.
04
M
74
M
S/
M
S
21

6
9
3
2.
4
1.
0
+3
2
-1
.6
0

0.
05
M
S/
M
S
94
-1
14
G
A
T
G
PG
N
SA
N
W
Q
G
L
G
SS
K
SY
V
10
19
.4
8
(+
2)
+1
6,
+3
2
-2
.1

0.
1
W
10
4
M
S/
M
S
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
67
9.
99
(+
3)
+3
2
-1
.9

0.
1
M
S/
M
S
0.
27

0.
15
0.
11

0.
03
2.
4
1.
5b
+3
2
-0
.8

0.
2
M
S/
M
S
0.
50

0.
18
0.
07

0.
03
7
4.
1b
+1
6,
+3
2
-0
.7

0.
1
M
S/
M
S
1.
4
0.
4
0.
38

0.
15
3.
7
1.
9
+1
6,
+3
2
fr
om
-0
.4
1
PG
N
SA
N
W
Q
-
1)
M
S/
M
S
id
en
tifi
es
pe
pt
id
e;
5.
3
1.
6
1.
2
0.
4
4.
4
1.
9
to
0.
00
G
L
G
SS
K
SY
V
2)
ve
ry
lik
el
y
W
10
4,
as
W
is
am
on
g
th
e
to
p
3
m
os
tr
ea
ct
iv
e
re
si
du
es
[1
29
];
bu
tp
ea
k
al
so
ov
er
la
ps
na
tiv
e
pe
pt
id
e,
th
us
ca
n
no
te
xc
lu
de
in
so
ur
ce
ox
id
at
io
n
11
5
-1
25
D
N
K
N
*G
SY
T
FK
F
66
1.
30
8
(2
+)
,4
41
.2
1
(3
+)
+1
6
fr
om
-0
.1
to
in
so
ur
ce
D
N
K
N
*G
SY
T
F
1)
m
od
ifi
ed
pe
pt
id
e
el
ut
es
im
m
ed
ia
te
ly
be
fo
re
th
e
na
tiv
e,
th
us
it
al
so
ov
er
la
ps
w
ith
th
e
in
so
ur
ce
ox
id
is
ed
pe
ak
s;
2)
M
S/
M
S
re
so
lu
tio
n
ve
ry
lo
w
;3
)p
ot
en
tia
lly
ox
id
is
ed
Ly
s,
4)
K
12
4
ha
s
be
en
id
en
tifi
ed
in
re
la
te
d
pe
pt
id
e
be
lo
w
an
d
sh
ow
s
si
m
ila
rr
at
es
of
m
od
ifi
ca
tio
n.
2.
7
0.
6
0.
7
0.
3
4.
0
1.
8
11
8
-1
25
N
*G
SY
T
FK
F
48
2.
72
(2
+)
+1
6
fr
om
-0
.1
to
in
so
ur
ce
K
12
4
1)
m
od
ifi
ed
pe
pt
id
e
el
ut
es
im
m
ed
ia
te
ly
be
fo
re
th
e
na
tiv
e
pe
pt
id
e
an
d
th
us
ov
er
la
ps
w
ith
th
e
si
gn
al
fr
om
in
so
ur
ce
ox
id
is
ed
pe
pt
id
e;
2)
Y
12
1,
T
12
2
or
K
12
4
ha
ve
be
en
id
en
tifi
ed
by
M
S/
M
S;
3)
pe
pt
id
es
w
ith
ox
id
is
ed
Ly
s
ty
pi
ca
lly
el
ut
e
ju
st
be
fo
re
th
e
na
tiv
e
pe
pt
id
e
[1
30
]
2.
2
0.
7
0.
4
0.
2
5.
6
2.
8
(T
ab
le
co
nt
in
ue
s
on
ne
xt
pa
ge
.)
Appendix 6.1 138
(C
on
tin
ue
d
fr
om
ov
er
le
af
.)
Pe
pt
id
e
N
at
iv
e
pe
pt
id
e
M
od
ifi
ed
pe
pt
id
e
R
at
e
co
ns
ta
nt
k
SE
(s

1
)
R
at
io
po
si
tio
n
Pe
pt
id
e
m
/z
∆
m
as
s
(D
a)
∆
R
T

SD
(m
in
)a
A
ss
ig
nm
en
t
A
ss
ig
nm
en
tc
ri
te
ri
a
M
tr
C
co
nt
ro
l
+
a-
Ti
O
2
(M
tr
C
/M
tr
C
:a
-T
iO
2
)
12
9
-1
52
D
SN
K
V
FN
A
Q
LT
Q
R
FN
A
Q
LT
Q
R
FN
-
86
0.
13
(3
+)
,
+1
6
-1
.8

0.
08
L
15
1
M
S/
M
S
0.
08
6
0.
03
8
0.
02
7
0.
00
62
3.
2
1.
6
64
5.
35
(4
+)
-1
.5
5

0.
04
L
13
8,
V
14
5
1)
hi
gh
no
is
e
in
M
S/
M
S
so
po
te
nt
ia
lly
co
nt
ai
ns
un
re
so
lv
ed
pe
ak
s,
2)
bo
th
L
eu
an
d
V
al
ha
ve
si
m
ila
rr
ea
ct
iv
iti
es
[1
29
]
0.
57

0.
18
0.
07
0
0.
00
5
8.
1
2.
6
V
V
SA
A
G
K
L
A
-0
.9
9

0.
07
V
14
5
M
S/
M
S
0.
25

0.
10
0.
07
3
0.
00
8
3.
5
1.
4
-0
.7
4
0.
05
D
SN
K
V
FN
A
Q
M
S/
M
S
ve
ry
no
is
y
an
d
al
lo
w
s
id
en
tifi
ca
tio
n
on
ly
to
pe
pt
id
e
le
ve
lf
or
bo
th
m
od
ifi
ed
pe
ak
s
0.
72

0.
09
0.
09
1
0.
00
7
7.
9
1.
2
-0
.4
9
0.
05
F1
34
an
d
w
ho
le
pe
pt
id
e
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
;2
)M
S/
M
S
in
di
ca
tin
g
F1
34
,
an
d
th
e
be
gi
nn
in
g
an
d
en
d
of
th
e
pe
pt
id
e,
i.e
.,
pe
pt
id
es
’D
SN
K
V
FN
’a
nd
’S
A
A
G
K
L
A
’,
th
us
it’
s
im
po
ss
ib
le
to
re
lia
bl
y
as
si
gn
pe
ak
s
4.
5
1.
1
0.
53

0.
11
8.
6
2.
7
15
3
-1
64
D
G
T
T
V
PV
A
E
M
V
E
no
ta
na
ly
se
d
ye
t;
th
e
un
m
od
ifi
ed
pe
pt
id
e
is
ab
se
nt
,a
s
m
od
ifi
ca
tio
n
at
M
ha
s
pr
ev
en
te
d
pr
ot
eo
ly
si
s
24
1
-2
53
D
N
K
IP
T
VA
Q
N
IV
Q
72
0.
40
(2
+)
+1
6
fr
om
-1
.5
2
to
-0
.9
8a
I2
44
M
S/
M
S
2.
1
0.
3
0.
04

0.
02
50

24
48
0.
60
(3
+)
+1
6
-0
.2
0

0.
08
K
24
3,
(P
)T
V
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
0.
8

0.
2
0.
09

0.
01
8.
6

2.
6
2)
M
S/
M
S
na
rr
ow
s
do
w
n
to
D
N
K
an
d
PT
V
3)
Pr
o,
T
hr
an
d
V
al
ha
ve
si
m
ila
rr
ea
ct
iv
iti
es
;P
ro
is
bu
ri
ed
w
ith
in
th
e
pr
ot
ei
n
st
ru
ct
ur
e,
T
hr
an
d
V
al
ar
e
ex
po
se
d
4)
Ly
s
is
4.
7x
an
d
7.
1x
m
or
e
re
ac
tiv
e
th
an
D
an
d
N
,
re
sp
ec
tiv
el
y
5)
pe
pt
id
es
w
ith
m
od
ifi
ed
Ly
s
ha
ve
pr
ev
io
us
ly
sh
ow
n
R
T
ve
ry
cl
os
e
to
th
at
of
th
e
na
tiv
e
pe
pt
id
e
[1
30
]
26
9
-2
78
A
K
N
W
SR
IP
T
M
60
2.
31
(2
+)
+1
6
-1
.9

0.
2
M
27
8
M
S/
M
S
5.
9
1.
5
4.
7
1.
7
1.
25

0.
55
40
7.
21
(3
+)
+1
6
-1
.0
1

0.
13
W
27
2
M
S/
M
S
4.
1
1.
9
2.
1
1.
5
1.
9
1.
6b
+3
2
-1
.2
8

0.
13
26
9
-2
79
A
K
N
W
SR
IP
T
M
E
66
6.
84
(2
+)
+1
6
-1
.4

0.
1
M
27
8
M
S/
M
S
9.
4
2.
7
5.
4
2.
1
1.
73

0.
83
44
4.
89
(3
+)
+1
6
-0
.9
1

0.
12
W
27
2
M
S/
M
S
1.
9
1.
1
3.
7
1.
5
0.
52

0.
36
b
+3
2
-1
.1
8

0.
11
31
7
-3
35
L
H
TA
K
T
TA
T
K
N
L
IN
*Y
G
IE
10
59
.0
7
(2
+)
,7
06
.3
8
(3
+)
+1
6
fr
om
-1
.6
to
-0
.5
TA
K
T
TA
T
K
N
L
IN
no
is
y
M
S/
M
S,
re
lia
bl
e
id
en
tifi
ca
tio
n
on
ly
to
pe
pt
id
e
le
ve
l
0.
23

0.
13
0.
14

0.
04
1.
6
1.
1b
53
0.
03
(4
+)
+1
6
fr
om
-0
.1
to
in
so
ur
ce
A
K
T
TA
T
no
is
y
M
S/
M
S,
re
lia
bl
e
id
en
tifi
ca
tio
n
on
ly
to
pe
pt
id
e
le
ve
l;
lik
el
y
K
32
1
as
el
ut
es
im
m
ed
ia
te
ly
be
fo
re
th
e
’n
at
iv
e’
pe
pt
id
e
[1
30
]
2.
4
1.
5
0.
5
0.
2
4.
5
3.
0b
34
4
-3
54
T
K
A
A
T
IS
V
Q
V
V
11
16
.6
7
(1
+)
+1
6
fr
om
-1
.4
5
to
-1
.1
3
V
35
4
M
S/
M
S
0.
40

0.
10
0.
03
0
0.
00
6
13
.5

4.
2
55
8.
84
(2
+)
+1
6
fr
om
-0
.1
to
in
so
ur
ce
K
34
5
1)
to
ov
er
la
pp
in
g
pe
ak
s
m
ix
ed
w
ith
th
e
in
so
ur
ce
ox
id
is
ed
na
tiv
e
pe
pt
id
e;
2.
0
0.
3
0.
3
0.
1
5.
9
2.
1
2)
M
S/
M
S
id
en
tif
y
to
T
K
,T
K
A
A
T
IS
V,
SV
Q
;
3)
T
an
d
K
ar
e
si
m
ila
rl
y
re
ac
tiv
e,
bu
tK
ty
pi
ca
lly
el
ut
es
ju
st
be
fo
re
th
e
na
tiv
e
pe
pt
id
e
(T
ab
le
co
nt
in
ue
s
on
ne
xt
pa
ge
.)
Appendix 6.1 139
(C
on
tin
ue
d
fr
om
ov
er
le
af
.)
Pe
pt
id
e
N
at
iv
e
pe
pt
id
e
M
od
ifi
ed
pe
pt
id
e
R
at
e
co
ns
ta
nt
k
SE
(s

1
)
R
at
io
po
si
tio
n
Pe
pt
id
e
m
/z
∆
m
as
s
(D
a)
∆
R
T

SD
(m
in
)a
A
ss
ig
nm
en
t
A
ss
ig
nm
en
tc
ri
te
ri
a
M
tr
C
co
nt
ro
l
+
a-
Ti
O
2
(M
tr
C
/M
tr
C
:a
-T
iO
2
)
36
2
-3
74
D
L
K
T
IL
PK
V
Q
R
L
E
77
6.
97
(2
+)
+1
6
-2
.4
4

0.
09
L
36
7
M
S/
M
S
0.
21

0.
06
0.
02
4
0.
00
1
8.
9
2.
4
51
8.
31
(3
+)
+1
6
fr
om
-1
.1
3
I3
66
;P
36
8
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
0.
36

0.
07
0.
05
4
0.
00
3
6.
58

1.
33
38
8.
99
(4
+)
to
-0
.7
4a
2)
M
S/
M
S
id
en
tifi
ed
bo
th
re
si
du
es
+1
6
fr
om
-0
.3
0
K
36
4;
P3
68
1)
Po
te
nt
ia
lly
ov
er
la
pp
in
g
pe
ak
s
in
E
IC
1.
8
0.
6
0.
16

0.
02
11
.0

4.
1
to
+0
.0
4a
2)
M
S/
M
S,
po
te
nt
ia
lly
in
cl
ud
e
al
so
in
so
ur
ce
ox
id
at
io
n
37
5
-3
91
II
T
N
V
G
PN
N
A
T
L
G
Y
SG
K
85
9.
96
(2
+)
+1
6
-1
.2
2

0.
12
L
38
6
M
S/
M
S
0.
18

0.
04
0.
00
9
0.
00
2
19
.5

6.
0
57
3.
64
(3
+)
+1
6
-0
.7
2

0.
07
I3
76
,
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
0.
20

0.
05
0.
13

0.
05
1.
5
0.
6
2)
M
S/
M
S
id
en
tif
y
I3
76
an
d
na
rr
ow
s
do
w
n
to
G
Y
SG
G
Y
SG
K
(3
91
)
3)
Ty
ra
bo
ut
40
x
m
or
e
re
ac
tiv
e
th
an
Se
ra
nd
Ly
s,
an
d
ab
ou
t
76
0x
m
or
e
re
ac
tiv
e
th
an
G
ly
,b
ut
Ty
ra
lr
ea
dy
as
si
gn
ed
be
lo
w
;S
er
an
d
Ly
s
ab
ou
t2
0x
m
or
e
re
ac
tiv
e
th
an
G
ly
[1
29
];
K
ty
pi
ca
lly
ha
s
sh
or
tR
T
[1
30
]
+1
6
-0
.3
6

0.
04
Y
38
8
1)
M
S/
M
S
na
rr
ow
s
do
w
n
to
G
Y
0.
20

0.
03
0.
01
4
0.
00
2
6.
0
1.
4
2)
Ty
ra
bo
ut
76
0x
m
or
e
re
ac
tiv
e
th
an
G
ly
[1
29
]
39
2
-4
02
D
SI
FA
IK
N
G
A
L
57
4.
82
(2
+)
+1
6
-3
.1
1

0.
09
F3
95
,L
40
2
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
0.
7

0.
1
0.
10

0.
01
7.
0
1.
7
38
3.
55
(3
+)
2)
M
S/
M
S
+1
6
-2
.2
7

0.
04
I3
94
,F
39
5
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
0.
70

0.
09
0.
09

0.
01
7.
6
1.
4
2)
M
S/
M
S
+1
6
-1
.1
4

0.
04
F3
95
M
S/
M
S
0.
6

0.
1
0.
05

0.
01
12
.3

4.
5
+1
6
-0
.1
4

0.
07
K
39
8
M
S/
M
S
1.
1

0.
1
0.
07

0.
03
15
.6

6.
2
41
0
-4
20
D
A
G
K
LV
Y
T
T
T
K
59
8.
83
(2
+)
+1
6
-0
.2
6

0.
05
V
41
5
M
S/
M
S
1.
5

0.
3
0.
11

0.
02
14
.1

3.
6
39
9.
55
(3
+)
+1
6
-0
.0
2

0.
03
Y
41
6,
K
42
0
1)
O
ve
rl
ap
pi
ng
pe
ak
s
in
E
IC
2.
4

0.
5
0.
6
0.
2
3.
8
1.
3
2)
M
S/
M
S
42
1-
42
9
D
L
K
L
G
Q
N
*G
A
no
ta
na
ly
se
d
ye
t
42
1-
43
1
D
L
K
L
G
Q
N
*G
A
D
S
11
18
.5
4
(1
+)
+1
6
fr
om
-0
.1
to
in
so
ur
ce
Q
42
6
1)
ov
er
la
pp
in
g
pe
ak
w
ith
an
in
so
ur
ce
ox
id
is
ed
pe
ak
2.
8
0.
5
0.
51

0.
12
5.
5
1.
6
2)
M
S/
M
S
id
en
tifi
es
pe
ak
el
ut
in
g
im
m
ed
ia
te
ly
be
fo
re
th
e
na
tiv
e
pe
pt
id
e
as
Q
42
6
43
2-
44
2
D
TA
FS
FV
G
W
SM
no
ta
na
ly
se
d
ye
t
(T
ab
le
co
nt
in
ue
s
on
ne
xt
pa
ge
.)
Appendix 6.1 140
(C
on
tin
ue
d
fr
om
ov
er
le
af
.)
Pe
pt
id
e
N
at
iv
e
pe
pt
id
e
M
od
ifi
ed
pe
pt
id
e
R
at
e
co
ns
ta
nt
k
SE
(s

1
)
R
at
io
po
si
tio
n
Pe
pt
id
e
m
/z
∆
m
as
s
(D
a)
∆
R
T

SD
(m
in
)a
A
ss
ig
nm
en
t
A
ss
ig
nm
en
tc
ri
te
ri
a
M
tr
C
co
nt
ro
l
+
a-
Ti
O
2
(M
tr
C
/M
tr
C
:a
-T
iO
2
)
43
2-
44
6
D
TA
FS
FV
G
W
SM
C
*S
SE
85
5.
84
(2
+)
+4
8
-4
.6
7

0.
15
W
44
0
an
d
M
44
M
S/
M
S
3.
0
0.
5
0.
67

0.
32
4.
5
2.
3
]]
57
0.
89
(3
+)
+1
6,
+3
2
fr
om
-3
.9
to
-3
.3
W
44
0
an
d
M
44
2
1)
ov
er
la
pp
in
g
pe
ak
s;
2)
M
S/
M
S
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
+4
8
-3
.3
7

0.
04
W
44
0
an
d
M
44
2
1)
M
S/
M
S
na
rr
ow
s
to
G
W
an
d
SM
;2
)W
an
d
M
m
or
e
re
ac
tiv
e
[1
29
]
0.
35

0.
30
0.
18

0.
09
6
1.
9
1.
9b
+3
2
fr
om
-3
.1
3
to
-2
.5
1
W
44
0
M
S/
M
S
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
+1
6
-2
.1
6

0.
12
M
44
2
M
S/
M
S
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
+1
6
fr
om
-2
.1
to
-1
.6
7
W
44
0
an
d
M
44
2
1)
tw
o
ov
er
la
pp
in
g
pe
ak
s;
2)
M
S/
M
S
na
rr
ow
s
to
G
W
an
d
SM
C
S;
3)
W
an
d
M
m
or
e
re
ac
tiv
e
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
+1
6
fr
om
-1
.4
3
to
-1
.0
6
W
44
0
an
d
M
44
2
1)
tw
o
ov
er
la
pp
in
g
pe
ak
s;
2)
M
S/
M
S
na
rr
ow
s
to
G
W
an
d
SM
;3
)W
an
d
M
m
or
e
re
ac
tiv
e
da
ta
to
o
no
is
y
fo
r
a
re
lia
bl
e
fit
b
45
8-
47
0
D
G
V
D
V
T
K
Y
T
G
M
K
A
69
2.
84
(2
+)
+1
6
fr
om
-1
.5
2
to
-1
.2
V
46
2,
M
46
8
1)
ov
er
la
pp
in
g
pe
ak
s;
2)
M
S/
M
S
no
tv
er
y
cl
ea
rb
ut
id
en
tif
y
to
pe
pt
id
es
G
V
D
an
d
Y
T
G
M
K
A
;3
)V
46
2
an
d
M
46
8
m
or
e
re
ac
tiv
e
an
d
bo
th
id
en
tifi
ed
in
in
di
vi
du
al
sa
m
pl
es
[1
29
]
2.
33

1.
17
2.
52

0.
76
0.
9
0.
5b
46
2.
23
(3
+)
+1
6
-0
.9
5
0.
05
V
46
0
M
S/
M
S
0.
92

0.
35
0.
34

0.
04
5
2.
7
1.
1
46
1-
47
0
D
V
T
K
Y
T
G
M
K
A
no
ta
na
ly
se
d
ye
t
47
1-
48
2
D
L
A
FA
T
L
SG
K
A
P
no
ta
na
ly
se
d
ye
t
47
1-
48
7
D
L
A
FA
T
L
SG
K
A
PS
T
R
H
V
88
5.
98
(2
+)
+1
6
fr
om
-1
.7
1
to
-1
.2
2
L
47
7
M
S/
M
S
1.
46

0.
52
0.
12

0.
03
12
.3

5.
2
59
0.
98
(3
+)
+3
2
fr
om
-1
.3
8
to
-1
.1
6
F4
74
an
d
T
L
SG
K
A
1)
ov
er
la
pp
in
g
pe
ak
s;
2)
M
S/
M
S
id
en
tif
y
to
F4
74
an
d
T
L
SG
K
A
0.
10

0.
03
0.
01
6
0.
00
3
6.
4
2.
3
44
3.
49
(4
+)
+1
6,
+3
2
fr
om
-0
.3
8
to
na
tiv
e
K
48
0,
F4
74
,
A
PS
T
R
H
1)
se
ve
ra
lo
ve
rl
ap
pi
ng
pe
ak
s;
2)
M
S/
M
S
id
en
tif
y
to
K
48
0
an
d
K
ty
pi
ca
lly
el
ut
es
cl
os
e
to
na
tiv
e
pe
pt
id
e;
3)
M
S/
M
S
al
so
na
rr
ow
s
to
D
L
A
F,
FA
T
an
d
A
PS
R
T
H
;4
)F
m
or
e
re
ac
tiv
e
th
an
D
,L
,A
,T
[1
29
]
3.
3
0.
5
0.
76

0.
21
4.
3
1.
4
47
1-
48
8
D
L
A
FA
T
L
SG
K
A
PS
T
R
H
V
D
no
ta
na
ly
se
d
ye
t
52
5-
53
4
D
A
N
*G
K
A
IV
G
L
no
ta
na
ly
se
d
ye
t
54
4-
55
6
D
G
T
Y
SF
A
N
R
G
A
L
E
no
ta
na
ly
se
d
ye
t
a
-I
n
ca
se
s
w
he
re
ov
er
la
pp
in
g
pe
ak
s
of
m
ul
tip
le
pe
pt
id
es
w
er
e
de
te
ct
ed
w
ith
in
E
IC
,t
he
se
w
er
e
pr
oc
es
se
d
cu
m
ul
at
iv
el
y
an
d
th
e
co
rr
es
po
nd
in
g
ra
ng
e
of
∆
R
T
is
re
po
rt
ed
.
b
-
In
co
nc
lu
si
ve
re
su
lt
du
e
to
hi
gh
no
is
e
ca
us
ed
by
at
yp
ic
al
or
no
is
y
da
ta
ca
us
in
g
da
ta
fit
tin
g
to
be
un
re
lia
bl
e.
Is
so
m
e
ca
se
s
re
lia
bl
e
fit
w
as
no
ta
ch
ie
ve
d.
In
ot
he
rs
,t
he
ra
tio
be
tw
ee
n
co
nd
iti
on
s
(M
tr
C
/M
tr
C
:a
-T
iO
2
)y
ie
ld
ed
er
ro
rt
ha
tw
as
m
or
e
th
an
60
%
.
*
-A
sn
de
am
id
at
io
n
w
as
de
te
ct
ed
141
Bibliography
[1] Neha P. Kamat, Joshua S. Katz, and Daniel A. Hammer. Engineering Polymersome
Protocells. The Journal of Physical Chemistry Letters, 2(13):1612–1623, jul 2011.
[2] Hans-Peter M. de Hoog, Madhavan Nallani, and Nikodem Tomczak. Self-assembled
architectures with multiple aqueous compartments. Soft Matter, 8(17):4552, 2012.
[3] Helen R Saibil. Chaperone machines in action. Current opinion in structural biology,
18(1):35–42, feb 2008.
[4] Xiaofeng Liu and Elizabeth C Theil. Ferritins: Dynamic Management of Biological Iron
and Oxygen Chemistry. Accounts of Chemical Research, 38(3):167–175, mar 2005.
[5] Geoffrey M Cooper. Lysosomes. In The Cell: A Molecular Approach. Sinauer Associates,
Sunderland (MA), 2nd editio edition, 2000.
[6] Rona Chandrawati, Martin P. van Koeverden, Hannah Lomas, and Frank Caruso.
Multicompartment Particle Assemblies for Bioinspired Encapsulated Reactions. The
Journal of Physical Chemistry Letters, 2(20):2639–2649, oct 2011.
[7] Maı¨te´ Marguet, Colin Bonduelle, and Se´bastien Lecommandoux. Multicompartmentalized
polymeric systems: towards biomimetic cellular structure and function. Chem. Soc. Rev.,
42(2):512–529, 2013.
[8] Nick Lane and William F. Martin. The Origin of Membrane Bioenergetics. Cell,
151(7):1406–1416, 2012.
[9] Kyeong Kyu Kim, Rosalind Kim, and Sung-hou Kim. Crystal structure of a small heat-
shock protein. 394(August):595–599, 1998.
[10] Masaki Uchida, Sebyung Kang, Courtney Reichhardt, Kevin Harlen, and Trevor Douglas.
The ferritin superfamily: Supramolecular templates for materials synthesis. Biochimica et
Biophysica Acta (BBA) - General Subjects, 1800(8):834–845, aug 2010.
BIBLIOGRAPHY 142
[11] Pierre Baudhuin, Henri Beaufay, and Christian de Duve. COMBINED BIOCHEMICAL
AND MORPHOLOGICAL STUDY OF PARTICULATE FRACTIONS FROM RAT
LIVER. The Journal of Cell Biology, 26(1):219–243, jul 1965.
[12] Stijn F. M. van Dongen, Hans-Peter M. de Hoog, Ruud J R W Peters, Madhavan Nallani,
Roeland J M Nolte, and Jan C. M. van Hest. Biohybrid Polymer Capsules. Chemical
Reviews, 109(11):6212–6274, nov 2009.
[13] Rupa R. Sawant and Vladimir P. Torchilin. Liposomes as ‘smart’ pharmaceutical
nanocarriers. Soft Matter, 6(17):4026, 2010.
[14] Qiang He, Yue Cui, and Junbai Li. Molecular assembly and application of biomimetic
microcapsules. Chemical Society reviews, 38(8):2292–303, 2009.
[15] Markus Antonietti and Stephan Fo¨rster. Vesicles and Liposomes: A Self-Assembly
Principle Beyond Lipids. Advanced Materials, 15(16):1323–1333, 2003.
[16] E. Kaler, A. Murthy, B. Rodriguez, and J. Zasadzinski. Spontaneous vesicle formation in
aqueous mixtures of single-tailed surfactants. Science, 245(4924):1371–1374, sep 1989.
[17] Dan D. Lasic. Novel applications of liposomes. Trends in Biotechnology, 16(7):307–321,
1998.
[18] A L Troutier and C Ladaviere. An overview of lipid membrane supported by colloidal
particles. Adv Colloid Interface Sci, 133(1):1–21, 2007.
[19] Stefan Egli, Helmut Schlaad, Nico Bruns, and Wolfgang Meier. Functionalization of Block
Copolymer Vesicle Surfaces. Polymers, 3(1):252–280, 2011.
[20] Katarzyna Kita-Tokarczyk, Julie Grumelard, Thomas Haefele, and Wolfgang Meier. Block
copolymer vesicles - Using concepts from polymer chemistry to mimic biomembranes.
Polymer, 46(11):3540–3563, 2005.
[21] Ozana Onaca, Ramona Enea, David W. Hughes, and Wolfgang Meier. Stimuli-Responsive
Polymersomes as Nanocarriers for Drug and Gene Delivery. Macromolecular Bioscience,
9(2):129–139, 2009.
[22] Pascal Tanner, Patric Baumann, Ramona Enea, Ozana Onaca, Cornelia Palivan, and
Wolfgang Meier. Polymeric Vesicles: From Drug Carriers to Nanoreactors and Artificial
Organelles. Accounts of Chemical Research, 44(10):1039–1049, oct 2011.
BIBLIOGRAPHY 143
[23] Weijun Tong and Changyou Gao. Multilayer microcapsules with tailored structures for
bio-related applications. Journal of Materials Chemistry, 18(32):3799, 2008.
[24] Anchao Feng and Jinying Yuan. Smart Nanocontainers: Progress on Novel Stimuli-
Responsive Polymer Vesicles. Macromolecular Rapid Communications, 35(8):767–779,
apr 2014.
[25] Zhikang Fu, Mirjam Andreasson Ochsner, Hans-Peter M. de Hoog, Nikodem Tomczak, and
Madhavan Nallani. Multicompartmentalized polymersomes for selective encapsulation of
biomacromolecules. Chemical Communications, 47(10):2862, 2011.
[26] Andre´ H Gro¨schel and Axel H E Mu¨ller. Self-assembly concepts for multicompartment
nanostructures. Nanoscale, 7(28):11841–76, 2015.
[27] Lise Schoonen and Jan C.M. Van Hest. Compartmentalization Approaches in Soft Matter
Science: From Nanoreactor Development to Organelle Mimics. Advanced Materials,
28(6):1109–1128, 2016.
[28] Peter Walde. Building artificial cells and protocell models: Experimental approaches with
lipid vesicles. BioEssays, 32(4):296–303, 2010.
[29] Young Rok Kim, Sungho Jung, Hyunil Ryu, Yeong Eun Yoo, Sun Min Kim, and
Tae Joon Jeon. Synthetic biomimetic membranes and their sensor applications. Sensors
(Switzerland), 12(7):9530–9550, 2012.
[30] S. Zhang, H.-J. Sun, A. D. Hughes, R.-O. Moussodia, A. Bertin, Y. Chen, D. J. Pochan,
P. A. Heiney, M. L. Klein, and V. Percec. Self-assembly of amphiphilic Janus dendrimers
into uniform onion-like dendrimersomes with predictable size and number of bilayers.
Proceedings of the National Academy of Sciences, 111(25):9058–9063, 2014.
[31] Enrico G Bellomo, Michael D Wyrsta, Lisa Pakstis, Darrin J Pochan, and Timothy J
Deming. Stimuli-responsive polypeptide vesicles by conformation-specific assembly.
Nature Materials, 3(4):244–248, apr 2004.
[32] Mazda Rad-Malekshahi, Koen M. Visscher, Joa˜o P. G. L. M. Rodrigues, Renko de Vries,
Wim E. Hennink, Marc Baldus, Alexandre M. J. J. Bonvin, Enrico Mastrobattista, and
Markus Weingarth. The Supramolecular Organization of a Peptide-Based Nanocarrier at
High Molecular Detail. Journal of the American Chemical Society, 137(24):7775–7784,
jun 2015.
BIBLIOGRAPHY 144
[33] Dindyal Mandal, Amir Nasrolahi Shirazi, and Keykavous Parang. Self-assembly of
peptides to nanostructures. Organic & biomolecular chemistry, 12(22):3544–61, 2014.
[34] Aya Koide, Akihiro Kishimura, Kensuke Osada, Woo Dong Jang, Yuichi Yamasaki, and
Kazunori Kataoka. Semipermeable polymer vesicle (PICsome) self-assembled in aqueous
medium from a pair of oppositely charged block copolymers: Physiologically stable micro-
/nanocontainers of water-soluble macromolecules. Journal of the American Chemical
Society, 128(18):5988–5989, 2006.
[35] Daniel A. Balazs and WT. Godbey. Liposomes for Use in Gene Delivery. Journal of Drug
Delivery, 2011(January 2011):1–12, 2011.
[36] Francis Szoka and Demetrios Papahadjopoulos. Comparative properties and methods of
preparation of lipid vesicles (liposomes). Ann. Rev. Biophys. Bioeng., 9:467–508, 1980.
[37] The Future of Solar Energy. Number 3. MIT, 2015.
[38] Scott A Walker, Michael T Kennedy, and Joseph A N Zasadzinski. Encapsulation of bilayer
vesicles by self-assembly. Nature, 387(6628):61–64, may 1997.
[39] Sadao Ota, Satoko Yoshizawa, and Shoji Takeuchi. Microfluidic Formation of
Monodisperse, Cell-Sized, and Unilamellar Vesicles. Angewandte Chemie International
Edition, 48(35):6533–6537, aug 2009.
[40] a L Klibanov, K Maruyama, V P Torchilin, and L Huang. Amphipathic polyethyleneglycols
effectively prolong the circulation time of liposomes. FEBS letters, 268(1):235–237, 1990.
[41] Joseph a. Zasadzinski, Benjamin Wong, Natalie Forbes, Gary Braun, and Guohui Wu.
Novel methods of enhanced retention in and rapid, targeted release from liposomes. Curr.
Opin. Colloid IN., 16(3):203–214, 2011.
[42] T Oberholzer, M Albrizio, and P L Luisi. Polymerase chain reaction in liposomes.
Chemistry & biology, 2(10):677–682, 1995.
[43] Yuchen Fan and Qiang Zhang. Development of liposomal formulations: From concept to
clinical investigations. Asian Journal of Pharmaceutical Sciences, 8(2):79–90, 2013.
[44] Peter Walde and Sosaku Ichikawa. Enzymes inside lipid vesicles: preparation, reactivity
and applications. Biomolecular Engineering, 18(4):143–177, 2001.
[45] Ozana Onaca, Madhavan Nallani, Saskia Ihle, Alexander Schenk, and Ulrich
Schwaneberg. Functionalized nanocompartments (Synthosomes): Limitations and
BIBLIOGRAPHY 145
prospective applications in industrial biotechnology. Biotechnology Journal, 1(7-8):795–
805, 2006.
[46] Anna Grochmal, Luba Prout, Robert Makin-Taylor, Rafel Prohens, and Salvador Tomas.
Modulation of Reactivity in the Cavity of Liposomes Promotes the Formation of Peptide
Bonds. Journal of the American Chemical Society, 137(38):12269–12275, 2015.
[47] T Kaneko, T J Itoh, and H Hotani. Morphological transformation of liposomes caused
by assembly of encapsulated tubulin and determination of shape by microtubule-associated
proteins (MAPs). Journal of molecular biology, 284(5):1671–81, 1998.
[48] Vincent Noireaux and Albert Libchaber. A vesicle bioreactor as a step toward an artificial
cell assembly. Proceedings of the National Academy of Sciences of the United States of
America, 101(51):17669–74, 2004.
[49] Kazuya Nishimura, Saburo Tsuru, Hiroaki Suzuki, and Tetsuya Yomo. Stochasticity in
Gene Expression in a Cell-Sized Compartment. ACS Synthetic Biology, 4(5):566–576, may
2015.
[50] Nathan Nelson and Adam Ben-Shem. The complex architecture of oxygenic
photosynthesis. Nature Reviews Molecular Cell Biology, 5(12):971–982, dec 2004.
[51] G Steinberg-Yfrach, J L Rigaud, E N Durantini, A L Moore, D Gust, and T A Moore. Light-
driven production of ATP catalysed by F0F1-ATP synthase in an artificial photosynthetic
membrane. Nature, 392(6675):479–482, 1998.
[52] Hyo-Jick Choi and Carlo D Montemagno. Artificial organelle: ATP synthesis from cellular
mimetic polymersomes. Nano Letters, 5(12):2538–2542, 2005.
[53] Wei Qi, Li Duan, Kewei Wang, Xuehai Yan, Yue Cui, Qiang He, and Junbai Li. Motor
protein CF0F1 reconstituted in lipid-coated hemoglobin microcapsules for ATP synthesis.
Advanced Materials, 20(3):601–605, 2008.
[54] Devens Gust, Thomas A. Moore, and Ana L. Moore. Mimicking Photosynthetic Solar
Energy Transduction. Accounts of Chemical Research, 34(1):40–48, jan 2001.
[55] David P Summers and David Rodoni. Vesicle Encapsulation of a Nonbiological
Photochemical System Capable of Reducing NAD + to NADH. Langmuir, 31(39):10633–
10637, oct 2015.
[56] Vincenzo Balzani, Alberto Credi, and Margherita Venturi. Photochemical Conversion of
Solar Energy. ChemSusChem, 1(1-2):26–58, feb 2008.
BIBLIOGRAPHY 146
[57] Janina Willkomm, Katherine L Orchard, Anna Reynal, Ernest Pastor, James R Durrant,
and Erwin Reisner. Dye-sensitised semiconductors modified with molecular catalysts for
light-driven H 2 production. Chem. Soc. Rev., 45(1):9–23, jan 2016.
[58] Jae Hong Kim, Dong Heon Nam, and Chan Beum Park. Nanobiocatalytic assemblies for
artificial photosynthesis. Current Opinion in Biotechnology, 28:1–9, 2014.
[59] Sahng Ha Lee, Jae Hong Kim, and Chan Beum Park. Coupling Photocatalysis and Redox
Biocatalysis Toward Biocatalyzed Artificial Photosynthesis. Chemistry - A European
Journal, 19(14):4392–4406, apr 2013.
[60] Martin A Green. Commercial progress and challenges for photovoltaics. Nature Energy,
1:15015, jan 2016.
[61] Shane Ardo, David Fernandez Rivas, Miguel A. Modestino, Verena Schulze Greiving,
Fatwa F. Abdi, Esther Alarcon Llado, Vincent Artero, Katherine Ayers, Corsin Battaglia,
Jan-Philipp Becker, Dmytro Bederak, Alan Berger, Francesco Buda, Enrico Chinello,
Bernard Dam, Valerio Di Palma, Tomas Edvinsson, Katsushi Fujii, Han Gardeniers,
Hans Geerlings, S. Mohammad H. Hashemi, Sophia Haussener, Frances Houle, Jurriaan
Huskens, Brian D. James, Kornelia Konrad, Akihiko Kudo, Pramod Patil Kunturu, Detlef
Lohse, Bastian Mei, Eric L. Miller, Gary F. Moore, Jiri Muller, Katherine L Orchard,
Timothy E. Rosser, Fadl Hussein Saadi, Jan-Willem Schu¨ttauf, Brian Seger, Stafford W.
Sheehan, Wilson A. Smith, Joshua Spurgeon, Maureen H. Tang, Roel van de Krol,
Peter C K Vesborg, and Pieter Westerik. Pathways to electrochemical solar-hydrogen
technologies. Energy & Environmental Science, 11(10):2768–2783, 2018.
[62] D. Lips, J. M. Schuurmans, F. Branco Dos Santos, and K. J. Hellingwerf. Many ways
towards ’solar fuel’: Quantitative analysis of the most promising strategies and the main
challenges during scale-up. Energy and Environmental Science, 11(1):10–22, 2018.
[63] Ee Taek Hwang, Khizar Sheikh, Katherine L. Orchard, Daisuke Hojo, Valentin Radu,
Chong-Yong Lee, Emma Ainsworth, Colin Lockwood, Manuela A. Gross, Tadafumi
Adschiri, Erwin Reisner, Julea N. Butt, and Lars J. C. Jeuken. A Decaheme Cytochrome
as a Molecular Electron Conduit in Dye-Sensitized Photoanodes. Advanced Functional
Materials, 25(15):2308–2315, apr 2015.
[64] Aaron M. Collins, Christine Kirmaier, Dewey Holten, and Robert E. Blankenship.
Kinetics and energetics of electron transfer in reaction centers of the photosynthetic
BIBLIOGRAPHY 147
bacterium Roseiflexus castenholzii. Biochimica et Biophysica Acta (BBA) - Bioenergetics,
1807(3):262–269, mar 2011.
[65] Dmitry V Matyushov. Protein electron transfer: is biology (thermo)dynamic? Journal of
physics. Condensed matter : an Institute of Physics journal, 27(47):473001, 2015.
[66] Melih S¸ener, Johan Stru¨mpfer, Jen Hsin, Danielle Chandler, Simon Scheuring, C. Neil
Hunter, and Klaus Schulten. Fo¨rster energy transfer theory as reflected in the structures of
photosynthetic light-harvesting systems. ChemPhysChem, 12(3):518–531, 2011.
[67] Anna Stikane, Ee Taek Hwang, Emma V. Ainsworth, Samuel E. H. Piper, Kevin Critchley,
Julea N. Butt, Erwin Reisner, and Lars J. C. Jeuken. Towards compartmentalized
photocatalysis: multihaem proteins as transmembrane molecular electron conduits.
Faraday Discussions, 215:26–38, 2019.
[68] Wei Wei, Peiqing Sun, Zhen Li, Kuisong Song, Wenyin Su, Bao Wang, Yangzhong Liu,
and Jing Zhao. A surface-display biohybrid approach to light-driven hydrogen production
in air. Science Advances, 4(2):eaap9253, feb 2018.
[69] Mrinal Kumar Sarma, Sharbani Kaushik, and Pranab Goswami. Cyanobacteria: A
metabolic power house for harvesting solar energy to produce bio-electricity and biofuels.
Biomass and Bioenergy, 90:187–201, jul 2016.
[70] Lærke Mu¨nter Lassen, Agnieszka Zygadlo Nielsen, Bibi Ziersen, Thiyagarajan
Gnanasekaran, Birger Lindberg Møller, and Poul Erik Jensen. Redirecting Photosynthetic
Electron Flow into Light-Driven Synthesis of Alternative Products Including High-Value
Bioactive Natural Compounds. ACS Synthetic Biology, 3(1):1–12, jan 2014.
[71] David J Vinyard, Javier Gimpel, Gennady M Ananyev, Stephen P Mayfield, and G Charles
Dismukes. Engineered Photosystem II reaction centers optimize photochemistry versus
photoprotection at different solar intensities. Journal of the American Chemical Society,
136(10):4048–55, mar 2014.
[72] Elshan Musazade, Roman Voloshin, Nathan Brady, Jyotirmoy Mondal, Samaya Atashova,
Sergey K. Zharmukhamedov, Irada Huseynova, Seeram Ramakrishna, Mohammad Mahdi
Najafpour, Jian-Ren Shen, Barry D. Bruce, and Suleyman I. Allakhverdiev. Biohybrid
solar cells: Fundamentals, progress, and challenges. Journal of Photochemistry and
Photobiology C: Photochemistry Reviews, 35:134–156, jun 2018.
BIBLIOGRAPHY 148
[73] Mariko Miyachi, Shu Ikehira, Daiki Nishiori, Yoshinori Yamanoi, Masato Yamada, Masako
Iwai, Tatsuya Tomo, Suleyman I. Allakhverdiev, and Hiroshi Nishihara. Photocurrent
Generation of Reconstituted Photosystem II on a Self-Assembled Gold Film. Langmuir,
33(6):1351–1358, 2017.
[74] Fangyuan Zhao, Felipe Conzuelo, Volker Hartmann, Huaiguang Li, Marc M. Nowaczyk,
Nicolas Plumere´, Matthias Ro¨gner, and Wolfgang Schuhmann. Light Induced H2 Evolution
from a Biophotocathode Based on Photosystem 1–Pt Nanoparticles Complexes Integrated
in Solvated Redox Polymers Films. The journal of physical chemistry. B, 119(43):13726–
31, oct 2015.
[75] Mariko Miyachi, Kyoko Okuzono, Daiki Nishiori, Yoshinori Yamanoi, Tatsuya Tomo,
Masako Iwai, Suleyman I. Allakhverdiev, and Hiroshi Nishihara. A Photochemical
Hydrogen Evolution System Combining Cyanobacterial Photosystem I and Platinum
Nanoparticle-terminated Molecular Wires. Chemistry Letters, 46(10):1479–1481, oct 2017.
[76] Lisa M. Utschig, Nada M. Dimitrijevic, Oleg G. Poluektov, Sergey D. Chemerisov, Karen L.
Mulfort, and David M. Tiede. Photocatalytic hydrogen production from noncovalent
biohybrid Photosystem I/Pt nanoparticle complexes. Journal of Physical Chemistry Letters,
2(3):236–241, 2011.
[77] Sunshine C. Silver, Jens Niklas, Pingwu Du, Oleg G. Poluektov, David M. Tiede, and
Lisa M. Utschig. Protein delivery of a Ni catalyst to photosystem i for light-driven hydrogen
production. Journal of the American Chemical Society, 135(36):13246–13249, 2013.
[78] Tomoyasu Noji, Hiroyuki Suzuki, Toshiaki Gotoh, Masako Iwai, Masahiko Ikeuchi,
Tatsuya Tomo, and Takumi Noguchi. Photosystem II–Gold Nanoparticle Conjugate as a
Nanodevice for the Development of Artificial Light-Driven Water-Splitting Systems. The
Journal of Physical Chemistry Letters, 2(19):2448–2452, 2011.
[79] Katarzyna P. Sokol, William E. Robinson, Julien Warnan, Nikolay Kornienko,
Marc M. Nowaczyk, Adrian Ruff, Jenny Z. Zhang, and Erwin Reisner. Bias-free
photoelectrochemical water splitting with photosystem II on a dye-sensitized photoanode
wired to hydrogenase. Nature Energy, 57(33):10595–10599, sep 2018.
[80] Fangyuan Zhao, Steffen Hardt, Volker Hartmann, Huijie Zhang, Marc M. Nowaczyk,
Matthias Ro¨gner, Nicolas Plumere´, Wolfgang Schuhmann, and Felipe Conzuelo. Light-
induced formation of partially reduced oxygen species limits the lifetime of photosystem
1-based biocathodes. Nature Communications, 9(1):1973, dec 2018.
BIBLIOGRAPHY 149
[81] Sahng Ha Lee, Da Som Choi, Su Keun Kuk, and Chan Beum Park. Photobiocatalysis:
Activating Redox Enzymes by Direct or Indirect Transfer of Photoinduced Electrons.
Angewandte Chemie - International Edition, 57(27):7958–7985, 2018.
[82] Janina Willkomm, Nicoleta M. Muresan, and Erwin Reisner. Enhancing H 2 evolution
performance of an immobilised cobalt catalyst by rational ligand design. Chemical Science,
6(5):2727–2736, 2015.
[83] Yue Li, Jinbo Fei, Guangle Li, Haiming Xie, Yang Yang, Jieling Junbai Li, Youqian Xu,
Bingbing Sun, Jiarui Xia, Xueqi Fu, and Jieling Junbai Li. Supramolecular Assembly of
Photosystem II and Adenosine Triphosphate Synthase in Artificially Designed Honeycomb
Multilayers for Photophosphorylation. ACS Nano, 12(2):1455–1461, 2018.
[84] Mingming Wang, Jinquan Chen, Tianquan Lian, and Wei Zhan. Mimicking Photosynthesis
with Supercomplexed Lipid Nanoassemblies: Design, Performance, and Enhancement Role
of Cholesterol. Langmuir, 32(29):7326–7338, 2016.
[85] Emma Victoria Ainsworth. Photoreduction of Outer Membrane Cytochromes : Solution
and Proteoliposome Nanocompartment Studies. Phd thesis, Univeristy of East Anglia,
2017.
[86] Benjamin C M Martindale, Georgina A M Hutton, Christine A. Caputo, and Erwin Reisner.
Solar Hydrogen Production Using Carbon Quantum Dots and a Molecular Nickel Catalyst.
Journal of the American Chemical Society, 137(18):6018–6025, may 2015.
[87] Youfu Wang and Aiguo Hu. Carbon quantum dots : synthesis , properties and applications.
Journal of Materials Chemistry C: Materials for optical and electronic devices, 2:6921–
6939, 2014.
[88] Georgina A.M. Hutton, Benjamin C.M. Martindale, and Erwin Reisner. Carbon dots as
photosensitisers for solar-driven catalysis. Chemical Society Reviews, 46(20):6111–6123,
2017.
[89] Benjamin C. M. Martindale, Georgina A. M. Hutton, Christine A. Caputo, Sebastian Prantl,
Robert Godin, James R. Durrant, and Erwin Reisner. Enhancing Light Absorption and
Charge Transfer Efficiency in Carbon Dots through Graphitization and Core Nitrogen
Doping. Angewandte Chemie International Edition, 56(23):6459–6463, jun 2017.
BIBLIOGRAPHY 150
[90] Marian Breuer, Kevin M Rosso, Jochen Blumberger, and Julea N Butt. Multi-haem
cytochromes in Shewanella oneidensis MR-1: structures, functions and opportunities.
Journal of the Royal Society, Interface / the Royal Society, 12(102):20141117, jan 2015.
[91] Gaye F White, Zhi Shi, Liang Shi, Zheming Wang, Alice C Dohnalkova, Matthew J
Marshall, James K Fredrickson, John M Zachara, Julea N Butt, David J Richardson,
and Thomas A Clarke. Rapid electron exchange between surface-exposed bacterial
cytochromes and Fe(III) minerals. Proceedings of the National Academy of Sciences of
the United States of America, 110(16):6346–51, 2013.
[92] James K Fredrickson, Margaret F Romine, Alexander S Beliaev, Jennifer M Auchtung,
Michael E Driscoll, Timothy S Gardner, Kenneth H Nealson, Andrei L Osterman, Grigoriy
Pinchuk, Jennifer L Reed, Dmitry a Rodionov, Jorge L M Rodrigues, Daad a Saffarini,
Margrethe H Serres, Alfred M Spormann, Igor B Zhulin, and James M Tiedje. Towards
environmental systems biology of Shewanella. Nature reviews. Microbiology, 6(8):592–
603, aug 2008.
[93] Marcus J. Edwards, Gaye F. White, Colin W. Lockwood, Matthew C. Lawes, Anne Martel,
Gemma Harris, David J. Scott, David J. Richardson, Julea N. Butt, and Thomas A.
Clarke. Structural modeling of an outer membrane electron conduit from a metal-reducing
bacterium suggests electron transfer via periplasmic redox partners. Journal of Biological
Chemistry, 293(21):8103–8112, may 2018.
[94] Marcus J. Edwards, Gaye F. White, Julea N. Butt, David J. Richardson, and Thomas A.
Clarke. The Crystal Structure of a Biological Insulated Transmembrane Molecular Wire.
Cell, 181(3):665–673.e10, 2020.
[95] Chong-Yong Lee, Bertrand Reuillard, Katarzyna P Sokol, Theodoros Laftsoglou, Colin
W. J. Lockwood, Sam F. Rowe, Ee Taek Hwang, Juan-Carlos C. Fontecilla-Camps, Lars J C
Jeuken, Julea N. Butt, and Erwin Reisner. A decahaem cytochrome as an electron conduit
in protein–enzyme redox processes. Chemical Communications, 52(46):7390–7393, 2016.
[96] Bertrand Reuillard, Khoa H. Ly, Peter Hildebrandt, Lars J. C. Jeuken, Julea N. Butt, and
Erwin Reisner. High Performance Reduction of H 2 O 2 with an Electron Transport
Decaheme Cytochrome on a Porous ITO Electrode. Journal of the American Chemical
Society, 139(9):3324–3327, mar 2017.
[97] Emma V. Ainsworth, Colin W. J. Lockwood, Gaye F. White, Ee Taek Hwang, Tsubasa
Sakai, Manuela A. Gross, David J. Richardson, Thomas A. Clarke, Lars J. C. Jeuken,
BIBLIOGRAPHY 151
Erwin Reisner, and Julea N. Butt. Photoreduction of Shewanella oneidensis Extracellular
Cytochromes by Organic Chromophores and Dye-Sensitized TiO 2. ChemBioChem,
17(24):2324–2333, dec 2016.
[98] Gise`le F. White, Kathleen I. Racher, Andre´ Lipski, F.Ross Hallett, and Janet M. Wood.
Physical properties of liposomes and proteoliposomes prepared from Escherichia coli polar
lipids. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1468(1-2):175–186, sep
2000.
[99] W. Dowhan. MOLECULAR BASIS FOR MEMBRANE PHOSPHOLIPID
DIVERSITY:Why Are There So Many Lipids? Annual Review of Biochemistry,
66(1):199–232, jun 1997.
[100] L O Ingram. Changes in lipid composition of escherichia coli resulting from growth
with organic solvents and with food additives. Applied and Environmental Microbiology,
33(5):1233–1236, 1977.
[101] Rosalba Passalacqua, Siglinda Perathoner, and Gabriele Centi. Semiconductor, molecular
and hybrid systems for photoelectrochemical solar fuel production. Journal of Energy
Chemistry, 26(2):219–240, mar 2017.
[102] N. S. Lewis and D. G. Nocera. Powering the planet: Chemical challenges in solar energy
utilization. Proceedings of the National Academy of Sciences, 103(43):15729–15735, oct
2006.
[103] Nikolay Kornienko, Jenny Z. Zhang, Kelsey K. Sakimoto, Peidong Yang, and Erwin
Reisner. Interfacing nature’s catalytic machinery with synthetic materials for semi-artificial
photosynthesis. Nature Nanotechnology, 13(10):890–899, oct 2018.
[104] Xiaoxin Zou and Yu Zhang. Noble metal-free hydrogen evolution catalysts for water
splitting. Chem. Soc. Rev., 44:5148–5180, 2015.
[105] J. K. Nørskov, T. Bligaard, A. Logadottir, J. R. Kitchin, J. G. Chen, S. Pandelov, and
U. Stimming. Trends in the exchange current for hydrogen evolution. Journal of the
Electrochemical Society, 152(3):J23, 2005.
[106] Changhong Wang, Feng Hu, Hongchao Yang, Yejun Zhang, Huan Lu, and Qiangbin
Wang. 1.82 wt.% Pt/N, P co-doped carbon overwhelms 20 wt.% Pt/C as a high-efficiency
electrocatalyst for hydrogen evolution reaction. Nano Research, 10(1):238–246, 2017.
BIBLIOGRAPHY 152
[107] Erwin Reisner. Solar hydrogen evolution with hydrogenases: From natural to hybrid
systems. European Journal of Inorganic Chemistry, (7):1005–1016, 2011.
[108] Kylie A. Vincent, Alison Parkin, and Fraser A. Armstrong. Investigating and exploiting the
electrocatalytic properties of hydrogenases. Chemical Reviews, 107(10):4366–4413, oct
2007.
[109] Claire Wombwell, Christine A. Caputo, and Erwin Reisner. [NiFeSe]-Hydrogenase
Chemistry. Accounts of Chemical Research, 48(11):2858–2865, 2015.
[110] Jia Wei Wang, Wen Ju Liu, Di Chang Zhong, and Tong Bu Lu. Nickel complexes
as molecular catalysts for water splitting and CO2 reduction. Coordination Chemistry
Reviews, 378:237–261, 2019.
[111] Sven E. Eklund and David E. Cliffel. Synthesis and Catalytic Properties of Soluble Platinum
Nanoparticles Protected by a Thiol Monolayer. Langmuir, 20(14):6012–6018, jul 2004.
[112] G. Berggren, A. Adamska, C. Lambertz, T. R. Simmons, J. Esselborn, M. Atta,
S. Gambarelli, J. M. Mouesca, E. Reijerse, W. Lubitz, T. Happe, V. Artero, and
M. Fontecave. Biomimetic assembly and activation of [FeFe]-hydrogenases. Nature,
499(7456):66–69, 2013.
[113] Christina Kamp, Alexey Silakov, Martin Winkler, Edward J. Reijerse, Wolfgang Lubitz,
and Thomas Happe. Isolation and first EPR characterization of the [FeFe]-hydrogenases
from green algae. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1777(5):410–416,
may 2008.
[114] Patricia Rodrı´guez-Macia´, Leonie Kertess, Jan Burnik, James A. Birrell, Eckhard Hofmann,
Wolfgang Lubitz, Thomas Happe, and Olaf Ru¨diger. His-Ligation to the [4Fe-4S]
Subcluster Tunes the Catalytic Bias of [FeFe] Hydrogenase. Journal of the American
Chemical Society, 141(1):472–481, 2019.
[115] T Happe and J D Naber. Isolation, characterization and N-terminal amino acid sequence
of hydrogenase from the green alga Chlamydomonas reinhardtii. European journal of
biochemistry, 214(2):475–81, jun 1993.
[116] George R. Heath, Mengqiu Li, Isabelle L. Polignano, Joanna L. Richens, Gianluca
Catucci, Paul O’Shea, Sheila J. Sadeghi, Gianfranco Gilardi, Julea N. Butt, and Lars J. C.
Jeuken. Layer-by-Layer Assembly of Supported Lipid Bilayer Poly-L-Lysine Multilayers.
Biomacromolecules, 17(1):324–35, jan 2016.
BIBLIOGRAPHY 153
[117] Paul E. Thomas, Dene Ryan, and Wayne Levin. An improved staining procedure for
the detection of the peroxidase activity of cytochrome P-450 on sodium dodecyl sulfate
polyacrylamide gels. Analytical Biochemistry, 75(1):168–176, sep 1976.
[118] Robert S. Hartshorne, Brian N. Jepson, Tom A. Clarke, Sarah J. Field, Jim Fredrickson,
John Zachara, Liang Shi, Julea N. Butt, and David J. Richardson. Characterization of
Shewanella oneidensis MtrC: A cell-surface decaheme cytochrome involved in respiratory
electron transport to extracellular electron acceptors. Journal of Biological Inorganic
Chemistry, 12(7):1083–1094, 2007.
[119] Physical Principles, chapter 2, pages 63–102. John Wiley & Sons, Ltd, 1998.
[120] A K Mallia, M D Frovenzano, E K Fujimoto, B J Olson, D C Klenk, and Pierce Chemical
Company. Measurement of Protein Using Bicinchoninic Acid ’. 85:76–85, 1985.
[121] Xiaoli Zhu and Tao Gao. Chapter 10 - spectrometry. In Genxi Li, editor, Nano-Inspired
Biosensors for Protein Assay with Clinical Applications, pages 237 – 264. Elsevier, 2019.
[122] Fanny Varenne, Ali Makky, Mireille Gaucher-Delmas, Fre´de´ric Violleau, and Christine
Vauthier. Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size
Distribution with 9 Size Measurement Methods. Pharmaceutical Research, 33(5):1220–
1234, 2016.
[123] Vasco Filipe, Andrea Hawe, and Wim Jiskoot. Critical Evaluation of Nanoparticle
Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein
Aggregates. Pharmaceutical Research, 27(5):796–810, may 2010.
[124] JLS Milne, MJ Borgnia, and A Bartesaghi. Cryo-electron microscopy–a primer for the
non-microscopist. Febs J., 280(1):28–45, 2013.
[125] Caroline A Schneider, Wayne S Rasband, and Kevin W Eliceiri. NIH Image to ImageJ: 25
years of image analysis. Nature Methods, 9(7):671–675, jul 2012.
[126] Kyle C. Dent, Rebecca Thompson, Amy M. Barker, Julian A. Hiscox, John N. Barr, Peter G.
Stockley, and Neil A. Ranson. The Asymmetric Structure of an Icosahedral Virus Bound to
Its Receptor Suggests a Mechanism for Genome Release. Structure, 21(7):1225–1234, jul
2013.
[127] Yunjun Cao, Min Yu, Shandong Qi, Tingting Wang, Shiming Huang, Zhengfeng Ren,
Shishen Yan, Shujun Hu, and Mingchun Xu. CO2 adsorption on anatase TiO2(101)
BIBLIOGRAPHY 154
surfaces: A combination of UHV-FTIRS and first-principles studies. Physical Chemistry
Chemical Physics, 19(46):31267–31273, 2017.
[128] Chi Lun Pang, Robert Lindsay, and Geoff Thornton. Chemical reactions on rutile
TiO2(110). Chemical Society Reviews, 37(10):2328–2353, 2008.
[129] Guozhong Xu and Mark R. Chance. Hydroxyl radical-mediated modification of proteins as
probes for structural proteomics. Chemical Reviews, 107(8):3514–3543, 2007.
[130] Owen Cornwell, Sheena E. Radford, Alison E. Ashcroft, and James R. Ault. Comparing
Hydrogen Deuterium Exchange and Fast Photochemical Oxidation of Proteins: a Structural
Characterisation of Wild-Type and ∆N6 β2-Microglobulin. Journal of The American
Society for Mass Spectrometry, 29(12):2413–2426, dec 2018.
[131] V. N. Bavro, S. Gupta, and C. Ralston. Oxidative footprinting in the study of structure
and function of membrane proteins: current state and perspectives. Biochemical Society
Transactions, 43(5):983–994, 2015.
[132] Sayan Gupta, Jun Feng, Leanne Jade G. Chan, Christopher J. Petzold, and Corie Y. Ralston.
Synchrotron X-ray footprinting as a method to visualize water in proteins. Journal of
Synchrotron Radiation, 23(5):1056–1069, sep 2016.
[133] Sayan Gupta, Richard Celestre, Christopher J. Petzold, Mark R. Chance, and Corie Ralston.
Development of a microsecond X-ray protein footprinting facility at the Advanced Light
Source. Journal of Synchrotron Radiation, 21(4):690–699, jul 2014.
[134] Tatsuya Fukushima, Sayan Gupta, Behzad Rad, Jose A. Cornejo, Christopher J. Petzold,
Leanne Jade G. Chan, Rena A. Mizrahi, Corie Y. Ralston, and Caroline M. Ajo-Franklin.
The Molecular Basis for Binding of an Electron Transfer Protein to a Metal Oxide Surface.
Journal of the American Chemical Society, 139(36):12647–12654, sep 2017.
[135] Jen Bohon, Rhijuta D’Mello, Corie Ralston, Sayan Gupta, and Mark R. Chance.
Synchrotron X-ray footprinting on tour. Journal of Synchrotron Radiation, 21(1):24–31,
jan 2014.
[136] Sayan Gupta, Michael Sullivan, John Toomey, Janna Kiselar, and Mark R. Chance.
The beamline X28C of the center for synchrotron biosciences: A national resource for
biomolecular structure and dynamics experiments using synchrotron footprinting. Journal
of Synchrotron Radiation, 14(3):233–243, 2007.
BIBLIOGRAPHY 155
[137] Maolian Chen and Kelsey D. Cook. Oxidation artifacts in the electrospray mass
spectrometry of Aβ peptide. Analytical Chemistry, 79(5):2031–2036, 2007.
[138] Richard Wang, F. P. Healey, and Jack Myers. Amperometric Measurement of Hydrogen
Evolution in Chlamydomonas . Plant Physiology, 48(1):108–110, jul 1971.
[139] Dino Mislov, Mario Cifrek, Igor Krois, and Hrvoje Dzapo. Measurement of dissolved
hydrogen concentration with clark electrode. In 2015 IEEE Sensors Applications
Symposium (SAS), pages 1–5. IEEE, apr 2015.
[140] S.C. Chang, J.R. Stetter, and C.S. Cha. Amperometric gas sensors. Talanta, 40(4):461–477,
apr 1993.
[141] L. W. Winkler. Die Lo¨slichkeit der Gase in Wasser. Berichte der deutschen chemischen
Gesellschaft, 24(1):89–101, jan 1891.
[142] R. Sander. Compilation of Henry’s law constants (version 4.0) for water as solvent.
Atmospheric Chemistry and Physics, 15(8):4399–4981, 2015.
[143] Joseph R H Manning, Eleni Routoula, and Siddharth V Patwardhan. Preparation of
Functional Silica Using a Bioinspired Method. JoVE, (138):e57730, 2018.
[144] V. Vasilca, A. Sadeghpour, S. Rawson, L. E. Hawke, S. A. Baldwin, T. Wilkinson,
D. Bannister, V. L.G. Postis, M. Rappolt, S. P. Muench, and L. J.C. Jeuken. Spherical-
supported membranes as platforms for screening against membrane protein targets.
Analytical Biochemistry, 549(March):58–65, 2018.
[145] R. A. Marcus and Norman Sutin. Electron transfers in chemistry and biology. BBA Reviews
On Bioenergetics, 811(3):265–322, 1985.
[146] Ee Taek Hwang, Katherine L. Orchard, Daisuke Hojo, Joseph Beton, Colin W.J. Lockwood,
Tadafumi Adschiri, Julea N. Butt, Erwin Reisner, and Lars J.C. Jeuken. Exploring Step-by-
Step Assembly of Nanoparticle:Cytochrome Biohybrid Photoanodes. ChemElectroChem,
4(8):1959–1968, 2017.
[147] Brian H. Lower, Liang Shi, Ruchirej Yongsunthon, Timothy C. Droubay, David E.
McCready, and Steven K. Lower. Specific bonds between an iron oxide surface and outer
membrane cytochromes MtrC and OmcA from Shewanella oneidensis MR-1. Journal of
Bacteriology, 189(13):4944–4952, 2007.
BIBLIOGRAPHY 156
[148] Marcus J Edwards, Gaye F White, Michael Norman, Alice Tome-fernandez, Emma
Ainsworth, Liang Shi, Jim K Fredrickson, John M Zachara, Julea N Butt, David J
Richardson, and Thomas A Clarke. Redox Linked Flavin Sites in Extracellular Decaheme
Proteins Involved in Microbe-Mineral Electron Transfer . Nature Publishing Group,
(July):1–11, 2015.
[149] A. Johs, L. Shi, T. Droubay, J. F. Ankner, and L. Liang. Characterization of the decaheme c-
type cytochrome OmcA in solution and on hematite surfaces by small angle x-ray scattering
and neutron reflectometry. Biophysical Journal, 98(12):3035–3043, 2010.
[150] Yoshihide Tokunou and Akihiro Okamoto. Geometrical Changes in the Hemes of Bacterial
Surface c-Type Cytochromes Reveal Flexibility in Their Binding Affinity with Minerals.
Langmuir, 35(23):7529–7537, 2019.
[151] Brian H. Lower, Roberto D. Lins, Zachery Oestreicher, Tjerk P. Straatsma, Michael F.
Hochella, Liang Shi, and Steven K. Lower. In vitro evolution of a peptide with a hematite
binding motif that may constitute a natural metal-oxide binding archetype. Environmental
Science and Technology, 42(10):3821–3827, 2008.
[152] Alexander S. Beliaev and Daad A. Saffarini. Shewanella putrefaciens mtrB encodes an
outer membrane protein required for Fe(III) and Mn(IV) reduction. Journal of Bacteriology,
180(23):6292–6297, 1998.
[153] J. M. Myers and C. R. Myers. Role for outer membrane cytochromes OmcA and
OmcB of Shewanella putrefaciens MR-1 in reduction of manganese dioxide. Applied and
Environmental Microbiology, 67(1):260–269, 2001.
[154] Wesley Carpentier, Lina De Smet, Jozef Van Beeumen, and Ann Brige´. Respiration
and growth of Shewanella oneidensis MR-1 using vanadate as the sole electron acceptor.
Journal of Bacteriology, 187(10):3293–3301, 2005.
[155] Marion J. Limo, Anna Sola-Rabada, Estefania Boix, Veeranjaneyulu Thota, Zayd C.
Westcott, Valeria Puddu, and Carole C. Perry. Interactions between Metal Oxides and
Biomolecules: From Fundamental Understanding to Applications. Chemical Reviews,
118(22):11118–11193, 2018.
[156] Haibin Chen, Xiaodi Su, Koon Gee Neoh, and Woo Seok Choe. Probing the interaction
between peptides and metal oxides using point mutants of a TiO2-binding peptide.
Langmuir, 24(13):6852–6857, 2008.
BIBLIOGRAPHY 157
[157] Y. Randika Perera, Rebecca A. Hill, and Nicholas C. Fitzkee. Protein Interactions
with Nanoparticle Surfaces: Highlighting Solution NMR Techniques. Israel Journal of
Chemistry, page ijch.201900080, sep 2019.
[158] Silvia H. De Paoli Lacerda, Jung Jin Park, Curt Meuse, Denis Pristinski, Matthew L.
Becker, Alamgir Karim, and Jack F. Douglas. Interaction of gold nanoparticles with
common human blood proteins. ACS Nano, 4(1):365–379, 2010.
[159] Yan Ling Zhao, Cui Hong Wang, Ying Zhai, Rui Qin Zhang, and Michel A. Van Hove.
Selective adsorption of l-serine functional groups on the anatase TiO2(101) surface in
benthic microbial fuel cells. Physical Chemistry Chemical Physics, 16(38):20806–20817,
2014.
[160] P. A. Connor and A. J. McQuillan. Phosphate adsorption onto TiO2 from aqueous solutions:
an in situ internal reflection infrared spectroscopic study. Langmuir, 15(8):2916–2921,
1999.
[161] Eunyoung Bae and Wonyong Choi. Effect of the anchoring group (carboxylate vs
phosphonate) in Ru-complex-sensitized TiO2 on hydrogen production under visible light.
Journal of Physical Chemistry B, 110(30):14792–14799, 2006.
[162] Willem Norde and Carla E. Giacomelli. BSA structural changes during homomolecular
exchange between the adsorbed and the dissolved states. Journal of Biotechnology,
79(3):259–268, 2000.
[163] David J. Richardson, Julea N. Butt, Jim K. Fredrickson, John M. Zachara, Liang Shi,
Marcus J. Edwards, Gaye White, Nanakow Baiden, Andrew J. Gates, Sophie J. Marritt,
and Thomas A. Clarke. The ’porin-cytochrome’ model for microbe-to-mineral electron
transfer. Molecular Microbiology, 85(2):201–212, 2012.
[164] Feng Yang, Bogdan Bogdanov, Eric F. Strittmatter, Andrey N. Vilkov, Marina Gritsenko,
Liang Shi, Dwayne A. Elias, Shuisong Ni, Margaret Romine, Ljiljana Pasˇa-Tolic´, Mary S.
Lipton, and Richard D. Smith. Characterization of purified c-type heme-containing peptides
and identification of c-type heme-attachment sites in Shewanella oneidenis cytochromes
using mass spectrometry. Journal of Proteome Research, 4(3):846–854, 2005.
[165] Sayan Gupta, Jin Chai, Jie Cheng, Rhijuta D’Mello, Mark R. Chance, and Dax Fu.
Visualizing the kinetic power stroke that drives proton-coupled zinc(ii) transport. Nature,
512(1):101–104, 2014.
BIBLIOGRAPHY 158
[166] Sayan Gupta, Miklos Guttman, Ryan L. Leverenz, Kulyash Zhumadilova, Emily G.
Pawlowski, Christopher J. Petzold, Kelly K. Lee, Corie Y. Ralston, and Cheryl A. Kerfeld.
Local and global structural drivers for the photoactivation of the orange carotenoid protein.
Proceedings of the National Academy of Sciences, 112(41):E5567–E5574, 2015.
[167] Elizabeth Jurrus, Dave Engel, Keith Star, Kyle Monson, Juan Brandi, Lisa E. Felberg,
David H. Brookes, Leighton Wilson, Jiahui Chen, Karina Liles, Minju Chun, Peter Li,
David W. Gohara, Todd Dolinsky, Robert Konecny, David R. Koes, Jens Erik Nielsen,
Teresa Head-Gordon, Weihua Geng, Robert Krasny, Guo-Wei Wei, Michael J. Holst,
J. Andrew McCammon, and Nathan A. Baker. Improvements to the apbs biomolecular
solvation software suite. Protein Science, 27(1):112–128, 2018.
[168] Schro¨dinger, LLC. The PyMOL molecular graphics system, version 1.8. November 2015.
[169] Ersin Emre Oren, Rebecca Notman, Il Won Kim, John Spencer Evans, Tiffany R.
Walsh, Ram Samudrala, Candan Tamerler, and Mehmet Sarikaya. Probing the molecular
mechanisms of quartz-binding peptides. Langmuir, 26(13):11003–11009, 2010.
[170] John Spencer Evans. ‘Apples’ and ‘oranges’: comparing the structural aspects of
biomineral- and ice-interaction proteins. Current Opinion in Colloid & Interface Science,
8(1):48–54, mar 2003.
[171] Zihao Liu, Shiqing Ma, Shun Duan, Deng Xuliang, Yingchun Sun, Xi Zhang, Xinhua Xu,
Binbin Guan, Chao Wang, Meilin Hu, Xingying Qi, Xu Zhang, and Ping Gao. Modification
of Titanium Substrates with Chimeric Peptides Comprising Antimicrobial and Titanium-
Binding Motifs Connected by Linkers to Inhibit Biofilm Formation. ACS Applied Materials
and Interfaces, 8(8):5124–5136, 2016.
[172] Marian Breuer, Piotr Zarzycki, Jochen Blumberger, and Kevin M. Rosso. Thermodynamics
of electron flow in the bacterial deca-heme cytochrome MtrF. Journal of the American
Chemical Society, 134(24):9868–9871, 2012.
[173] Frauke Kracke, Igor Vassilev, and Jens O. Kro¨mer. Microbial electron transport and energy
conservation - The foundation for optimizing bioelectrochemical systems. Frontiers in
Microbiology, 6(JUN):1–18, jun 2015.
[174] D. Docter, D. Westmeier, M. Markiewicz, S. Stolte, S. K. Knauer, and R. H. Stauber. The
nanoparticle biomolecule corona: lessons learned - challenge accepted? Chemical Society
Reviews, 44(17):6094–6121, 2015.
BIBLIOGRAPHY 159
[175] Feifang Zhang, Ayfer Yediler, Xinmiao Liang, and Antonius Kettrup. Ozonation of the
purified hydrolyzed azo dye Reactive Red 120 (CI). Journal of Environmental Science and
Health - Part A Toxic/Hazardous Substances and Environmental Engineering, 37(4):707–
713, may 2002.
[176] Andre´ B. dos Santos, Francisco J. Cervantes, and Jules B. van Lier. Review paper on
current technologies for decolourisation of textile wastewaters: Perspectives for anaerobic
biotechnology. Bioresource Technology, 98(12):2369–2385, 2007.
[177] Mayara Carantino Costa, Francisco Suetoˆnio B Mota, Andre´ Bezerra Dos Santos, Glaydson
Leandro Farias Mendonc¸a, and Ronaldo Ferreira do Nascimento. Effect of dye structure
and redox mediators on anaerobic azo and anthraquinone dye reduction. Quı´mica Nova,
35(3):482–486, 2012.
[178] Stephen G. Mayhew. The Redox Potential of Dithionite and SO-2 from Equilibrium
Reactions with Flavodoxins, Methyl Viologen and Hydrogen plus Hydrogenase. European
Journal of Biochemistry, 85(2):535–547, apr 1978.
[179] Robert S Hartshorne, Catherine L Reardon, Daniel Ross, Jochen Nuester, Thomas a Clarke,
Andrew J Gates, Paul C Mills, Jim K Fredrickson, John M Zachara, Liang Shi, Alex S
Beliaev, Matthew J Marshall, Ming Tien, Susan Brantley, Julea N Butt, and David J
Richardson. Characterization of an electron conduit between bacteria and the extracellular
environment. Proceedings of the National Academy of Sciences, 106(52):22169–22174,
dec 2009.
[180] CCI Guarantini, A. G. Fogg, and Maria Valnice Boldrin Zanoni. Electrochemical reduction
of azo-based chlorotriazine reactive dyes. In A. J. Ricco, P. Vanyek, G. Horvai, and
A. F. Silva, editors, Proceedings of the Symposium on Chemical and Biological Sensors
and Analytical Electrochemical Methods, pages 467–476. Electrochemical Society Series,
1997.
[181] John N Weinstein, Robert Blumenthal, and Richard D. Klausner. [38] Carboxyfluorescein
leakage assay for lipoprotein-liposome interaction. In Methods Enzymology, volume 128,
pages 657–668. Academic Press, 1986.
[182] Yiqun Zhou, Piumi Y. Liyanage, Daniel L. Geleroff, Zhili Peng, Keenan J. Mintz,
Sajini D. Hettiarachchi, Raja R. Pandey, Charles C. Chusuei, Patricia L. Blackwelder, and
Roger M. Leblanc. Photoluminescent Carbon Dots: A Mixture of Heterogeneous Fractions.
ChemPhysChem, 19(19):2589–2597, oct 2018.
BIBLIOGRAPHY 160
[183] Jeremy B. Essner, Jennifer A. Kist, Luis Polo-Parada, and Gary A. Baker. Artifacts
and Errors Associated with the Ubiquitous Presence of Fluorescent Impurities in Carbon
Nanodots. Chemistry of Materials, 30(6):1878–1887, mar 2018.
[184] Erwin Reisner, Juan C. Fontecilla-Camps, and Fraser A. Armstrong. Catalytic
electrochemistry of a [nifese]-hydrogenase on tio2 and demonstration of its suitability for
visible-light driven h2 production. Chem. Commun., pages 550–552, 2009.
[185] Erwin Reisner, Daniel J. Powell, Christine Cavazza, Juan C. Fontecilla-Camps, and
Fraser A. Armstrong. Visible Light-Driven H 2 Production by Hydrogenases Attached
to Dye-Sensitized TiO 2 Nanoparticles. Journal of the American Chemical Society,
131(51):18457–18466, dec 2009.
[186] Yu Kang, Xin Li, Yaoquan Tu, Qi Wang, and Hans A˚gren. On the mechanism of protein
adsorption onto hydroxylated and nonhydroxylated TiO2 surfaces. Journal of Physical
Chemistry C, 114(34):14496–14502, 2010.
[187] Charith E. Nanayakkara, Whitney A. Larish, and Vicki H. Grassian. Titanium Dioxide
Nanoparticle Surface Reactivity with Atmospheric Gases, CO 2 , SO 2 , and NO 2 : Roles of
Surface Hydroxyl Groups and Adsorbed Water in the Formation and Stability of Adsorbed
Products. The Journal of Physical Chemistry C, 118(40):23011–23021, oct 2014.
[188] Kyoung Taek Kim, Silvie A. Meeuwissen, Roeland J. M. Nolte, and Jan C. M. van Hest.
Smart nanocontainers and nanoreactors. Nanoscale, 2(6):844, 2010.
[189] Juewen Liu. Interfacing zwitterionic liposomes with inorganic nanomaterials: Surface
forces, membrane integrity, and applications. Langmuir, 32(18):4393–4404, 2016.
[190] Gustav Nordlund, Jovice Boon Sing Ng, Lennart Bergstro¨m, and Peter Brzezinski.
A membrane-reconstituted multisubunit functional proton pump on mesoporous silica
particles. ACS Nano, 3(9):2639–2646, sep 2009.
[191] Benjamin D. Gould, Olga A. Baturina, and Karen E. Swider-Lyons. Deactivation of Pt/VC
proton exchange membrane fuel cell cathodes by SO2, H2S and COS. Journal of Power
Sources, 188(1):89–95, 2009.
[192] Katherine Telfeyan, Artas A. Migdisov, Sachin Pandey, Velimir V. Vesselinov, and Paul W.
Reimus. Long-term stability of dithionite in alkaline anaerobic aqueous solution. Applied
Geochemistry, 101(December 2017):160–169, 2019.
BIBLIOGRAPHY 161
[193] Sam F. Rowe, Gwe´nae¨lle Le Gall, Emma V. Ainsworth, Jonathan A. Davies, Colin W.J.
Lockwood, Liang Shi, Adam Elliston, Ian N. Roberts, Keith W. Waldron, David J.
Richardson, Thomas A. Clarke, Lars J.C. Jeuken, Erwin Reisner, and Julea N. Butt. Light-
Driven H 2 Evolution and C=C or C=O Bond Hydrogenation by Shewanella oneidensis:
A Versatile Strategy for Photocatalysis by Nonphotosynthetic Microorganisms. ACS
Catalysis, 7(11):7558–7566, 2017.
[194] Joseph R.H. Manning, Thomas W.S. Yip, Alessia Centi, Miguel Jorge, and Siddharth V.
Patwardhan. An Eco-Friendly, Tunable and Scalable Method for Producing Porous
Functional Nanomaterials Designed Using Molecular Interactions. ChemSusChem,
10(8):1683–1691, 2017.
[195] Siddharth V. Patwardhan, Graham E. Tilburey, and Carole C. Perry. Interactions of amines
with silicon species in undersaturated solutions leads to dissolution and/or precipitation of
silica. Langmuir, 27(24):15135–15145, 2011.
[196] Patricia Wand, Johannes D. Bartl, Ueli Heiz, Martin Tschurl, and Mirza Cokoja.
Functionalization of small platinum nanoparticles with amines and phosphines: Ligand
binding modes and particle stability. Journal of Colloid and Interface Science, 478:72–80,
sep 2016.
[197] Ange´lique Coutable, Irina Randrianjatovo, Vincent Noireaux, Christophe Vieu, Christophe
Thibault, Emmanuelle Tre´visiol, and Jean M. Franc¸ois. A Comparative Study of α-
Hemolysin Expression in Supported Lipid Bilayers of Synthetic and Enriched Complex
Bacterial Lipid. BioNanoScience, 4(2):104–110, jun 2014.
[198] Ryugo Tero. Substrate effects on the formation process, structure and physicochemical
properties of supported lipid bilayers. Materials, 5(12):2658–2680, 2012.
[199] Ralf P. Richter, Re´mi Be´rat, and Alain R. Brisson. Formation of solid-supported lipid
bilayers: An integrated view. Langmuir, 22(8):3497–3505, 2006.
[200] Xiaoshun Wang, Xiaoqiu Li, Hui Wang, Xiaohan Zhang, Lei Zhang, Feng Wang, and
Juewen Liu. Charge and Coordination Directed Liposome Fusion onto SiO 2 and TiO 2
Nanoparticles. Langmuir, 35(5):1672–1681, 2019.
[201] Annette Grane´li, Jan Rydstro¨m, Bengt Kasemo, and Fredrik Ho¨o¨k. Formation of supported
lipid bilayer membranes on SiO2 from proteoliposomes containing transmembrane
proteins. Langmuir, 19(3):842–850, 2003.
BIBLIOGRAPHY 162
[202] Juewen Liu, Alison Stace-Naughton, Xingmao Jiang, and C. Jeffrey Brinker. Porous
nanoparticle supported lipid bilayers (protocells) as delivery vehicles. Journal of the
American Chemical Society, 131(4):1354–1355, 2009.
[203] Scott A. Trammell, John A. Moss, John C. Yang, Bassam M. Nakhle, Cheryl A. Slate,
Fabrice Odobel, Milan Sykora, Bruce W. Erickson, and Thomas J. Meyer. Sensitization
of TiO <sub>2</sub> by Phosphonate-Derivatized Proline Assemblies. Inorganic
Chemistry, 38(16):3665–3669, 1999.
[204] Erwin Reisner, Daniel J. Powell, Christine Cavazza, Juan C. Fontecilla-Camps,
and Fraser A. Armstrong. Visible Light-Driven H <sub>2</sub> Production by
Hydrogenases Attached to Dye-Sensitized TiO <sub>2</sub> Nanoparticles. Journal
of the American Chemical Society, 131(51):18457–18466, 2009.
[205] Wenchao Sheng, Hubert a. Gasteiger, and Yang Shao-Horn. Hydrogen Oxidation and
Evolution Reaction Kinetics on Platinum: Acid vs Alkaline Electrolytes. Journal of The
Electrochemical Society, 157(11):B1529, 2010.
[206] Graham A. Rance and Andrei N. Khlobystov. Nanoparticle-nanotube electrostatic
interactions in solution: The effect of pH and ionic strength. Physical Chemistry Chemical
Physics, 12(36):10775–10780, 2010.
[207] Alexander F. Mason, Bastiaan C. Buddingh’, David S. Williams, and Jan C. M. van Hest.
Hierarchical Self-Assembly of a Copolymer-Stabilized Coacervate Protocell. Journal of
the American Chemical Society, 139(48):17309–17312, dec 2017.
[208] N. Amy Yewdall, Bastiaan C. Buddingh, Wiggert J. Altenburg, Suzanne B. P. E.
Timmermans, Daan F. M. Vervoort, Loai K. E. A. Abdelmohsen, Alexander F. Mason, and
Jan C. M. van Hest. Physicochemical Characterization of Polymer-Stabilized Coacervate
Protocells. ChemBioChem, pages 1–11, 2019.
[209] Fatma Pir Cakmak, Alex T. Grigas, and Christine D. Keating. Lipid Vesicle-Coated
Complex Coacervates. Langmuir, 35(24):7830–7840, 2019.
[210] Fabian Axthelm, Olivier Casse, Willem H. Koppenol, Thomas Nauser, Wolfgang Meier,
and Cornelia G. Palivan. Antioxidant nanoreactor based on superoxide dismutase
encapsulated in superoxide-permeable vesicles. Journal of Physical Chemistry B,
112(28):8211–8217, 2008.
BIBLIOGRAPHY 163
[211] Lisanne M.P.E. Van Oppen, Loai K.E.A. Abdelmohsen, Sjenet E. Van Emst-De Vries,
Pascal L.W. Welzen, Daniela A. Wilson, Jan A.M. Smeitink, Werner J.H. Koopman,
Roland Brock, Peter H.G.M. Willems, David S. Williams, and Jan C.M. Van Hest.
Biodegradable Synthetic Organelles Demonstrate ROS Shielding in Human-Complex-I-
Deficient Fibroblasts. ACS Central Science, 4(7):917–928, 2018.
[212] Dennis M. Vriezema, Paula M.L. Garcia, Nu´ria Sancho Oltra, Nikos S. Hatzakis,
Suzanne M. Kuiper, Roeland J.M. Nolte, Alan E. Rowan, and Jan C.M. Van Hest. Positional
assembly of enzymes in polymersome nanoreactors for cascade reactions. Angewandte
Chemie - International Edition, 46(39):7378–7382, 2007.
[213] Dominik Dobrunz, Adriana C. Toma, Pascal Tanner, Thomas Pfohl, and Cornelia G.
Palivan. Polymer nanoreactors with dual functionality: Simultaneous detoxification of
peroxynitrite and oxygen transport. Langmuir, 28(45):15889–15899, 2012.
[214] Hailong Che, Shoupeng Cao, and Jan C.M. Van Hest. Feedback-Induced temporal control
of ”breathing” polymersomes to create self-adaptive nanoreactors. Journal of the American
Chemical Society, 140(16):5356–5359, 2018.
[215] Fei Peng, Nan Nan Deng, Yingfeng Tu, Jan C.M. Van Hest, and Daniela A. Wilson.
Continuous fabrication of polymeric vesicles and nanotubes with fluidic channels.
Nanoscale, 9(15):4875–4880, 2017.
[216] Ryuji Kawano, Yutaro Tsuji, Koji Sato, Toshihisa Osaki, Koki Kamiya, Minako Hirano,
Toru Ide, Norihisa Miki, and Shoji Takeuchi. Automated parallel recordings of
topologically identified single ion channels. Scientific Reports, 3(Dcm):1–7, 2013.
[217] Olivier Biner, Thomas Schick, Yannic Mu¨ller, and Christoph von Ballmoos. Delivery of
membrane proteins into small and giant unilamellar vesicles by charge-mediated fusion.
FEBS Letters, 590:2051–2062, 2016.
[218] Supramaniam, Ces, and Salehi-Reyhani. Microfluidics for Artificial Life: Techniques for
Bottom-Up Synthetic Biology. Micromachines, 10(5):299, 2019.
[219] Jeanne C Stachowiak, David L Richmond, Thomas H Li, Allen P Liu, Sapun H Parekh,
and Daniel a Fletcher. Unilamellar vesicle formation and encapsulation by microfluidic
jetting. Proceedings of the National Academy of Sciences of the United States of America,
105(12):4697–702, 2008.
BIBLIOGRAPHY 164
[220] Kei Funakoshi, Hiroaki Suzuki, and Shoji Takeuchi. Formation of giant lipid vesiclelike
compartments from a planar lipid membrane by a pulsed jet flow. Journal of the American
Chemical Society, 129(42):12608–12609, 2007.
[221] Michaela A. Teravest and Caroline M. Ajo-Franklin. Transforming exoelectrogens for
biotechnology using synthetic biology. Biotechnology and Bioengineering, 113(4):687–
697, 2016.
[222] Yoon Sung Nam, Taeho Shin, Heechul Park, Andrew P Magyar, Katherine Choi,
Georg Fantner, Keith A Nelson, and Angela M Belcher. Virus-Templated Assembly
of Porphyrins into Light-Harvesting Nanoantennae. Journal of the American Chemical
Society, 132(5):1462–1463, feb 2010.
[223] Yoon Sung Nam, Andrew P Magyar, Daeyeon Lee, Jin-woong Kim, Dong Soo Yun,
Heechul Park, Thomas S. Pollom, David A Weitz, and Angela M Belcher. Biologically
templated photocatalytic nanostructures for sustained light-driven water oxidation. Nature
Nanotechnology, 5(5):340–344, may 2010.
[224] Kai Liu, Ruirui Xing, Yongxin Li, Qianli Zou, Helmuth Mo¨hwald, and Xuehai Yan.
Mimicking Primitive Photobacteria: Sustainable Hydrogen Evolution Based on Peptide-
Porphyrin Co-Assemblies with a Self-Mineralized Reaction Center. Angewandte Chemie
International Edition, 55(40):12503–12507, sep 2016.
[225] Kai Liu, Manzar Abass, Qianli Zou, and Xuehai Yan. Self-assembly of biomimetic
light-harvesting complexes capable of hydrogen evolution. Green Energy & Environment,
2(1):58–63, 2017.
[226] Jae Hong Kim, Minah Lee, Joon Seok Lee, and Chan Beum Park. Self-Assembled Light-
Harvesting Peptide Nanotubes for Mimicking Natural Photosynthesis. Angewandte Chemie
International Edition, 51(2):517–520, jan 2012.
[227] Xiaoyuan Ji, Yong Kang, Zhiguo Su, Ping Wang, Guanghui Ma, and Songping Zhang.
Graphene Oxide and Polyelectrolyte Composed One-Way Expressway for Guiding
Electron Transfer of Integrated Artificial Photosynthesis. ACS Sustainable Chemistry &
Engineering, 6(3):3060–3069, mar 2018.
[228] Wooyul Kim, Beth Anne McClure, Eran Edri, and Heinz Frei. Coupling carbon dioxide
reduction with water oxidation in nanoscale photocatalytic assemblies. Chemical Society
Reviews, 45(11):3221–3243, 2016.
